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Abstract 
Previous studies have identified the Notch signalling pathway as an important 
regulator of haematopoietic development. However its role in definitive 
haematopoietic stem cell (dHSC) development is still unclear mainly due to the fact 
that Notch mutants die around mid- gestation before the emergence of the first dHSC. 
Here I investigated the role of the Notch signalling pathway in dHSC development 
focusing on the ligand Jaggedl and the receptor Notchl. I carried out a detailed 
characterisation of the expression pattern of Notchl and Jaggedl in the aorta- gonad- 
mesonephros (AGM) region, where dHSCs first emerge in the embryo, by 
immunocytochemistry and immunohistochemistry. I then determined, by sorting 
cells from the AGM region based on their level of Notchl, that Notchl was highly 
expressed in endothelial cells, precursors of dHSCs (called pre -HSC) and dHSCs, 
and its expression then decreases in haematopoietic progenitors. 
I also generated a Jaggedl dtTomato knock -in reporter mouse using a combination of 
recombineering and traditional cloning to produce a targeting vector, followed by 
targeting a B16 ES cell line, and producing a mouse line from a correctly targeted ES 
cell clonal line. This mouse line allowed me to visualise Jaggedl expression during 
dHSC development. With the line I showed that pre -HSCs express both Jaggedl and 
Notchl and that Jaggedl+Notchl+ cell surface marker phenotype can enrich the pre - 
HSC population 1 in 8. 
To further investigate the implication of Jaggedl in dHSC development the gene was 
conditionally deleted in the HSC lineage using a CD41 -Cre. Our result indicated that 
Jaggedl is not required for HSC development in a cell autonomous manner. 
Furthermore, I carried out experiments with a conventional Jaggedl knock -out 
mouse line. It has previously been shown that Jaggedl null embryos die around 
E10.5 and contain fewer intra- haematopoietic progenitors. I used an explant culture 
system to culture E10.5 AGM regions from Jaggedl-- embryos past the point of 
embryo lethality and in culture HSCs were produced. This result indicates that 
Jaggedl"- embryos contain pre -HSCs that can mature efficiently into dHSC in vitro. 
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Lay Summary 
In adult organisms all blood cells are derived from blood stem cells, called 
Haematopoietic Stem Cells (HSC). In the mouse the first HSC emerge in the main 
artery of the embryo around mid- gestation. The appearance of HSCs in the embryo 
results from the expansion and maturation of precursors that are called pre -HSCs. A 
cell signalling pathway, called Notch, has previously been shown to play an 
important role in the formation of the blood system in the mouse embryo. However 
its exact role in HSC formation is still unclear. The aim of my project is to determine 
the roles of two important molecules involved in the Notch pathway, Jaggedl and 
Notchl, during HSC development. First I showed that Notchl is expressed by cells 
involved in the development of HSCs and that the levels of Notchl expression 
decreases as the cells get closer to becoming mature blood cells. Then I created a 
reporter mouse line in which we can easily detect cells expressing Jaggedl. Using 
this mouse I showed that pre -HSCs express both Notchl and Jaggedl. Finally to 
further investigate the role of Jaggedl in the development of HSCs, I used a mouse 
line that is deficient for Jaggedl. The mutant embryos are defective and die before 
the first HSC develops. To overcome this problem, the embryos were harvested 
before their death and they were cultured for a few days. The results of this 
experiment showed that even in absence of Jaggedl pre -HSCs are present in the 
embryos and can mature efficiently into HSCs during the culture. Altogether I 
showed that even though Jaggedl is expressed by the HSC lineage in the mouse 
embryo, it is dispensable for their development. 
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1 Introduction 
1.1 Stem Cells 
The first studies of stem cells started over 40 years ago with the works of Stevens, 
Pierce, and Kleinsmith on teratocarcinomas, and Till and McCulloch on 
haematopoietic stem cells (HSCs) (Kleinsmith & Pierce Jr 1964; Till & McCulloch 
1961). Since then, many studies to characterise different populations of stem cells 
have been carried out and the concept of stem cells has evolved. A consensual 
definition of stem cells has arisen based on their functional properties: A stem cell 
(SC) is defined as an undifferentiated cell that possesses the ability to self -renew and 
differentiate to give rise to multiple mature and functional cell types. The process of 
differentiation occurs when cells mature into a cell type with a more distinct form 
and function. Cells undergo self -renewal by dividing and maintaining the 
undifferentiated state, stem cells can replicate for the life of the organism. Stem cells 
differentiate into functional cell types through intermediate cells type called 
progenitors. Progenitors have a more limited self -renewal capacity and more limited 
differentiated potential than their parent cell and are a step further towards becoming 
fully differentiated cells. 
It is possible to classify stem cells based on their differentiation potential: 
- Pluripotent stem cells can give rise to all cell lineages from all 3 germ layers 
(endoderm, mesoderm, and ectoderm). Some examples of pluripotent stem cells 
include: embryonic stem (ES) cells; epiblast stem cells (EpiSC); and induced 
pluripotent stem (iPS) cells. These cells can also be maintained in an undifferentiated 
state in vitro and used as a source for the production of differentiated cells. ES cells 
are derived from the inner cell mass of the pre -implantation developing blastocyst 
(Evans & Kaufman 1981; Martin 1981; Thomson et al. 1998). Induced pluripotent 
stem cells (iPS cells) are produced in vitro from differentiated adult cells by enforced 
gene expression (Takahashi & Yamanaka 2006; Yu et al. 2007). These cells are 
pluripotent like ES cells and present an exciting opportunity for the production of 
patient tailored cells for treatment and drug discovery. EpiSC are derived from the 
post -implantation embryo (Tesar et al. 2007; Brons et al. 2007). 
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- Multipotent stem cells have the capacity to differentiate into multiple cell types that 
constitute a tissue. For instance HSC are multipotent as they can give rise to all blood 
cells. 
- Oligopotent/Unipotent stem cells generate a small number or only one cell type in a 
tissue for example satellite cells in the muscle (Sacco et al. 2008). 
Multipotent /Oligopotent/Unipotent stem cells are also called tissue specific stem 
cells and differentiate to regenerate the specialised cells of that tissue during the 
lifespan of the individual. 
However, stem cells do not always play a physiological role. In 1994 it was 
discovered that human acute myeloid leukaemia was transplantable (Lapidot et al. 
1994) and the concept of a cancer stem cell (CSC) arose. It is thought that many 
cancers arise through a hierarchy of differentiation with a CSC at the top, similar to 
how normal tissue is maintained. A CSC is defined as "a cell within a tumour that 
possesses the capacity to self -renew and to cause heterogeneous lineages of cancer 
cells that comprise that tumour ". It is thought that in that majority of cases CSCs 
arise from the accumulation of mutations in normal stem cells leading to their 
transformation. Like normal stem cells they are difficult to phenotypically define, 
and isolate, and understanding of the process is further complicated by a possible 
"dynamic sternness" of non -CSC in a tumour under certain conditions. It is however 
clear that understanding the process of tumour production and targeting of CSC in 
cancer therapy are very important factors in cancer therapeutics (reviewed in 
Sugihara & Saya 2013). 
Understanding the processes involved in stem cell generation, self -renewal, and 
differentiation therefore has important applications in regenerative medicine, and 
cancer studies. The remainder of this introduction will focus on haematopoietic stem 
cells (HSC). 
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1.2 Adult HSC 
1.2.1 HSC and Haematopoiesis 
The adult HSCs maintain the adult blood system throughout the life of the organism, 
in both steady and stressed states, through a process called haematopoiesis. This is 
achieved by producing different haematopoietic progenitors which contribute to all 
blood cells lineages through a hierarchy of differentiation, as a multi -step process, of 
which one simplified version is shown in figure 1.1. This process is well defined in 
mammals due to the characterization of immunophenotypic markers, the existence of 
powerful in vitro and in vivo functional tests, and the use of genetic tools. 
Downstream of HSCs in the adult haematopoietic hierarchy a heterogeneous 
population of multipotent progenitors (MMPs) still possess multilineage 
differentiation potential but lack unlimited self -renewal ability. Further downstream 
of MMPs, common lymphoid progenitors (CLP) and common myeloid progenitors 
(CMP) possess limited self -renewal capacity and their differentiation potential is 
restricted to the lymphoid and myeloid lineages respectively. Through a range of 
intermediate progenitors which are progressively more lineage restricted and less 
able to self -renew CLPs give rise to mature lymphocytes (B cells, T cells and NK 
cells) and CMPs give rise to erythrocytes, platelets, granulocytes (neutrophils, 
basophils, eosinophils) and monocytes (when within tissues called macrophages). 
(Reviewed by (Seita & Weissman 2010)) This hierarchy has been shown to be 
flexible with other route of differentiation possible. 
The HSC population is quite heterogeneous. Some HSCs remain quiescent in the 
bone marrow and rarely divide or differentiate, some HSCs give rise to more 
myeloid lineages than lymphoid and vice versa (Challen et al. 2010; Dykstra et al. 
2007; Müller- Sieburg et al. 2002; Sieburg et al. 2006; Oguro et al. 2013). Thanks to 
functional assays described in the next paragraph, it has been shown that there is 
approximately 1 HSC in 10,000 nucleated murine bone marrow cells and that HSCs 
are highly enriched in the Liri Scal +c- kit +CD150 +CD48 "CD34"Flt3" population (Kiel 
et al. 2005; Kumaravelu et al. 2002; Osawa et al. 1996; Spangrude et al. 1989; 
Wilson et al. 2008; Boyer et al. 2011). Lineage negative (Lin -) refers to the exclusion 
of cells expressing known markers of lineage committed haematopoietic cells and 
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can include: CD3, CD4, CD5, CD8, B220, Grl, Macl and Ter119 (Boyer et al. 
2011). However, we still cannot identify with certainty an individual HSC based only 
on the expression of its immunophenotypic markers. This is an important 
experimental limitation when trying to isolate HSCs by fluorescence activated cell 
sorting (FACS) or visualize them in their niche. 
1.2.2 Assessment of HSC activity 
HSC were initially characterized based on their capacity to generate colonies on the 
spleen of irradiated mice after transplantation (Till and McCulloch, 1961; Wu et al., 
1968). However these cells, called colony -forming unit- spleen (CFU -S), are 
progenitors that are more mature than HSCs (Purton & Scadden 2007). The gold 
standard assay to identify a HSC is to show engraftment after transplantation into 
irradiated adult recipients. This shows the HSC is able to home to the bone marrow, 
engraft, regenerate, and contribute to all the blood cell lineages in the recipient 
(Harrison 1980). Subsequent transplantation of the bone marrow of recipient mice 
into secondary recipients and detection of cells derived from the primary donor show 
the capacity of the HSC to self -renew (they can be transplanted 5 or 6 times) 
(Lemischka et al. 1986). Large numbers of tested HSCs can be transplanted without 
carrier cells, such as secondary transplantation of bone marrow. However, 
transplantation is usually carried out with co- transplanted competitor /carrier cells 
HSCs which are distinguishable from the recipient and test donor cells. These carrier 
cells have two purposes: firstly, to provide short-term haematopoiesis to the recipient 
before HSC engraftment, and secondly, they can be used to measure the ability of the 
test HSCs to engraft and survive relative to the competitor HSCs (competitive 
repopulating units (CRU). Limiting dilution studies can be carried out to estimate the 
number of HSCs in a sample using Poisson statistics (Szilvassy et al. 1990). The 
CD45.1/CD45.2 system can be used to distinguish donors, recipients and carrier 
cells. (Reviewed (Purton & Scadden 2007; van Os et al. 2004)) 
Other less reliable methods for HSC assessment include in vitro clonogenic growth 
assays: the cobblestone area- forming cells (CAFC) and long -term culture- initiating 
cell (LTC -IC) co- culture systems. The frequency of day 28 CACFs correlates well 
with HSCs though interlaboratory variability of these assays is observed due to the 
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use of different feeder layers (Reviewed (Purton & Scadden 2007; van Os et al. 
2004)). 
The colony -forming cell culture (CFU -C) assay uses commercially available 
methylcellulose -based culture medium, to assess the presence of myeloid lineage 
restricted progenitors, by the formation of colonies of haematopoietic cells in culture. 
The colony types formed after 10 days culture include: BFU -E: burst forming unit 
erythroid; CFU -Mac: colony -forming cell macrophage; CFU -GM: granulocyte, 
macrophage; CFU -GEMM: granulocyte, erythroid, macrophage, megakaryocyte. B 
and T cell production can be assessed from haematopoietic progenitors by co- culture 
with cell lines (Whitlock & Witte 1982; Schmitt & Zúfiiga- Pflücker 2002). 
The mechanisms that regulate HSC functions are complex and the next sections will 
briefly discuss some examples of intrinsic and extrinsic processes that together 
permit the coordination of HSC activity with the physiologic needs of the individual. 
1.21 The role of the niche 
HSC reside in the bone marrow in close association with the endosteum and also are 
found adjacent to sinusoidal blood vessels. Endosteum residing osteoblasts and 
osteoclasts, sinusoidal endothelial cells, and perivascular cells have all been shown to 
be involved in HSC maintenance. Experiments which lead to an increase in 
osteoblast numbers resulting in an increase in HSCs (Calvi et al. 2003). Ablation of 
osteoblasts using Co12.3A -TK transgenic mice resulted in decreased haematopoietic 
cells and haematopoietic progenitors (Zhu et al. 2007; Visnjic et al. 2004), however, 
using a biglycan- deficient (reduced osteoblasts) transgenic line showed no defects in 
HSC frequency or haematopoiesis (Kiel et al. 2007). Therefore the role of osteoblast 
in HSC maintenance and haematopoiesis remains unclear. Ablation of perivascular 
nestin- expressing mesenchymal stem cells (Nest MSC) also reduced the number of 
LTR -HSCs (Méndez- Ferrer et al. 2010) and a very recent study showed that deletion 
of Jagged I in bone marrow endothelial cells resulted in HSC exhaustion (Poulos et 
al. 2013). It is not known exactly through which mechanisms these cells regulate 
HSCs, by direct cell contact, secreted factors, or actions on intermediate cells. For 
example the cytokine CXCL12 is known to be important in HSC homeostasis 
through its activation of CXCR4. It is expressed by many cells in the bone marrow 
14 
including osteoblasts, perivascular CXCL12- abundant reticular cells (CAR cells) 
(Sugiyama et al. 2006), and perivascular mesenchymal progenitors. This means it is 
unclear which cell type is the effector CXCL12 function on HSCs or if all the cells 
expressing CXCL12 play a role. Whether these cell types constitute separate 
microenvironments or cooperate as part of one HSC niche is unclear. It is likely that 
different factors play a role at different stages of HSC quiescence, self -renewal and 
differentiation. The HSC niche remains and unresolved open question. Other factors 
known to be important in HSC homeostasis found in the niche include: angiopoieitn 
(Arai et al. 2004) secreted by osteoblast and perivascular cells; Cat+ ions released 
from bone by osteoclasts; sonic hedgehog (SHH) (Trowbridge et al. 2006); 
Osteopontin produced by osteoblasts (Nilsson et al. 2005); stem cell factor (SCF) 
(Bowie et al. 2007); Thrombopoieitin expressed by osteoblasts (Kaushansky 2003); 
oxygen tension mediated through HIFla (Takubo, et al. 2010); and sheer force. The 
various components of the bone marrow HSC niche are summarised in figure 1.2. 
(Reviewed in (Wang & Wagers 2011; Kiel & Morrison 2008)). 
It is thought that long -term repopulating haematopoietic stem cells (LTR -HSC) only 
arise during development de novo. The next part of the introduction will describe the 
mechanisms involved in the generation of HSC, focusing on the mouse model. 
Determining the many factors involved in the ontogeny and maintenance of HSCs 
has important implications, such as use in developing an in vitro system for the 
production of HSC, progenitors and mature blood cells from alternative sources 
(such as ES cells and iPS cells) for clinical use, and to develop a better understanding 
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Figure 1.1: Adult haematopoietic hierarchy. 
All blood cells are derived from HSCs through a series of downstream progenitors. 
LT -HSC: long -term haematopoietic stem cell; MPP: multipotent progenitor; CMP: 
common myeloid progenitor; CLP: common lymphoid progenitor; MEP: 
megakaryocyte /erythroid progenitor; GMP: granulocyte- macrophage progenitor; 
CD135: also known as FLK2 and FLT3; IL -7R: interleukin -7 receptor; lin: lineage 
markers (which are a combination of markers found on mature blood cells but not 
HSCs or progenitors); NK: natural killer; SCA1: surface cell antigen 1. Adapted 
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Figure 1.2: Components of the HSC 
niche in adult bone marrow. 
The niche consists of supportive factors 
for HSC renewal and differentiation. 
These factors include cells, cytokines, 
cell adhesion molecules and physical 
factors. 
CAR, CXCL12- abundant reticular; 
GPCR, G protein -coupled receptor; MPP, 
multipotent progenitor; MSC, 
mesenchymal stem cell; RTK, receptor 
Tyr kinase. 
From (Wang & Wagers 2011). 
16 
1.3 Haematopoietic development 
Haematopoiesis occurs in the embryo in different tissues including the yolk sac (YS), 
aorta -gonad -mesonephros (AGM) region, placenta and fetal liver (FL). There are two 
distinguishable waves of haematopoiesis: embryonic haematopoiesis, which 
generates a transitory hematopoietic cell population and definitive haematopoiesis 
that occurs later during development from dHSCs. These are distinguished by 
genetic control and lineage output. Early embryonic haematopoiesis is summarized 
in figure 1.3. 
1.3.1 Embryonic haematopoiesis 
The first wave of haematopoiesis, the embryonic wave, begins in the yolk sac (YS) 
where differentiated primitive nucleated erythrocytes and progenitors of primitive 
macrophages and megakaryocytes arise from E7.5 in the YS blood islands (Moore & 
Metcalf 1970; Silver & Palis 1997). The role of these primitive blood cells is to 
support blood function during embryonic development before the emergence of 
HSCs. Hematopoietic cells produced by progenitors in the YS differ from their adult 
counterparts: The primitive erythrocyte is nucleated and synthesizes embryonic 
haemoglobins such as globin (Leder et al. 1992), primitive macrophages undergo 
accelerated maturation and synthesize a different set of enzymes compared to adult 
macrophages (Naito et al. 1996), primitive megakaryocytes produce platelets at an 
accelerated rate and have a reduced ploidy (Xu M et al. 2001). 
Later the YS can also produce progenitors with an adult blood cell output as 
demonstrated by the ability of eyrthroid progenitors to contribute to definitive 
erythropoiesis after activation of the EpoR (erythropoietin receptor) (Lee et al. 2001). 
Haematopoietic progenitors of the erythroid myeloid lineage are found in the 
allantois at E7.5, the YS at E8.25, and the placenta at E9.0 (Dzierzak & Speck 2008; 
Alvarez -Silva et al. 2003). Multipotent progenitors are found in the para -aortic 
splanchnopleura (P -Sp) region at E7.5 (Dzierzak & Speck 2008). CFU -S are found in 
the YS and aorta- gonads -mesonephros (AGM) at E9.0 (Medvinsky et al. 1993). The 
liver does not generate haematopoietic cells de novo, it is colonized at E9 with 
haematopoietic cells from other tissues (Johnson & Moore 1975). 
17 
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I I I 
E7.5 E8.5 E9.5 
I i I I 
Onset of 
I I 1 
E10.5 E11.5 E12.5 Birth 




Figure 1.3 Summary of haematopoietic emergence in the embryo. 
Haematopoiesis begins in the YS at E7.5 with the emergence of primitive 
erythrocytes and macrophages through primitive haematopoiesis. After the onset of 
circulation at E8 multipoent progenitors are detected in the P -Sp, YS, fetal liver and 
placenta. Pre -HSCs are detected in the E9 P -Sp and YS by transplantation of 
condition newborns at E9. Adult repopulating HSCs are first detected in the AGM 
region around E10.5 -11.5 and subsequently in the YS, placenta and fetal liver. HSC 
eventually migrate to the bone marrow where they reside for the life of the organism. 
YS: yolk sac; P -Sp: para -aortic splanchnopleura; FL: fetal liver; CFU -S: colony 
forming unit spleen. 
18 
1.3.2 Emergence of dHSCs / Definitive Haematopoiesis 
Definitive haematopoiesis is marked by the emergence of the first HSCs in the 
embryo. Investigating the development and the source of HSCs has been a 
challenging task notably because haematopoietic cells are scattered throughout the 
organism and multiple sites of hematopoietic activity exist in the embryos. At E11.5 
the AGM, the YS and the placenta each contain approximately one HSC. 
1.3.2.1 AGM region 
The first adult repopulating, multilineage, LTR -HSCs are autonomously generated in 
the AGM at around day E10.5 of gestation (Medvinsky & Dzierzak 1996; Muller et 
al. 1994). At this stage the AGM region is capable of autonomous initiation and 
expansion of HSCs indicating its crucial role in HSC development. By E11.5 the 
AGM region contains one HSC, and between E11.5 and E12.5 HSCs are generated at 
an extremely high rate via maturation of HSC precursors called pre -HSC type I 
(CD41' °CD45-VE- Cadherin +) and pre -HSC type II (CD45+VE- Cadherin +) 
populations (Kumaravelu et al. 2002; Taoudi et al. 2008; Rybtsov et al. 2011). 
Subsequently HSCs are found in the foetal liver and eventually the bone marrow 
(Medvinsky & Dzierzak 1996; Muller et al. 1994; Gekas et al. 2005; Ottersbach & 
Dzierzak 2005). 
More specifically, HSCs arise in the dorsal aorta of the AGM region, in the ventral 
domain and the developing aorta maintains a polarity that is important in HSC 
emergence (Taoudi & Medvinsky 2007; de Bruijn et al. 2000). Haematopoietic intra- 
aortic clusters (HIAC), which are clusters of haematopoietic precursors within the 
lumen of the major arteries, are first detected in the ventral part of the main arteries 
(aorta, vitelline and umbilical arteries) (de Bruijn et al. 2000) at E10.5 (Garcia - 
Porrero et al. 1995). HIAC are shown to express markers of the haematopoietic 
lineage such as CD41 and CD45, and express factors that are required for 
haematopoiesis in the embryo such as Runxl, c -myb and GATA2 (Godin & Cumano 
2002). The size and number of HIACs peak when the number of haematopoietic 
progenitors in the AGM (Godin et al. 1999) peaks, and at this stage, precursors 
become detectable in the blood stream (Delassus & Cumano 1996). 
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1.3.2.2 Yolk Sac 
As the yolk sac is the first site of haematopoiesis it was suggested to be the site of 
HSC development. However experiments performed producing chicken/quail 
chimeras by grafting chick YS onto quail embryos showed that in the avian model 
the adult haematopoietic hierarchy is derived from the intra- embryonic region 
(Dieterlen -Lievre 1975). This grafting strategy is not currently possible for mouse 
embryos but transplantation of cultured pre -circulatory (E8) YS and P -Sp region into 
adult immunodeficent mice showed long -term multilineage engraftment from P -Sp 
only (Cumano et al. 2001) indicating that the P -Sp has HSC potential before YS 
precursors can migrate there through blood flow. In addition, CFU -S from the E9.5 
P -Sp region are significantly higher than in YS at the same stage (Medvinsky et al. 
1993). These results indicate that the definitive haematopoietic system does not have 
a YS origin but it cannot yet be ruled out that early precursors of definitive 
haematopoiesis, which are not detectable by these assays, arise in the YS. Yoder and 
colleagues showed that injection of E9 YS into conditioned newborns gave rise to 
long -term mulitlineage engraftment suggesting the presence of pre -HSCs (Yoder et 
al. 1997). Culture of Ell YS shows only one HSC before and after culture indicating 
that it is unable to expand HSCs or mature pre -HSCs, if present at this stage 
(Kumaravelu et al. 2002). This haematopoietic activity is observed after the onset of 
circulation and it is therefore unclear whether YS can autonomously generate pre - 
HSCs and HSCs. It is however clear that the P -Sp /AGM region has far greater 
multilineage long term repopulation potential than the YS. 
1.3.2.3 Placenta 
The placenta is a major site of haematopoiesis in the embryo containing multilineage 
progenitors from around E9 and from E 10 onwards, containing higher numbers of 
haematopoietic progenitors than found in the YS (Alvarez -Silva et al. 2003). High 
level repopulating HSC activity is detected in the placenta, around the time of HSC 
emergence in the AGM, approximately El1, and numbers increase dramatically 
between El1 and E12 (Gekas et al. 2005; Ottersbach & Dzierzak 2005). Ly -6A, 
CD34, and CD31 staining co- localise in the placenta and some of these cells are seen 
in the endothelium of the vascular of the placenta suggesting that HSCs emerge in 
the vasculature, as in the AGM (Ottersbach & Dzierzak 2005). Explant culture of 
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placenta was not able to produce HSCs suggesting that the placenta does not contain 
pre -HSCs and is colonised by HSC emerging elsewhere but it is possible that the 
explant organ culture systems used do not support placental pre -HSC maturation due 
to technical reasons (Robin et al. 2006; Ottersbach & Dzierzak 2005). In addition, 
experiments in embryos lacking a heartbeat (Nxcl) show multipotent haematopoietic 
cells in the placenta as early as E8.5, prior to the onset of circulation, though no 
transplantation experiments were done to assess if the placenta could autonomously 
produce HSCs (Rhodes et al. 2008). It therefore remains unclear whether the 
placenta can autonomously generate pre -HSCs and HSCs or if it is seeded by cells 
from other sites. 
1.3.3 Possible origins of dHSCs 
It has been shown that HSCs arise through the maturation of pre -HSCs but it is still 
unclear from where these cells originate and in what location the pre -HSC to HSC 
maturation takes place. Some possible theories, summarised in figure 1.4, are 
discussed further in this section. 
1.3.3.1 Identification of precursors of HSCs 
E9.5 P -Sp cells have been shown to give long term multilineage engraftment of 
conditioned newborns and Rag2yc t NK cell deficient, mice (Kumano et al. 2003; 
Kieusseian et al. 2012). These cells cannot however contribute to long term 
multilineage engraftment of adult irradiated recipients (Muller et al. 1994). After 
explant organ culture adult repopulating HSCs can be detected in E10 AGM region 
at higher numbers than found in uncultured AGM ( <1) (Muller et al. 1994; 
Medvinsky & Dzierzak 1996; Robin et al. 2006). These results indicated the 
existence of an immature "pre -HSC" population of cells that can mature into HSCs: 
in vivo; in certain in vitro conditions; or in a newborn/immunodeficient environment 
(discussed (Medvinsky et al. 2011). To further investigate these immature cells a re- 
aggregate culture system was developed in our lab (Taoudi et al. 2008). This 
technique involves the dissociation of an organ into a single cell suspension thus 
allowing manipulation of cell populations of interest before the cells are re- 
aggregated and cultured. Using this technique it was determined that the generation 
of HSCs that occurs in the E11.5 AGM regions is through the maturation of pre -HSC 
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Type II cells (CD45+VE- Cadherin+) (Taoudi et al. 2008). Investigation of earlier 
HSC precursors through a similar technique which involved co- aggregation of the 
populations of interest with OP9 cells, rather than AGM cells, showed that pre -HSC 
Type I cells (CD41 +CD45- VE- Cadherin+) mature to HSC through the pre -HSC Type 
II stage in hierarchical organised way (Rybtsov et al. 2011). Cells with the pre -HSC 
surface marker phenotype are found throughout the developing embryo, however, 
only those found in the AGM possess the ability to mature into HSCs. Identification 
of further surface markers of the pre -HSC is required. 
1.3.3.2 Haemangioblast 
The close association of the development of haematopoietic progenitors and 
angioblasts in the blood islands of the YS has led to the idea of the existence of a 
common progenitor termed the haemangioblast. The haemangioblast is a precursor 
that is restricted to differentiate into endothelial and haematopoietic cells (Sabin 
1920). The cells which give rise to endothelial cells, haematopoietic cells and smooth 
muscle cell are detected in the mouse during the mid- streak stage of gastrulation, 
these cells are mesoderm precursors rather than bi- potent haemangioblast (Huber et 
al. 2004). Blast colony forming cells which can give rise to haematopoietic colonies 
and vascular endothelium in the presence of certain cytokines have been isolated 
from ESC -derived embryoid bodies (EB) (Choi et al. 1998). However it is not clear 
that if certain culture conditions were met that smooth muscle cells would also be 
present, suggesting the cell is merely a mesodermal progenitor. In vivo lineage 
tracing of presumptive haemangioblasts is required to further investigate this 
hypothesis. 
1.3.3.3 Haematogenic Endothelium 
Haematogenic endothelium is thought to give rise to haematopoietic progenitors 
from differentiated endothelium by a transdifferentiation process that is dependent on 
Runxl. Experimental evidence that supports this hypothesis includes the close 
association of haematopoietic progenitors, in the HIAC, with endothelial cells (Smith 
& Glomski 1982) and the incorporation of fluorescent acetyl low- density lipoprotein 
(Ac- LDL -DiI) into haematopoietic progenitors and HSCs (Sugiyama et al. 2005). In 
addition, presumptive endothelial cells (CD45"Ter119-VE- Cadherin +) from E9.5 
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AGM and YS produced endothelial and haematopoietic cells in vitro and 
reconstituted newborn recipients (Nishikawa et al. 1998; Fraser et al. 2002). 
Presumptive haematogenic endothelium has been show to form in vitro from mouse 
ES cells (Eilken et al. 2009; Lancrin et al. 2009). Haematopoietic progenitors are 
also labelled by Cre recombinase expressed under the control of VE- Cadherin 
(Zovein et al. 2008) and removal of Runxl from cells of the VE- Cadherin lineage 
results in loss of HSC activity (Chen et al. 2009). However, this evidence does not 
take into account that the incorporation of acetyl low- density lipoprotein into a cell 
has not been shown to be endothelial specific, and that VE- cadherin has been shown 
to be a marker of pre -HSCs (Taoudi et al. 2008; Rybtsov et al. 2011). Pre -HSC Type 
I cells are CD45" which coincides with the endothelial populations studied in 
Nishikawa et al. 1998 and Fraser et al. 2002. As the pre -HSC Type I population also 
expresses CD41, a marker of the haematopoietic system, it cannot be considered 
purely endothelial (Medvinsky et al. 2011). In 2010 live imaging techniques of 
zebrafish and mouse explant cultures showed haematopoietic cells arising from the 
ventral part of the dorsal aorta and entering circulation (Kissa & Herbomel 2010; 
Boisset et al. 2010). These experiments relied on phenotypical identification of HSC 
and functional analysis of cells which emerge from the aorta in this manner is 
required to confirm HSCs arise from this process. 
1.3.3.4 Sub -aortic patches 
The sub aortic patches (SAPs) are mesodermal structures located below the aorta in 
E10.5 -E11.5 AGM. This model hypothesises that pre -HSCs, are generated below the 
aortic floor in SAPs. They then migrate up through the endothelium of aortic floor to 
integrate into the endothelium and form the HIAC before entering the circulation. 
The SAPs have been shown to reside below the ventral domain of the dorsal aorta 
(Manaia et al. 2000) and early haematopoietic progenitors have been shown to be 
present in the SAPs (Bertrand et al. 2005). Proteins involved in haematopoietic 
development such as BMP4 (bone morphogenic protein 4), GATA3 and AA4.1 are 
also present in the SAPs (Godin & Cumano 2002). In the absence of Runxl, which 
results in loss of HSC production, there are no SAPs present in the AGM (North et 
al. 1999). It has also been shown that at E11.5, some pre -HSC Type I reside in the 
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sub -endothelial layers, whereas pre -HSC Type II and dHSCs reside in the endothelial 
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Figure 1.4: Mechanisms of intra- aortic cluster formation. 
Representatives of ventral domain of aorta. A: Specialised endothelium in the ventral 
wall of the dorsal aorta called haematogenic endothelium produces haematopoietic 
cells. B: A bi- potent precursor called the haemangioblast produces endothelial cells 
and haematopoietic precursors which both integrate into the aorta endothelium. C: 
Haematopoietic precursors emerge in the sub -aortic mesenchyme and integrate or 
pass through the endothelium of the aorta. 
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1.3.4 Factors involved in the ontogeny of HSCs 
Disruption of genes and other external factors has revealed important information 
about the function of certain genes in the ontogeny of the haematopoietic system. 
The removal of genes that are important for primitive and defmitive haematopoiesis, 
results in embryonic death around E8.5- E10.5. Disruption of SCL and Lmo2, which 
have a role in the early stage of haematopoietic determination in the embryo, 
GATA1, which is required for final differentiation into an erythrocyte, and Flkl and 
Tie2, which are required for normal endothelial cell production, results in markedly 
reduced YS haematopoiesis and no following of definitive haematopoiesis (reviewed 
in Godin & Cumano 2002). Some genes when disrupted do not cause a significant 
disruption to primitive haematopoiesis but are essential for definitive haematopoiesis 
such as Runxl, GATA2, c -myb, CBFß and Notch (reviewed in Godin & Cumano 
2002). 
1.3.4.1 SCL 
The SCL gene is a basic helix -loop -helix (bHLH) transcription factor and is 
expressed in E7.5 blood islands and haematopoietic and vascular cells (Begley & 
Green 1999). SCL null embryos, which die in utero between E8.5 and E10.5, fail to 
initiate both primitive and definitive haematopoiesis shown by the absence of 
primitive erythrocytes and CFU -Cs (Robb et al. 1995; Shivdasani et al. 1995). In 
addition, SCL- /- ES cells do not contribute to adult haematopoiesis in chimeric mice 
(Porcher et al. 1996) suggesting an important role for SCL in haematopoietic 
commitment. 
Conditional inactivation of SCL in the adult revealed that SCL was dispensable for 
maintenance, engraftment, self -renewal and multilineage differentiation of LTR- 
HSCs (Mikkola et al. 2003). However, in a lyll /SCL conditional double knockout 
HSCs failed to repopulate irradiated recipients and underwent rapid apoptosis 
(Souroullas et al. 2009) indicating that lyll is essential for HSC function in the 
absence of SCL. Ly11 is a bHLH transcription factor that is highly related to SCL 
suggesting a functional redundancy between the two in HSC function. 
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1.3.4.2 Lmo2 
Lmo2 is a LIM- domain nuclear protein which functions as a bridging protein in SCL 
and GATA1 protein complexes (Warren et al. 1994). Lmo24" cells fail to undergo 
erythroid differentiation but can still produce myeloid cells, similar to the phenotype 
seen in GATA14" cells, suggesting primitive haematopoiesis is not completely 
abolished (Warren et al. 1994; Weiss et al. 1994). Lmo2 is expressed in the E8 -11 
aorta endothelium and HIACs, and Lmo24" ES cells are unable to contribute to 
definitive haematopoiesis in chimeras, suggesting a possible role for Lmo2 in HSC 
development (Yamada et al. 2000; Manaia et al. 2000). 
1.3.4.3 GATA2 
GATA2 is a zinc finger protein that influences cell fate in adult and developing 
HSCs. GATA2 is expressed in immature haematopoietic cells, and in the 
endothelium of the E9.5 -10.5 aorta, of the AGM region (Minegishi et al. 1999; 
Robert- Moreno et al. 2005; Robert- Moreno et al. 2008). Disruption of the GATA2 
gene results in embryonic lethality at around E10.5 and reduced expansion of 
haematopoietic lineages (Tsai et al. 1994). Conditional deletion of GATA2 in VE- 
Cadherin+ cells resulted in loss of FL HSCs (Lim et al. 2012). GATA24" ES cells fail 
to contribute to definitive haematopoiesis in the embryo or adult (Tsai et al. 1994). In 
addition, GATA2 +i" haploinsufficient embryos have impaired HSC 
expansion/maturation compared to wild -type (Ling et al. 2004). Therefore it is clear 
that GATA2 plays a role in HSC development but the mechanism of this action is 
unclear. 
1.3.4.4 GATA3 
GATA3 is from the GATA zinc finger protein family. GATA3 gene inactivation 
results in embryonic lethality around E11.75 -12.5 due to extensive internal 
haemorrhages, growth retardation and central nervous system malformations 
(Pandolfi et al. 1995). GATA3 has been shown to be expressed in the SAPs, which 
may be involved in HSC development (Yoon et al. 2008). In GATA34" embryos at 
E11.5 YS progenitors are unaffected while progenitors in the FL are markedly 
decreased suggesting a role in definitive but not primitive haematopoiesis (Pandolfi 
et al. 1995). However, GATA3 " ", RAG24" ES cells contribute to the myeloid and B- 
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cell lymphoid lineage in adult chimeras, but not the T -cell lineage, suggesting 
GATA3 is not an essential factor for HSC development but is required in T -cell 
differentiation (Ting et al. 1996). In GATA34- embryos no direct analysis of pre - 
HSCs or HSCs during HSC development has been carried out, therefore it is not 
clear if the process is dependent on GATA3 or what is it's role might be. 
1.3.4.5 C -myb 
C -myb is a DNA -binding, proto- oncogene. Disruption of the c -myb gene results in 
embryonic lethality at E15 due to a proliferative defect of immature progenitors 
which results in a failure of definitive haematopoiesis (Mucenski et al. 1991). 
1.3.4.6 Runx1 
Runxl (AML1, CBFa2) contains the Runt DNA -binding domain that can bind to 
many genes expressed in haematopoietic cells, such as genes encoding cell surface 
markers and is a subunit of the core -binding factor (CBF). CBF is a non DNA 
binding subunit of the CBF required for Runxl function and CBF(3 -'- embryos have a 
similar phenotype to Runxl mutants (Q Wang et al. 1996). Runxl is also involved in 
many oncogene translocations (Lam & Zhang 2012). 
Runxl is expressed in the ventral part of the dorsal aorta and in the under lying 
mesenchyme (North et al. 1999). Targeted deletion of the Runxl gene leads to 
haemorrhaging and embryonic lethality at around E12.5 (Qing Wang et al. 1996). YS 
haematopoiesis was normal but FL haematopoiesis is impaired (Qing Wang et al. 
1996). Runxl is necessary for the formation of intra -aortic clusters, LTR -HSCs 
express Runxl and Runxl is required for HSC generation (Cai et al. 2000; North et 
al. 1999). Runxl deletion in the adult bone marrow leads to a deregulation of the 
HSC pool and defects of downstream lineages (megakaryocyte and lymphoid 
differentiation) (Ichikawa et al. 2004; Kumano & Kurokawa 2010). 
The level of Runxl expression also plays a role in haematopoietic development and 
spatial and temporal patterns of HSC development are disrupted in Runx1+i" embryos. 
In Runx1+'- embryos HSC are readily detectable in the E10.5 AGM region and YS 
(Cai et al. 2000). This is in contrast to wild -type embryos where HSCs are infrequent 
in the AGM region and not found in the YS at E10.5 (Muller et al. 1994; Medvinsky 
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& Dzierzak 1996). In Runx1+i_ embryos HSCs are detected in the CD45- 
compartment at E10.5 and E11.5 (North et al. 2002). In wild -type they are only 
detected in the CD45+ compartment (Taoudi et al. 2005; North et al. 2002). This data 
led to the hypothesis that Runxl may be involved in the maintenance and 
differentiation of non -haematopoietic populations. 
Conditional Runxl knock -out with VE- Cadherin cre resulted in loss of HSCs and 
HIACs but use of Vav cre (expressed by early HSCs) resulted in normal HSC 
development (Chen et al. 2009). In addition to this data, experiments in vitro have 
shown that partial rescue of the haematopoietic programme is possible in cultured 
cells prepared from E9.5 but not E11.5 AGM by introduction of Runxl cDNA 
(Mukouyama et al. 2000). This data suggests a role for Runxl before HSC 
emergence in the VE- Cadherin+ populations possibly in the control of the endothelial 
to haematopoietic transition. 
1.3.4.7 ß- catenin 
(3- catenin is a downstream effector of canonical Wnt signalling pathway. Canonical 
Wnt signalling leads to the inhibition of f3- catenin destruction which then 
accumulates and enters the nucleus to activate gene specific transcription (Bigas et 
al. 2013). Experiments involving inhibition of 13- catenin activation in E10.5 and 
E11.5 AGM explant cultures showed that blocking of (3- catenin activation at E10.5 
but not at E11.5 inhibited HSC production (Ruiz -Herguido et al. 2012). In addition, 
deletion of 3- catenin in VE- Cadherin+ cells but not Vav+ cells led to a decrease in 
haematopoietic output from the E10.5 and E11.5 AGM region (Ruiz -Herguido et al. 
2012). These results suggest that like Runxl, 13- catenin may be involved in cell 
maintenance before HSC emergence and possibly in the haematopoietic to 
endothelial transition. In the adult, the role of (3- catenin in the adult remains unknown 
with conflicting reports of ß- catenin reduction causing HSC exhaustion or having no 
effect on HSC maintenance in the adult (reviewed in Bigas et al. 2013). 
1.3.4.8 Extrinsic factors involved in the ontogeny of HSCs 
Explant culture experiments indicated that ventral tissues (gut) induce AGM region 
HSC potential whereas dorsal tissues (neural tube and notochord) had a negative 
effect (Peeters et al. 2009). This highlights the importance of surrounding tissues in 
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the establishment of the dorso- ventral polarity in the dorsal aorta and their influence 
on HSC development (Jaffredo et al. 2013). BMP4 has been shown to be expressed 
in the ventral mesenchyme of the dorsal aorta (Durand et al. 2007; Pimanda et al. 
2007). The use of a BMP antagonist results in El() AGM region explant culture 
results in loss of HSC potential (Durand et al. 2007). In addition, the BMP pathway 
has also been shown to be connected to SCL and Runxl (Pimanda et al. 2007). This 
data suggests BMP4 as a critical extrinsic factor in HSC development and its ventral 
expression may be involved in establishing dorso- ventral polarity in the dorsal aorta. 
In zebrafish it has been established that Hedgehog is required for tbx20 expression in 
the dorsal side of the dorsal aorta conferring a non -haematopoietic fate to these cells 
(Gering & Patient 2005; Wilkinson et al. 2009). 
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1.4 Notch Signalling and hematopoietic development 
1.4.1 The Notch Signalling Pathway 
Notch signalling is an evolutionarily conserved system which controls cell fate and 
has been shown in all metazoans studied so far, in particular in Drosophila 
melanogaster (Portin 2002), Caenorhabditis elegans (Priess 2005), and vertebrates, to 
be mandatory in various developmental processes, including stem cell homeostasis, 
cell growth, cell differentiation, and survival (Koch et al. 2013). 
Notch signalling takes place through cell -to -cell contact. In mammals the Notch 
signalling pathway consists of four receptors Notch 1 -4 with ligands Jagged 1 and 2, 
and Delta -like 1, 3 and 4. The Notch receptor is a heterodimer consisting of 36 EGF- 
like repeats and Lin12 repeats linked non -covalently via a heterodimerization domain 
to a single pass transmembrane protein whose intra cellular domain consists of RAM 
(RBPjx Associate Molecule), Ankyrin repeats and a PEST domain. The Notch 
ligands are single pass transmembrane proteins that contain an extracellular 
Delta/Serrate /LAG -2 (DSL) domain, several EGF -like repeats and in the case of 
Jaggedl and 2 a cystein -rich region. Notch receptors undergo S1 cleavage in the 
golgi before transport to the cell membrane. In the canonical Notch signalling 
pathway the Notch receptor binds to a Notch ligand, on a neighbouring cell, the 
ectodomain is shed and this exposes the S2 cleavage site to the transmembrane 
ADAM -family metalloproteases. After S2 cleavage the S3 cleavage site is exposed 
to the multi pass membrane protein, y- secretase complex. These successive cleavages 
result in the release of the Notch intracellular domain (NICD) which translocates to 
the nucleus and interacts with the DNA -binding protein RBPjx and co- activator 
Mastermind to promote transcription of Notch target genes which encode 
transcriptional repressors of the Hairy and Hey- related families. In the absence of 
NICD, RBPjx recruits repressor complexes. Notch signalling is summarised in figure 
1.45 (From Reviews (Bray 2006; Fortini 2009; Fiuza & Arias 2007; Lai 2004)) The 
best characterised target genes of the Notch signalling pathway are the bHLH genes 
of the HES class (Bray 2006; Bigas & Espinosa 2012). In general they function as 
DNA binding transcription repressors and are involved in Notch actions that involve 
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the suppression of one cell fate to allow determination of an alternate fate (Bigas & 
Espinosa 2012). 
Differential gene expression of Notch receptors and ligands is not sufficient to 
explain the patterns of Notch activation in tissues and cells. Regulation of Notch 
activity involves precise post -translational modification of ligands and receptors. 
Notch ligand endocytosis is essential for ligand activation and is regulated by the E3 
ubiquitin ligases, Mind bomb (Mib) and Neuralized (Neur). Other factors controlling 
ligand activation include ligand localization within the cell and proteolytic cleavage 
that may down regulate the Notch ligands. Production of a functional Notch receptor 
relies on the enzyme 0-fucosyl transferase (O -fut) to glycosylate an EGF repeat and 
chaperone protein folding during Notch receptor processing in the endoplasmic 
reticulum. Further glycosyl- modifications by members of the glycosyl -tranferase 
family Fringe affect binding affinity of different ligands to the Notch receptor. 
Therefore regulation of Notch signalling can occur through the control of the 
enzymes involved in the post -translational modification of Notch receptors and 
ligands as well as the enzymes involved in the proteolytic cleavage of the Notch 
receptor during activation. (From Reviews (Bray 2006; Fortini 2009; Fiuza & Arias 
2007; Lai 2004)) 
Notch has various modes of action. These include lateral inhibition, lineage decisions 
and boundary induction (figure 1.6). Lateral inhibition occurs when cells with the 
same potential are induced to different fates due to slight changes in the equilibrium 
of Notch signalling, one cell commits to a specialized fate and inhibits surrounding 
cells from adopting this fate. Lineage decisions between two daughter cells can be 
dependent on inheritance of Notch signalling pathway components. Asymmetrical 
division may lead to higher Notch activation in one daughter cell than in another and 
therefore direct the daughter cells to different fates. Another role of Notch is to 
promote the development of a cell type or body region, often by inducing the 
expression of positively acting regulatory molecules. In many of these cases, Notch 
signalling creates a new cell type as a result of cell -cell interactions at the boundary 
between distinct cell populations. (From Reviews (Bray 2006; Fortini 2009; Fiuza & 
Arias 2007; Lai 2004)) 
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1: Ligand binds to 
Notch receptor 
2: Endocytosis of 
ligand exposes 52 
cleavage site to 
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secretase and the 
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Figure 1.5: Schematic representation of the Notch Signalling pathway. 
ADAM: a desintegrin and metallopeptidase; NICD: Notch intra- cellular domain. 
Adapted from (Bray 2006). 
Notch receiving cell 
Notch sending cell 
Notch signalling 
Notch receptors 
Figure 1.6: Different modes of Notch action. 
A: Lateral inhibition. Notch signalling amplifies small difference between roughly 
equivalent cells that resolves cells into distinct cell fates. B: Lineage decisions. 
Asymmetrical inheritance of Notch signalling components can determining lineage 
output of daughter cells. Adapted from (Bray 2006). 
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1.4.2 The role of Notch signalling in adult haematopoiesis 
It has been clearly shown that Notch signalling plays an important role in T cell 
specification and differentiation in the thymus, through Notchl/D114 interaction, and 
the emergence of splenic marginal zone B cells is dependent on Notch2/D111 
interaction (Radtke et al. 2010). It has also been suggested that Notch signalling is an 
important component of the HSC niche in the adult bone marrow. These conclusions 
were drawn mainly from gain of function experiments. Elevated levels of notch 
signalling, achieved through the expression of active Notch alleles in vitro (Varnum- 
finney et al. 2003), over expression of the downstream Notch target Hesl (Kunisato 
et al. 2003), increased levels of Jaggedl expression in the HSC niche of the bone 
marrow, through increased numbers of osteoblasts, ( Calvi et al. 2003), and over 
expression of activated Notchl (Stier et al. 2002), all result in an increased self - 
renewal of HSCs and decreased differentiation of haematopoietic progenitors. Indeed 
culture of human CD34+ cord blood cells in the presence of Notch ligands showed a 
100 fold increase in CD34+ cells which repopulated NSG mice providing a powerful 
method for therapeutic expansion of HSC (Delaney et al. 2010). These gain of 
function experiments suggest that Notch signalling can expand the HSC pool but do 
not address the physiological role of Notch signalling in HSC expansion, 
maintenance and differentiation. Loss of function experiments give less clear results. 
Disruption of canonical Notch signalling, through the disruption of Mastermind 
(Maillard et al. 2008), Jaggedl (Mancini et al. 2005) and Notchl (Radtke et al. 
1999), have been shown to be dispensable for the maintenance of adult HSCs. 
However, these studies do not take into account possible redundancy with other 
Notch receptors or ligands in haematopoietic tissue. To address this issue RBPjx, a 
DNA -binding factor required for all canonical Notch signalling was deleted in adult 
bone marrow and no effect on the HSC pool was observed (Maillard et al. 2008). In 
contrast to this study inhibition of Notchl signalling, using a dominant negative form 
of RBPjx, in LSK cells in vitro resulted in an increase of lineage restricted cells and a 
reduction HSCs suggesting a role for Notch signalling in controlling HSC 
maintenance and differentiation (Duncan et al. 2005). In addition, a recent study 
showed deletion of Jaggedl in bone marrow endothelium resulted in premature 
exhaustion of the HSC pool (Poulos et al. 2013). Assessment of Jaggedl deletion in 
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the VE- Cadherin cre mice compared to the classically used Mx 1 -cre mice showed 
that Jaggedl is not efficiently deleted in the bone marrow endothelial cells when the 
inducible Mxl -cre line was used (Poulos et al. 2013). So the question of Notch 
signalling's role in physiological HSC maintenance, differentiation and expansion 
remains open. 
1.4.3 The role of Notch signalling in blood vessel development 
and haematopoietic development 
The Notch signalling pathway plays a very important role in both blood vessel 
development and haematopoiesis. This is evident from the phenotypes that result 
from the disruption of genes encoding components of the Notch signalling pathway, 
as summarised in Table 1. 
1.4.3.1 Notch in blood vessel development and specification 
Notch signalling has been shown to have an important role in blood vessel 
development during embryogenesis and in angiogenesis (figure 1.7). 
During the first stage of blood vessel development blood vessels are formed de novo 
from the lateral plate mesoderm, this process is called vasculogenesis. The 
angioblast, the precursor of blood vessels, differentiates to form endothelial cells and 
tubes that connect to form the primary capillary plexus. Vasculogenesis is directed 
by 3 main factors, basic fibroblast growth factor (FGF2), vascular endothelial growth 
factor (VEGF) and angiopoietin -1 (Angl) (Gilbert 2000; Risau & Flamme 1995; 
Flamme et al. 1997). In the next stage of blood vessel development, called 
angiogenesis, the primary capillary plexus is remodelled and vessel sprouting occurs. 
During angiogenesis new blood vessels are formed by sprouting from existing blood 
vessels, the main factor in this process is VEGF -A (Gilbert 2000). Endothelial cells 
that are stimulated by VEGF -A to become tip cells which contain numerous 
filopodia, are specialized for guided migration, rarely proliferate and do not contain a 
lumen (Gerhardt et al. 2003). These cells are followed by stalk cells which proliferate 
when stimulated by VEGF -A, form a lumen, tight adherence junctions and deposit a 
basement membrane (Gerhardt et al. 2003). The control of vessel branching and 
migration, i.e. tip cell stimulation, is controlled by the interaction of the Notch 
pathway with VEGF -A (figure 1.8). It has been shown that endothelial cells are 
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stimulated by VEGF -A through the VegfR2 /3 receptor. This up regulates the 
expression of D114 on the endothelial cells and stimulates Notch signalling through 
the Notchl receptor in neighbouring cells. Notch signalling in the neighbouring cells 
prevents these cells from becoming tip cells by inhibiting their response to VEGF -A, 
this is achieved through down regulation of VegfR2 /3 and up regulation of VegfR1, 
which sequesters VEGF -A, another example of lateral inhibition (Roca & Adams 
2007). The Notch ligand Jaggedl has also been shown to be involved in tip and stalk 
cell specification. In this case Jaggedl antagonizes the D114 -Notch signalling, this 
further down regulates Notch signalling in the tip cells and down regulates D114- 
Notch signalling in stalk cells which allows expression of VegfR2 /3 receptors and 
VEGF -A to stimulate proliferation (Roca & Adams 2007). D114 -Notch signalling in 
the rest of the artery is in balance, stabilising the artery endothelial cells by reducing 
VEGF signalling which decreases cell proliferation and allows the cells to mature 
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formation of aortae 
and cardinal veins 
differentiated 
arteries and veins 
lymphatic endothelial 
cells sprouting from veins 
mature lymphatics 
Figure 1.7: Representation of the development of endothelium from 





Notchl Notch4 Notchl Notch4 
Delt -like4 1 Delt -like4 
XX 
EphB4 Efnb2 EphB4 Efnb 
Figure 1.9: Notch Signalling in Arterial versus Venous specification. 
VEGF -A up regulates Notch components in arterial specification, Notch signalling 
inhibits EphB4 a venous marker and up regulates Efnb2 an arterial marker. During 
venous specification COUPTFII inhibits Notch signalling therefore Efnb2 is not up 




Figure 1.8: Notch Signalling 
in Angiogenesis. 
1: Notchl/D114 signalling 
balance between endothelial 
cells. 2: VEGF -A binds to 
VegfR2 /3 receptor which 
signals upregulation of D114, 
this up regulates Notchl 
signalling in adjacent cells. 
Notchl signalling up regulates 
VegfRl which sequesters 
VEGF -A and down regulates 
VegfR2, this reduces VEGF -A 
signalling in adjacent cells 
amplifying the difference 
between the cells. 3: The high 
D114 cells become tip cells 
which have filopodia, are 
migratory, have no lumen and 
rarely divide. Adjacent cells 
become stalk cells, they 
proliferate when stimulated 
with VEGF -A, form a vascular 
lumen, establish adherence 
junctions and deposit a 
basement membrane (adapted 
from Phng & Gerhardt 2009). 
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Specification of arteries, which are EphrinB2 (Efnb2) positive, and veins, which are 
Ephrin receptor B4 (EphB4) positive, is also dependent on Notch signalling (Wang et 
al. 1998; Lawson et al. 2001). The Notch pathway components Notchl, Notch3, 
Notch4, D114, Jagl and Jag2 are all expressed in arteries, but are not expressed in the 
veins of embryos (Villa et al. 2001). Efnb2 is a direct target of Notch signalling and 
EphB4 expression is repressed by Notch signalling. This is again stimulated by 
VEGF -A via VegfR2 /3 which up regulates Notch 1/4 and D114 (Duarte et al. 2004) 
(figure 1.9). 
Double knock -out of Notch 1 and Notch4, knock -out of D114, double knock -out of 
Heyl and Hey2, knock -out of Mind -bombi, and disruption of the canonical Notch 
signalling pathway through disruption of RBPjx, result in severe defects of vascular 
remodelling as well as loss of arterial markers (Duarte et al. 2004; Fischer et al. 
2004; Koo et al. 2005; Krebs et al. 2000; Krebs et al. 2004). Expression of activated 
Notch4 in the endothelium of embryos results in defects of vascular patterning 
(Uyttendaele et al. 2001) and ectopic activation of Notchl signalling the zebrafish 
embryo results in loss of venous markers (Lawson et al. 2001). Deletion of Notchl 
in Tie2+ cells produces embryos with a vascular phenotype similar to Notchl full 
knock -outs indicating the cell autonomous role of Notchl in vascular development. 
Coup is essentially expressed in the endothelium of the veins. During venous 
specification COUP -TFII inhibits Notch signalling and EphB4 is up regulated (You 
et al. 2005). Loss or gain of COUP -TFII function results in vascular defects, loss of 
COUP -TFII results in ectopic expression of arterial markers in veins and gain of 
COUP -TFII activity results in loss of arterial markers in arteries through the 
suppression of Notchl (You et al. 2005). 
1.4.4 Notch pathway and HSC development 
Notchl, Notch4, Jaggedl, Jagged2 and D114 are expressed in the endothelium of the 
E9.5 and E10.5 aorta (Robert- Moreno et al. 2008). Notchl and Jaggedl are 
expressed in HIAC clusters, Notch4 is not, and Jagged2 and D114 have a 
heterogeneous expression (Robert- Moreno et al. 2008). In addition, Notchl, Mind - 
bombl and Dlll are also expressed in the sub -aortic patches (Yoon et al. 2008). 
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Triple positive Notchl, Jaggedl and GATA2 expressing cells were also observed in 
the E10.5 aorta endothelium (Robert- Moreno et al. 2005). 
A requirement for Notch signalling in the development of intra- embryonic 
haematopoietic progenitors has been shown in various studies (Tablel.1). P -Sp from 
E9.5 Notchl knock -outs produce little to no CFU -Cs after culture, have reduced 
GATA2 and Runxl expression, and contain increased proportions of VE- 
Cadherin+CD45- cells (Kumano et al. 2003). YS from the same embryos produce 
similar numbers of CFU -Cs as wild type YS after culture suggesting an effect on 
intra- embryonic but not primitive haematopoiesis (Kumano et al. 2003). In RBPjx 
mutant's intra- embryonic haematopoiesis is impaired in a similar way as in Notchl 
mutants. No CFU -Cs are produced from E9.5 RBPjx -/- p -Sp, GATA2 and Runxl 
expression are decreased and a multi -layered endothelium is present in the dorsal 
aorta (fig 1.10b) (Robert- Moreno et al. 2005). Again this phenotype is observed in 
Mind -bombi mutants (Yoon et al. 2008). Mind -bombi is an E3 ubiquitin ligase 
essential for generation of functional Notch ligands. In these mutants again no CFU - 
Cs are generated in the E9.5 p -Sp and the aorta contains a disorganized morphology 
(Yoon et al. 2008). 
Embryos lacking genes of the Notch signalling pathway such as RBPjx (Krebs et al. 
2004), Notchl (Krebs et al. 2000), Jaggedl (Xue et al. 1999), D111 (Hrabé de Angelis 
et al. 1997), D114 (Duarte et al. 2004) or Heyl/Hey2 (Fischer et al. 2004) and genes 
involved in the regulation of the Notch pathway such as Mind -bombi (Koo et al. 
2005), die before or around E10.5, the time of HSC emergence meaning direct 
assessment of HSC activity cannot be carried out. Transplantation of E9.5 Notch14" 
p -Sp into conditioned newborns, as a direct assessment of pre -HSCs, showed no 
repopulation by Notchl cells indicating that HSC development is impaired in these 
mutants (Kumano et al. 2003). However these mutants along with embryos of other 
Notch mutant, RBPjx and Mind -Bombi, present with systemic defects, retarded 
development and disrupted arterial specification. This has made the study of the 
effects of Notch signalling disruption on HSC development difficult. As the Notchl, 
and RBPjx mutant embryos are severely retarded any effects observed in the 
haematopoietic lineage may be a result of general systematic defects (fig 1.10 a and 
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b). In addition, Notch signalling plays a vital role in determination of arterial identity 
as discussed in the previous section. Arterial identity may be an important 
prerequisite for HSC emergence as HSC emerge in close association with the 
endothelium of the dorsal aorta. In COUP -TFII mutants notch signalling is no longer 
suppressed in veins, they up regulate arterial markers and cell clusters are found in 
veins similar to the HIACs seen in arteries (You et al. 2005). HIACs are also found 
in veins of other mutants with arterial malformations (Sorensen et al. 2003). Blood 
flow has also been shown to be essential for HSC development (Adamo et al. 2009) 
therefore development of the cardiovascular system may play an indirect role in 
haematopoietic development. 
To circumvent this issue Notchl null ES cells were shown to contribute to primitive 
haematopoiesis but not definitive haematopoiesis when injected into mouse embryos 
at the blastocyst stage (Hadland et al. 2004) suggesting a cell autonomous 
requirement for Notchl in definitive haematopoiesis. In addition, it has very recently 
been shown that Hes 1 " / "Hes54" double knock -outs maintain normal arterial 
specification but contain increased numbers of HIACs (Guiu et al. 2013) and after 
culture of E10.5 AGM little to no CFU -Cs and no HSCs are produced in these mice 
(Guiu et al. 2013). These results indicate a direct effect of Notch signalling on HSC 
development although further work into the process is required. 
In the Jaggedl mutant it was described that intra- embryonic haematopoiesis was 
decreased and that, as seen in other Notch mutants, YS haematopoiesis was 
comparable to wild type (Robert- Moreno et al. 2008). These embryos also contained 
a multi -layered dorsal aorta endothelium (fig 1.10c) but contrary to Notchl, RBPjx 
and Mind -Bomb 1 mutants maintained arterial specification (Robert- Moreno et al. 
2008). In addition these mutants do not present with a severe developmental 
retardation as do some other Notch mutants. At E9.5 they are indistinguishable from 
littermate controls, and at El0 approximately half present with gross defects (Robert- 
Moreno et al. 2008; Xue et al. 1999 and own observations). These results lead to the 
idea that Jaggedl was the ligand involved with Notchl in the AGM region during 
HSC development. However, though intra- embryonic CFU -Cs are reduced in these 
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mutants no transplantation assays were carried out to determine if HSC development 
was affected. 
Loss of Notch signalling by disruption of RBPjx, Notchl, or Jaggedl results in 
reduced haematopoietic activity in the AGM but also a corresponding increase in 
endothelial cells in the AGM (fig 1.10 b and c) (Robert- Moreno et al. 2008; Robert- 
Moreno et al. 2005). This suggests a possible role of Notch signalling in the cell fate 
determination of the haemangioblast or control of differentiation of the haematogenic 
endothelium. The mechanism of Notch action in definitive haematopoiesis is still 
unclear; a summary of what is so far thought to occur is shown in figure 1.11. Levels 
of Runxl and GATA2 are reduced in RBPjx and Jaggedl mutant AGM regions and 
ectopic expression of Runxl and GATA2 partially rescue the haematopoietic 
phenotype in these mutants (Robert- Moreno et al. 2005; Robert- Moreno et al. 2008; 
Nakagawa et al. 2006). Control of GATA2 by Notch signalling has been shown to be 
by a feed -forward loop. The GATA2 promoter has two RBPjic binding sites allowing 
Notch signalling to activate GATA2 expression after which GATA2 is repressed by 
Notch target Hes genes (Guiu et al. 2013). Hesl/Hes5 double knock outs show up 
regulation of GATA2 and loss of HSC activity (Guiu et al. 2013). Further studies in 
zebrafish have contributed to the picture of the mechanism of Notch actions in HSC 
development. It has been shown that Runxl expression is required for successful 
EHT. In the absence of Runxl cells begin EHT but then disintegrate (Kissa & 
Herbomel 2010). In addition c -myb+ HSC have been rescued by ectopic expression 
of Runxl in mind bomb mutant zebrafish (Burns et al. 2005). These observations 
suggested Runxl is a downstream effect of Notch signalling in HSC development 
and through Runxl Notch may play a role in EHT. It has been shown that loss of 
function of all Notch ligands, through the deletion of Mind bomb -1, results in loss of 
intra- embryonic haematopoiesis (Koo et al. 2005; Yoon et al. 2008). However, 
targeted deletion of Mind bomb -1 in the aortic endothelium only results only in a 
reduction of intra- embryonic haematopoiesis (Yoon et al. 2008) suggesting a site for 
intra- embryonic haematopoiesis outside the aortic endothelium, the sub -aortic patch. 
It was shown that GATA3, Notchl and Dlll were expressed in the sub -aortic patch 
suggesting they are the effectors of Notch signalling's role in haematopoiesis at this 












Figure 1.10: Notch mutants. 
A: E9.5 wild -type embryo on left and 3 Notch knock -outs on right (Kumano et al. 
2003). B: E9.5 RBPjx mutants and transverse sections of dorsal aorta (Robert- 
Moreno et al. 2005). C: E10.5 transverse sections of dorsal aorta from Jaggedl 
mutants (Robert- Moreno et al. 2008). 
Aorta endothelium 
Jag1 
DI14? Notchl ; 
Hes1 GATA2 Rúnxl 
HIAC / r 
DI11 -> Notchl 
SAP 
GATA3 
Figure 1.11: Schematic representation of the mechanism of Notch action in 
haematopoietic development. 
HIAC: Haematopoietic intra -aortic cluster, SAP: Sub -aortic patch. 
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1.5 Project Aims 
The first aim of this project was to determine at which stages and though which cell 
types Notch signalling plays a role in HSC development and to determine the 
potential of Notchl +Jaggedl+ cells previously identified in the E11.5 AGM region. 
This was investigated by carrying out: 
A detailed phenotypical characterisation of Notchl expression in various cells 
types and at different stages of HSC development using anti -Notchl and 
visualisation by flow cytometry and confocal microscopy. 
The production of a Jaggedl reporter mouse line to characterise Jaggedl 
expression at E11.5, the time the first HSC is detected, using flow cytometry 
and confocal microscopy. 
Sorting Notchl+ cells from the E10.5 and E11.5 AGM region and assessing 
their functional potential in a range of assays. 
Sorting Notchl +Jaggedl+ cells from the E11.5 AGM region and determining 
by functional assay whether they are pre -HSCs. 
The second main goal of the project was to more closely assess the role of Jaggedl in 
HSC development. As discussed, Jaggedl mutants have normal arterial marker 
expression but have been shown to have reduced intra- embryonic haematopoiesis. 
This makes Jaggedl mutants a good model to assess the role of Notch signalling in 
haematopoietic development without the confounding factor of impaired arterial 
development. Previous work on these mutants did not assess the presence of pre - 
HSC or HSC in the mutant embryos and did therefore not show if the HSC 
development was affected in the absence of Jaggedl. To determine if HSCs can 
develop in the absence of Jaggedl, E10.5 AGM regions were cultured to allow any 
pre -HSCs to develop to HSC which could then be detected by transplantation. In 
addition to determine if Jaggedl is required by HSCs in a cell autonomous manner 
Jaggedl conditionally deleted using a CD41 -Cre. CD41 is expressed cell 
autonomously early in HSC development. 
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2 Material and Methods 
2.1 General Solutions 
Dissecting solution: Dulbecco's phosphate buffered saline (PBS) solution with Mgt+ 
and Caz+ ions (Sigma or Gibco) containing 7% fetal calf serum (FCS) (Invitrogen) 
and 50units /ml penicillin and streptomycin (P /S) (Gibco). 
Cell suspension/Staining solution/Washing solution: Dulbecco's PBS solution 
without Mg2+ and Ca2 +, containing 7% FCS and 50units /ml P /S. 
2.2 Animal Procedures 
2.2.1 Animal Husbandry 
C57BL6 wild -type and transgenic lines were housed and bred within the University 
of Edinburgh animal houses and according to the regulations of the Animals 
Scientific Procedures Act, UK, 1986. Animals were provided with a constant supply 
of water and chow food, and were housed in a constant environment with a 14 hours 
light/10 hours dark cycle. Litters obtained were left with parents for three weeks 
postnatally before weaning by separating parents and offspring. Only mice older than 
6 weeks were used for matings. Mice used in this project are listed in table 2.1. 
Table 2.1: Mouse Lines 
Line Reference 
C57BL /6J Jackson Laboratories 
CD41 -Cre (Emambokus & Frampton 2003) 
sGFP (Gilchrist et al. 2003) 
Jaggedl floxed (Nyfeler et al. 2005) 
Jaggedl knock -out Produced from Jaggedl foxed mice 
Jaggedl Tomato Produced in house 
2.2.2 Timed Matings 
Time matings were organised to obtain embryonic tissue of a specific gestational 
stage. Matings were setup overnight and females examined the next morning for the 
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presence of a vaginal plug. The day of vaginal plug discovery was determined as 
E0.5. 
2.2.3 Genotyping 
After weaning ear biopsies were taken from pups for genotyping by PCR. Ear 
biopsies were incubated in 100111 lysis buffer (containing 10% Tween 20, NP40, and 
10 mg /ml proteinase K in PCR buffer (Qiagen)) at 56 °C overnight. The following 
day they were heat inactivated at 95 °C for 10min. 51,tl of this solution was used for 
PCR. Samples were stored at 4 °C or -20 °C. 
2.3 ES cell and Stromal Cell Tissue Culture 
Tissue culture procedures were carried out in class 2 laminar flow hoods (Nuaire and 
Bassaire) using aseptic technique. Cells were cultured in 5% CO2 at 37 °C in 
humidified incubators (Sanyo). All medium were freshly prepared and kept for no 
longer than 2 weeks. Supplementary reagents were prepared by the tissue culture 
core facility were stored appropriately. Solutions were stored at 4 °C and allowed to 
warm up to RT prior to use. 
2.3.1 Solutions and Medium 
PBS (Sigma) (no Ca +, Mg +) 
B16 ES cell media 
500 ml Knockout DMEM (Gibco) 
50 ml FBS (Invitrogen) 
5 ml L- Glutamine (Gibco) 
500µl f3- mercaptoethanol 
5.5 ml 100X P/S Glutamine (Gibco) 
Murine LIF 10x104IU /ml (in house) 
B16 ES cell Trypsin 
500m1 PBS (Gibco) 
0.1g EDTA (Sigma) 
0.5g D- glucose (Sigma) 
35ml Chicken Serum (Gibco) 
20m1 2.5% Trypsin (Gibco) 
(Aliquot and store at -20 °C) 
OP9 medium /Stromal Cell medium 
150m1 IMDM (Gibco) 
40m1 FCS (Gibco) 
2m1 L- Glutamine (Gibco) 
200111 ß- mercaptoethanol (Sigma) 
2m1 P/S (optional) 
0.1% Gelatin Solution 
25ml of 2% Gelatin solution (Sigma) 
500m1 PBS (Sigma) 
Freezing Medium 
Dimethylsulphoxide (DMSO) (Sigma) 
10% v/v 
Cell medium 
Filter sterilise 22µm 
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Table 2.2: Appropriate volumes to use in protocols depending on flask size. 
Dish /Flask /Plate Gelatin /PBS Trypsin Medium Freezing 
96 well 100µl 50µI 800µI 
24 well 750µl 12511l 1.5ml 1ml 
6 well 3ml 0.5ml 5ml 2ml 
25cm2 flask 5ml 1ml 10m1 4ml 
75cm2 flask 10m1 3ml 30m1 8ml 
125cm2 flask 10m1 5ml 40m1 
10cm dish 5ml 1.5ml 10m1 
2.3.2 Thaw Cells 
10 ml medium was added to a universal tube. One well of a plate or a flask was 
coated with 0.1% gelatin ( >2min), and excess solution aspirated off. A frozen vial of 
cells was quickly thawed in a water bath (or in hand) with agitation. The outside of 
tube was wiped with 70% ethanol and air dried. The cell suspension was added to the 
universal tube containing medium. The cells were gently resuspend by swirling the 
tube and spun down in a centrifuge for 3min (300 x g). The media was aspirated, 
taking care not to disturb the cell pellet. Cells were resuspended in the appropriate 
media and gently pipette until cells dispersed. They were transfer to the 
gelantinised plate or flask. Cells were incubated overnight and medium changed the 
next morning. 
2.3.3 Passaging Cells 
When cells were healthy and near confluent, medium was aspirated and cells were 
washed with an appropriate amount of warm PBS which was then aspirated. The 
appropriate amount of trypsin was the added and cells incubated for 5min (or until 
cells have rounded up and lifted off the flask). Cell medium was added to inactivate 
trypsin and cells were disperse by gently pipetting. For B16 ES cells the appropriate 
number of cells were added to a freshly gelatinised plate /flask and topped up with the 
appropriate amount of medium. Cells were incubated overnight and the following 
day the medium was changed. For other cell types, after trypsin treatment and 
inactivation of trypsin, cells were transferred to a universal and spun down in a 
centrifuge for 3min (300 x g). Cells were resuspended in fresh medium and the 
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appropriate amount transferred into a freshly gelatinised flask, topped up with the 
appropriate volume of medium and incubated. 
2.3.4 Freezing Cells 
Cell passaging was started as in 2.3.3. Once cells were spun down they were 
resuspended in the appropriate volume of freezing medium, 1 ml quickly transferred 
to each labelled cryovial (Nunc), and place directly onto dry ice. Cells were stored at 
80 °C overnight and transferred to liquid nitrogen cell bank for long term storage. 
2.3.5 Electroporation of Cells 
The cell medium was changed 4 hours prior to electroporation. Cell passaging was 
started as in 2.3.3. Once cells were spun down they were gently resuspend in 10mis 
of RT PBS. l0111 was taken and cells counted using a haemocytometer. The PBS cell 
suspension was spun down in a centrifuge for 3min (300 x g). PBS was aspirated and 
cells resuspend in a final volume of PBS that would mean 1 x 107 cells per 25µl. 3- 
5x107 cells were taken and added to PBS to make a final volume of 700111. Cells were 
added to l00111 of 5 -15mg linearized DNA, gently mixed, quickly added to the 
cuvette, and electroporated at 800V 3µF. Cells were left to recover at RT for 20min. 
10cm dishes were gelatinised with 2% gelatin. 10m1 medium was added to each 
plate. The electroporated cells were transferred to 10m1 medium and 5x106, 2x106 
and 1x106 cells added onto 10cm dishes. Plates were incubated overnight and next 
day growth was checked. The medium was changed to medium + 150ug /ml G418. 
G418 media was changed every 2 days. Colonies were picked after 8 -10 days. 
2.3.5.1 Production of Strome! Cell Lines 
Cells from E10.5 AGM region were transfected with pB -PGK- TAG- CER -M20 -2 
(produced by Yiding Zhao in house) and helper plasmid pcylo43helper using the 
Neon Transfection System (Invitrogen). After culture single cells were plated in a 96 
well plate. 
2.3.6 Picking Colonies 
A 96 well U bottomed (Sterlilin) plate was prepared by adding 2511l trypsin to each 
well. A gelatinised flat bottomed 96 well plate (Corning) was prepared by adding 
l00µ1 of 2% gelatin to each well, incubating for 10min and then aspirating the 
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gelatin. The medium was aspirated from the plate containing the colonies to be 
picked. 10m1 RT PBS was gently added. Colonies were gently dislodged with a 2011.l 
pipette and tip set to 151.t1 and taken up in 10 -15111 PBS. The colony was then 
dispensed into a fresh well of the 96 well trypsin plate. Colonies were pick for no 
more than 30min or until the 96 well plate was full. The trypsin plate with colonies 
plate was then incubated at 37 °C for 10min. 16411 of medium was added to each 
well using a multichannel pipette and cells gently dispersed 4 -5 times. The cells were 
then transferred to the gelatinised 96 well flat bottomed plate and incubated 
overnight. The medium was changed the following day to G418 medium. Cell were 
expanded and passaged as described above maintaining selection with G418 medium 
for 2 -3 passages. 
2.4 Molecular Methods 
2.4.1 PCR 
Mastermix was prepared in MilliQ water containing PCR buffer, 10mM dNTPs, 5 
units /µ1 Taq polymerase, primers at 0.1 pM /µl final concentration, and template 
DNA. Sample were run on a Biometra T3 Thermocycler with the following 
protocol: denaturation at 95 °C for 3min; followed by 35 cycles of - denaturation at 
94 °C for 30 seconds, annealing at X °C for 40 seconds, extension at 72 °C for Ymin; 
72 °C for l Omin. Samples were examined with a 2% agarose gel electrophoresis (90V 
for 45min). DNA was labelled with ethidium bromide and pictures were taken with a 
Syngene G:Box with GeneSys software. All primers were obtained from sigma and 
all other reagents used for PCR were obtained from Qiagen. 
High fidelity PCR was carried out as described above with Platinum® Pfx DNA 
Polymerase (Invitrogen). U fragment and G fragment production required a slightly 
modified PCR programme. This consisted of: denaturation at 95 °C for 2min; 4 cycles 
of - 95 °C for 30s, annealing at X °C for 30s and 72 °C for 4min; 25 cycles of -95 °C for 
30s, 72 °C for Ym (increasing each cycle); finally 72 °C for 7min. After PCR 20 units 
of DpnI were added to the reaction and it was incubated at 37 °C for 2 hours. The 
PCR product was purified using a PCR purification kit (Qiagen) and eluted in water. 
DNA concentration was measure using a Nanodrop Spectrophotometer. 
49 
Primer sequences and PCR reactions are summarised in table 2.3. 
Tables 2.3: Summary of primers, PCR conditions and 
Annealing 
Temp (X) 
Primer Name Sequence 5' -3' 






Jagl Rev 1 
Jagl Rev 2 
Ja¢eed1T°m 
Jag1TomFor 
Jag 1 To m Rev 














GCAA GTCTGTCTGCT T TA TC. 
A GGTT GGCCA CCTCTA AA T C 
GAGATGCAGGTAAGAAGTCCA A TC 
CA GTCGTGCA TGCTCCAA TCCA C 
GA TGACGGCCA TGTTGTTGTCCT 
TCGATGCAACGAGTGATGAG 
















56°C 45s Neo 460bp 







CCGCCTA CTGCGA CTA TA GA 
60 °C 
2m 30s 
UJI frag 2018bp 
increase 5s/cycle 
GTAAAAA GAA CA CTTCGGGA TGTT 
TGAAATGATATGGACCTACAATGA 
A A TCCT GTGTGA AA TTGTTA TCCGC 
TA CTTTAACAATAATGAGAACAA 
GJ1 Rev AATAAACTTTTCTTCCAAGGGCTGG 
A A CCA CTGGCCGT CGT TTTA CA 
Southern Blot Probe 1 
SB1 For GTGGAGCTGGCAGAGACTTC 
SB1 Rev CTTTCCCGGA GTCA GA CTTG 
Southern Blot Probe 2 
SB2 For TA CA GGA GTTGGCCTTTGCT 
SB2 Rev A GCCTGTGGAGCA A GTCTGT 
JAG! qPCR 
JI For 
JI Rev GACCCATGCTTGGGACTG 
Tomato qPCR 
Tom For CTGAAGGGCGAGATCCAC 
Tom Rev TGGCCATGTAGATGGTCTTG 
AGAA CGGCAA CAAAA CTTGC 
55 °C 
increase Os/cycle 








2.4.2 Molecular Method Kits 
Many molecular methods were carried out using well established kits details and 
protocols will not be discussed here as the information is readily available from 
manufacturers. All kits were used according to the manufacturer's instructions. 
Enzyme digestion was carried out using restriction enzymes from New England 
Biolabs and Sigma. 
Gel purification of digested fragments was carried out using a gel purification kit 
from Qiagen. 
DNA ligation was carried using T4 DNA ligase from Invitrogen. 
One Shot® INV 110 Competent Cells from Invitrogen were used for 
transformation of DNA of interest. 
Mini and maxi preps were carried out using Qiagen kits. Maxi prep of the 
Jaggedl- dtTomato targeting vector was carried out using an EndoFree Maxi prep 
kit from Qiagen. 
The 3 -way gateway reaction was carried out using the Gateway® Technology 
with ClonaseTM II from Invitrogen. Cells with the resultant product were selected 
on YEG agar plates containing Spectinomycin (final concentration 50µg /ml) and 
Glucose (final concentration 0.4 %). 
Mini RNA purification kit from Qiagen was used for RNA purification. 
SuperScript® VILOTM cDNA Synthesis Kit from Invitrogen for cDNA 
production. 
qPCR was carried out using the UPL probe system and the LightCycler® 480 
from Roche. The reaction mixture consisted of l0µ1: lx master mix (2x stock); 
primers (final conc. 0.5µM); lx UPL probe (10x stock); approx. 50ng cDNA; and 
PCR grade H2O. 
2.4.3 Southern Blotting 
Genomic DNA for southern blot was isolated using phenol chloroform extraction. 4- 
1Oµg of DNA was incubated overnight with 50IU of the appropriate enzyme. The 
following day digested DNA samples were loaded on a 0.7% agarose gel and 
electrophoresis took place overnight in TAE buffer at approximately 30V. The 
following morning the gel was place between layers of filter paper on top of a nylon 
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membrane (Bio -Rad). A downward transfer was carried out for at least 4 hours with 
alkaline transfer buffer (0.4M NaOH, 0.6M NaC1). After the transfer the dried 
membrane underwent pre- hybridisation for 3hrs at 65 °C. Pre -hybridisation buffer 
consisted of: 0.5M [Na +]PO4; 7% SDS; 2mM EDTA; and heterologous denatured 
DNA (100µg /m1). DNA probe was labelled using dCTP32P and purified using Micro 
Bio -Spin P -30 Tris Column (Bio -Rad). The labelled probe was added to fresh pre - 
hybridisation buffer and the membrane incubated with it overnight at 65 °C. The 
following morning was washed in pre- heated wash buffer (0.2X SSC, 0.1% SDS) for 
20min each wash until the washing buffer was no longer radioactive. Membrane was 
incubated with a storage phosphor screen and the image developed using a FLA- 
3000 form (Fujifilm). 
2.4.4 Producing Electrocompetent Cells and Electroporation 
A saturated culture of the cells of interest was grown at the appropriate temperature, 
at 200rpm in 2m1 LB, with selection, in a 14ml round bottom tube. In the morning 
the saturated culture was diluted 1:50 in a fresh 2m1 of LB with selection in a 14ml 
tube and incubated at the appropriate temperature, at 200rpm for 2 -2'/2 hours until the 
optical density at 600nm was 0.2 -0.4. The culture was then chilled on ice and 
transferred to an eppendorf tube. The cells were centrifuged at 14,500rpm for 5min 
(Sigma Michael Christ edition 1 -14 Micro -centrifuge), supernatant removed and 
cells resuspended in 1ml ice cold HPLC quality water. From this point on cells were 
kept cold. Cells were again centrifuged at 14,500rpm for 5min in a refrigerated 
centrifuge, the supernatant removed and cells resuspended in 1ml ice cold HPLC 
quality water. This step was repeated twice more and after the final wash water was 
carefully drained well and cells were resuspended in 50µ1 HPLC water containing 
50ng of the DNA to be electroporated. The mixture was added to a chilled 
electroporation cuvette (Biorad) and electroporated on a Biorad Micro -Pulser on the 
"EC1" setting (1800V). After electroporation 4500 of recovery medium (2X LB + 
0.1% glucose) was quickly added to the cells and cells were transferred to a 14m1 
tube for 70min incubation at 37 °C, at 200rpm. 2500 of the culture was then 
inoculated into 7500 of LB containing the appropriate selection and cultured at the 
appropriate temperature for 24hrs or 48hrs. 
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2.4.5 Recombineering 
The BAC host E. Coli were made electrocompetent and the recombineering plasmid, 
pSC101- BAD- 703A -tet, was electroporated into the cells and selected with 
tetracycline (final conc. in lml 51.1g/m1) and chloramphenicol (final conc. in 1ml 
12.5µg/ml). After 48hr growth at 30 °C the saturated culture was used to make 
electrocompetent cells as discuss in the previous section. One slight modification 
was made in that after the cells had reached 0.2 -0.4 OD600 they were incubated with 
arabinose (fmal conc. 0.02 %) at 37 °C, 200rpm for 40min before being chilled on ice. 
After the host cells were made electrocompetent the first gateway cassette, the U- 
fragment, was electroporated into the cells. Recombineering took place during the 
70min recovery at 37 °C and after the cells were again grown at 30 °C for 48hrs and 
selection with Zeocin (final conc. 101..tg/ml) and Tetracycline (final conc. 511g/ml) 
was carried out. The host cells were again made electrocompetent as described above 
and again when at 0.2 -0.4 OD600 cells were incubated with arabinose (fmal conc. 
0.02 %) at 37 °C, 200rpm for 40min before being chilled on ice. The second gateway 
cassette, the G- fragment, was electroporated into the cells. Recombineering took 
place during the 70min recovery at 37 °C and after the cells were then grown at 37 °C 
overnight, to remove the recombineering plasmid from the culture, and selected with 
Zeocin (fmal conc. 10µg/m1) and Carbenicillin (final conc. 501.tg/ml in 1m1). The cell 
culture was then plated on agar containing Carbenicillin (final conc. 50µg/ml in 1m1) 
and Zeocin (final conc. 104ml) and incubated overnight. Colonies are examined 
for the presence of the Jaggedl intermediate targeting vector. The vector was isolated 
by maxi prep (Qiagen), analysed by restriction digest and sequencing, and prepared 
for the gateway reaction. 
2.5 Tissue Isolation and Preparation 
2.5.1 Isolation of Embryonic Tissue 
Pregnant females were sacrificed according to schedule 1 method of cervical 
dissociation. The uterus was dissected and embryos were removed in dissecting 
solution. The embryo was then separated from the extra -embryonic tissues including 
the yolk sac (YS) which was retained when appropriate. The developmental stage of 
the embryo was staged according to Theiler criteria (http: / /www.emouseatlas.org). 
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E11.5 corresponds to stage 19, with 41 -47 somite pairs (sp); the anterior "handplate" 
is formed and incomplete eye pigmentation. E 1 0 corresponds to stage 16, with 30- 
34sp, hindlimb and tail buds and no eye pigmentation. Embryonic organs of interest 
were dissected using forceps and sharpened tungsten needles under a dissecting 
microscope (Leica). The AGM region was dissected by first removing the head 
anterior embryo body above the fetal liver, followed by the neural tube and ventral 
tissue (including fetal liver and gut). The ribs were then cut away from the UGRs 
along with any excess dorsal tissue. For embryos at a stage earlier than E 10 the 
caudal part of the embryo, dissected free of the anterior portion and ventral tissue, 
was used. 
2.5.2 Dissociation of Embryonic Tissue into a Single Cell 
Suspension 
To obtain single cell suspensions, embryonic organs were transferred to a 5m1 
polystyrene tube (BD Falcon) and suspended in dissecting solution with 1 mg /ml 
collagenase dispase (Roche). Organs were digested in a gently shaking water bath at 
37 °C for 35min. Immediately after, 1ml of dissecting solution was added and the 
sample centrifuged at 1,200rpm for 5min at 4 °C (Sigma 4 -16K). The supernatant was 
removed and 1 ml of cell suspension/staining solution was added. Cells were gently 
dissociated by pipetting 20 times in cell suspension solution. The sample was again 
centrifuged at 1,200rpm for 5min at 4 °C and supernatant removed. Cells were 
resuspended in the appropriate volume of cell suspension/staining solution for further 
processing. 
2.5.3 Dissociation of Adult Organs into Single Cells Suspension 
Adult animals were all sacrificed according to schedule 1 method of cervical 
dissociation. For haematopoietic cell analysis spleen and thymus were dissected free 
of connective tissue and fat and immediately placed in cell suspension solution. 
Single cell suspensions were obtained by dissociating grossly cut organs with a 26- 
gauge syringe needle in a 30mm dish. After that, tissues were filtered through a 
40µm cell strainer (BD Falcon) to get rid of cell clumps. Bone marrow was obtained 
by flushing femurs with cell suspension solution with a 26 -gauge syringe needle and 
cells mechanically dispersed in cell suspension solution (BD Microlance). Peripheral 
54 
blood was obtained by bleeding from lateral tail vein, and immediately collected into 
1ml PBS/EDTA (20014ml). Cells were centrifuged at 1,200rpm for 5min, 
resuspended in 1ml PharM Lyse solution (BD Bioscience), and incubated in dark at 
RT for 15min. After incubation cells were again centrifuged at 1,200rpm for 5min, 
supernatant removed, and cells resuspended in cell solution. Prepared adult cells 
were immediately placed on ice or at 4 °C. 
To obtain thymic epithelial cells thymi were dissected out into a PBS filled Petri dish 
and further cleaned of any non -thymic tissue. The thymic capsule was ripped and the 
lobes were gently agitated to release T- cells. The thymic lobes are then transferred 
into a tube and disrupted using scissors. They are then resuspended in a dissociation 
media (I -1840 HEPES media (Invitrogen) with collagenase D 1.25mg/m1 (Roche) 
and Dnase I 0.05mg /ml) for 15min at 37 °C. To aid the dissociation process every 
5min the solution with the thymic fragments was disrupted by pipetting using a lml 
blue tip. After the incubation was complete the supernatant was taken off and filtered 
through a 7011m cell strainer. The remaining thymic fragments were resuspended in 
fresh dissociation media and the process described above was repeated a further 2 
times. Any remaining fragments of tissue are resuspended in RPMI -1840 Hepes 
media with collagenase /dispase 1.25mg/m1 for a further 30min. Dissociated cells 
were then spun down at 1,200rpm at 4 °C for 5min and collected into lml cell 
suspension solution. 
2.6 Culture Systems 
2.6.1 Co- aggregate and Explant Culture 
Durapore 0.651.im membrane filters were rinsed 3 times in autoclaved water with 100 
units /ml P/S then air dried before use. Dry membranes were gently placed on top of 
5m1 medium consisting of IMDM medium (Iscove's Modified Dulbecco's Medium 
(IMDM) containing 20% FCS; 4mM glutamine; 50 units /ml P /S; 100ng/m1 IL -3; 
100ng/ml SCF; and 100ng/ml Flt3L in a 6 well plate (Corning). Following placement 
of explant organs or co- aggregates on the membranes cultures were incubated 5 or 7 
days culture at 37 °C, 5% CO2. 7 days cultures had medium changed on day 1 of 
culture. No more than four co- aggregates /explants were culture on one membrane. 
To obtain single cell suspensions after culture, pieces of membrane were transferred 
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to a 5m1 polystyrene tube (BD Falcon) and suspended in dissecting solution with 
1 mg /ml collagenase dispase (Roche). Samples were digested in a gently shaking 
water bath at 37 °C for 35min. Immediately after, 1ml of dissecting solution was 
added, the cells gently pipette off the membrane, and the membrane discarded. The 
sample was then centrifuged at 1,200rpm for 5min at 4 °C. The supernatant was 
removed and lml of cell suspension/staining solution was added. Cells were gently 
dissociated by pipetting 20 times in cell suspension solution. The sample was again 
centrifuged at 1,200rpm for 5min at 4 °C and supernatant removed. Cells were 
resuspended in the appropriate volume of cell suspension/staining solution for further 
processing. 
2.6.2 Co- aggregate with OP9 and Embryonic Cells 
Approximately 1 ee of embryonic cells were used in each co- aggregate. 1 x 105 OP9 
cells per co- aggregate were added to the cell suspension of embryonic cells for co- 
aggregate culture. The cell mixture was centrifuged at 1,200rpm for 5min at 4 °C, 
supernatant removed, and cells resuspended in 200 culture medium per aggregate. 
200 were then added to 2000 pipette tips sealed with Paraflim (VWR 
International). Tips were then placed in 5ml polystyrene tube (BD Falcon) and 
centrifuged at 1,500rpm for 10min at 4 °C. Parafilm was gently removed from the 
pipette tips and the cell pellets gently expelled onto a prepared membrane in a 6 well 
plate as described above. 
2.7 Flow Cytometry 
All antibodies used for flow cytometry and the concentration they were used at are 
shown in table 2.4. Cell suspensions were obtained as described in the previous 
section. Staining was carried out in 5ml polystyrene tubes (BD Falcon) or U 
bottomed 96 well plates (Sterilin). Cells were spun down at 1,200rpm for 5min in 
4 °C and the supernatant aspirated. Cells were resuspended in staining solution 
containing Fc block and primary antibodies. Controls included FMOs (fluorescence 
minus one), which consisted of all antibodies minus one for each antibody used, and 
on occasion isotype controls. Cells were incubated on ice or at 4 °C for 20- 30min. 
After incubation washing solution was added to the well /tube, cells spun down at 
1,200rpm for 5min in 4 °C, and supernatant aspirated. Cells were resuspended in 
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staining solution containing the appropriate streptavidin and incubated on ice or at 
4 °C for 15- 20min. After incubation washing solution was added to the well /tube, 
cells spun down at 1,200rpm for 5min in 4 °C, and supernatant aspirated. Cells were 
resuspended in staining solution, again spun down at 1,200rpm for 5min in 4 °C, and 
supernatant aspirated. Cells were then resuspended in cell suspension solution ready 
for flow cytometry or cell sorting. 7AAD or DAPI was added to cells just before 
analysis. 
Flow cytometry was carried out on a FACSCalibur (BD) or LSRFortessa (BD). Cell 
sorting was carried out by Simon Monard or Olivia Rodrigues on a FACSAria II 
(BD). Compensation was calculated based on positively stained beads (produced in 
house) and 7AAD only stained cells. FMOs were used to set gates. Flow cytometry 
data was analysed with FlowJo v7.6.2 software (Tree Star). For cell sorting, cells 
were sorted into cell suspension solution and kept on ice after sorting. Purity checks 
were done on the FACSAria II (BD) when appropriate. 
2.8 In Vitro Assays 
2.8.1 CFU -C Assay 
Prior to use, methylcellulose based MethoCult medium containing erythropoietin, IL- 
3, IL -6, and SCF (M3434, Stem Cell Technologies) was thawed at RT and 50 
units /ml P/S was added. After cell suspensions were added to MethoCult cultures 
were processed and plated according to manufacturer's instructions 
(www.stemcell.com). Haematopoietic colonies were counted and scored after 9 -11 
days of differentiation. The colonies were scored according to described standard 
criteria (Taoudi, 2006). 
2.8.2 Endothelial /CFU Assay 
2hr hours prior to setup 2 x 105 OP9 cells were plated in the required number of 
gelatinised wells of a 6 well plate. Methylcellulose based MethoCult medium 
containing erythropoietin, IL -3, IL -6, and SCF (M3434, Stem Cell Technologies) 
was supplement with 50ng /ml VEGF (Peprotech) and cells were added mixed and 
plated over the OP9s. After 10 -12 days culture haematopoietic colonies were scored 
and then the methylcellulose washed from the well with PBS. Cells were fixed with 
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5% DMSO in methanol for 10min at RT. Cells were washed twice with PBS (2min 
each wash) and incubated with 30% FCS in PBS for 1Omin. The blocking solution 
was removed and cells were incubated with anti -CD31 in 7% FCS in PBS for 2 hour 
at RT. Cells were then washed with 0.05% Tween in PBS 3 times. Cells were 
incubated with anti -rat AP for lhr at RT and again washed with 0.05% Tween in 
PBS 3 times. Blue Alkaline Phosphatase Substrate Kit (Vector Labs) was then used 
according to manufacturer's instructions. After cells were washed twice with 0.05% 
Tween in PBS, the endothelial colonies were scored and photographed using an 
inverted microscope (Motic). 
2.9 Long -term HSC Repopulating Assay 
Cells for long -term repopulation assay were obtained from either fresh or cultured 
embryonic organs from CD45.2/.2 mice. Appropriate doses of cells were 
resuspended in ice cold 1% FCS /PBS and co- injected along with 8x104 adult carrier 
bone marrow cells from CD45.1/.2 animals. Prior to transplantation, CD45.1 /.1 
animals were irradiated. A total dose of 9.5 Gy was split into two doses separated by 
at least 3 hours and delivered by sealed Cs source at a rate of 21.6 rad /min. No more 
than 200µ1 of cell suspension were injected into each recipient mouse using a 30- 
gauge syringe needle (BD Plastipak). All injections were performed in the lateral tail 
vein according to the procedures described by project licence and the regulations of 
the Animals Scientific Procedures Act, UK, 1986. 
Recipients' peripheral blood chimerism (PBC) was assessed by flow cytometry at 6 
weeks post -transplantation for short-term repopulation, and at least 16 weeks post - 
transplantation for long -term repopulation. Blood samples were processed as 
described in Sections 2.5.3 and 2.7. Only animals with donor chimerism higher than 
5% were considered reconstituted. 
Multilineage analysis was performed on animals reconstituted for at least 16 weeks 
post -transplantation. Bone marrow, spleen, and thymus were isolated and processed, 
(see Sections 2.5.3) and myeloid and lymphoid donor contribution was assessed by 
flow cytometry (see Section 2.7). 
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2.10 Microscopy Analysis 
All antibodies used for staining tissue sections and whole mount embryos are shown 
in table 2.4 with working concentration. 
2.10.1 Fluorescent Microscopy of Live Embryos 
Picture of embryos were taken with a stereoscope microscope (Nikon 
AZ100superzoom) using a Qlmaging ExiBlue camera. The software used for 
analysis was NISElement Nikon, and multiple focal planes were combined into a 
single focus 2D image using NIS -A EDF Module for Extended Depth of Focus plug- 
in. 
2.10.2 Sections 
Fresh or fixed (4% PFA) embryos were snap- frozen in O.C.T compound (BDH Gurr) 
on dry ice. 10µm thick frozen sections were produced using a LEICA CM1900 
cryostat (Leica) and directly put onto polysine- coated slides (VWR International). 
Sections were air -dried and stored at -20 °C. Sections were warmed up at RT and 
fixed with -20 °C cold 100% acetone for 1 min. Sections were then air -dried and 
encircled with a pap pen. Once the PAP was dry sections were rehydrated with one 
wash of 2min PBS (containing MgCl and CaCI (Sigma)). From this point on sections 
were kept hydrated, and all staining was done in a staining chamber in the dark. 
Sections were then incubated with 30% FCS in PBS for 30 -60min at RT. Sections 
were then washed once before adding staining solution containing primary antibodies 
(minus Notchl or Jaggedl). Sections were incubated for 1hr at RT. Sections were 
washed with 3 changes of PBS incubated for 5min each. The appropriate secondary 
antibodies were added together or in succession (depending on the reactivity and 
isotype). They were also incubated for lhr at RT and followed by 3 changes of PBS 
as a wash. The sections were then incubated with 30% serum (Notchl = rat serum; 
Jaggedl = goat serum) for 30min at RT and washed 3 times with PBS. Sections 
being stained for Notchl were then treated with an Avidin/Biotin blocking kit 
(Vector Labs) according to manufacturer's instructions. After washing with 3 
changes of PBS sections were incubated with Notchl or Jaggedl at 4 °C overnight. 
The following day sections were washed with 3 changes of PBS followed by 1hr 
incubation at RT with Strepavidin A1488 (Notchl) or anti -human Fc A1488 
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(Jaggedl). Sections were washed with 3 changes of PBS, incubated with DAPI for 
15min, and washed with 3 changes of PBS a final time. Sections were mounted in 
ProLong Gold anti -fade mounting medium (Invitrogen) and left to cure for 24hr at 
RT in the dark. Stained sections were analysed and pictures were taken using an 
inverted confocal microscope (Leica DM IRE2). Images were process using ImageJ 
software. The staining processes for used some section stains are shown in figure 2.1. 
2.10.3 Wholemount 
For wholemount staining all steps were carried out in the cold room with gentle 
shaking. Embryos were fixed for lhr in 1% PFA/PBS. Embryos were then 
dehydrated with 10min incubations in each 50 %, 75% and 100% methanol in PBS. 
The limbs and lateral body of the embryos were removed using a tungsten needles 
and forceps. Embryos were rehydrated in 50% methanol in PBS for I Omin. 4 washes 
in ice cold PBS were carried out for 10min each. Embryos were incubated in 
blocking solution (PBS with 0.4% Tween and 50% FCS) for 3 hrs. Embryos were 
then incubated overnight with primary antibodies diluted in PBS with 0.4% Tween 
and 7% FCS. The following morning embryos were washed in PBS with 0.4% 
Tween and 7% FCS 3 times for 2hrs each wash. Embryos were incubated with 
secondary antibodies diluted in PBS with 0.4% Tween and 7% FCS. The following 
morning embryos were washed in PBS with 0.4% Tween and 7% FCS twice times 
for lhrs each wash. Followed by 3 washes in PBS with 0.4% Tween and dehydration 
with 50% methanol in PBS for 10min and 100% methanol for 10min. Embryos were 
then cleared by incubating with 3 changes 50% methanol in BABB (1 part benzyl 
alcohol to 2 parts benzyl benzoate) for 20min each. Embryos are then washed in 
100% BABB for 2min and stored in a fresh change of BABB. Embryos were 
examined and pictures taken using an inverted confocal microscope (Leica DM 
IRE2). Images were process using ImageJ software and Microsoft Powerpoint. 
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2.11 Statistical Analysis 
Microsoft Excel and GraphPad Prism 6 were used for analysis of results. Mean and 
standard deviation were calculated in Excel and statistics were calculated in 
GraphPad. Data was analysed for normal distribution but in general: data from fresh 
tissue was analysed parametric data and data post culture was analysed as non - 
parametric data. Initial comparison of groups was done by One -Way ANOVA 
(parametric) or Friedmen Test (non -parametric). If significant, groups of parametric 
data were compared using t -test with Welch's correction. Groups of non -parametric 




Anti- Notchl (rat) 
Anti -goat NL577 (donkey) A /Anti rat A1633 (goat) 
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Anti -goat NL577 (donkey) /Anti rat A1633 (goat) 
\AA 
Anti -CD45 (goat) Anti-VE-Cadherin (rat) 
C Anti-human Fc A1488 (goat) 
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A A ' Anti -Jaggedl (phage) 
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Anti -rat A1633 (goat) 
AAAA/ 
Anti -Runxl (rabbit) Anti-VE-Cadherin (rat) 
Figure 2.1: Order of use of antibodies when staining sections. 
A: CD45, VE- Cadherin and Notchl with rat serum blocking. B: CD45, VE- Cadherin 
and Jaggedl with goat serum blocking. C: Runxl, VE- Cadherin and Jaggedl. 
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Antigen Clone Isotype Working Conc. Conjugate Supplier 
CD16/CD32 
93 rIgG2b 14ml unconjugated eBioscience 
(Fc block) 
Notchl 22E5.5 IgG2a 1.5pg/m1 BIO MacDonald Lab 
CD45 30E-11 rIgG2b 2pg/m1 V450, V500, APC BD Horizon 
CD41 MWReg30 rIgG1 10pg/ml A1488 BioLegend 
VE-Cadhein/CD144 eBioBV13 rIgG1 2pg/m1 A1647 eBioscience 
Ter119 TER-119 rIgG2b 2pg/m1 PerCP_Cy5.5, APC eBioscience 
CD45.1 A20 mlgG2a IpgJml APC, FITC eBioscience 
CD45.2 104 mIgG2a 1 pg/ml PE, V450 eBioscience 
B220 RA3-6B2 rIgG2a 2.5pg/ml BIO eBioscience 
CD3e 145-2C11 hIgG 2pg/ml PE, F1TC eBioscience 
Macl/CD11b M1/70 rIgG2b 2.5pg/m1 BIO, APC eBioscience 
Grl RB6-8C5 rIgG2b 2.5pg/ml PE, FITC eBioscience 
CD4 GK1.5 rIgG2b 1.25pg/ml BIO eBioscience 
CD8a 53-6.7 rIgG2a 2.5pg/ml PE, FITC eBioscience 
EpCAM G8.8 rIgG2a 1 pg/ml PerCP_Cy5.5 BioLegend 
UEA1 B10d 5pg/m1 BIO VectorLabs 
lectin 
CD31 390 rIgG2a 1 pg/ml APC BioLegend 
I mmuno- 
histoche mistry 
Jagged! D05 phage N/A hFc + flag + HisX6 McCafferty Lab 
Notchl 22E5.5 rat 1.5pg/m1 BIO MacDonald Lab 
VE- Cadherin 11D4.1 rat 2.5pg/ml none BD Phamiingen 
CD45 AFI 14 goat 2pg/m1 none R&D Systems 
Runxl EPR3099 rabbit 1:100 none abcam 
Tomato (RFP) 600 -401 -379 rabbit. 20pg/m1 none Rockland 
Rabbit IgG NL004 donkey 10pg/m1 NL557 R&D Systems 
Goat IgG NL001 donkey 10pg/ml NL557 R&D Systems 
Goat IgG A21082 donkey 20pg/m1 A1633 Invitrogen 
Rat IgG A21208 donkey 20pg/m1 A1488 Invitrogen 
Rat IgG A21094 goat 20pg/m1 A1633 Invitrogen 
Human IgG Fc 
109- 546 -008 goat 3pg/m1 A1488 Jackson Immuno 
Fragment 
Other 
CD31 MEC13.3 rIgG2a lpg/ml none BDPharmmgen 
Rat IgG 2A 8F4 mIgG2a N/A AP SouthernBiotech 
Strepavidin 1pg/ml BV421 BioLegend 
Strepavidin 0.5pg/m1 PE BD Pharmmgen 
Strepavidin 0.2pg/m1 APC BD Phamimgen 
Strepavidin 2pg/m1 A1488 BD Pham>ingen 
7AAD 0.5pg/m1 Molecular Probes 
DAPI 0.5pg/m1 Biotúun 
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3 Notchl Expression during Haematopoietic 
Development 
It has previously been shown that Notchl and N1ICD (Notch 1 intracellular domain) 
are expressed in the dorsal aorta of the AGM region during haematopoietic 
development at E9.5, El 0.5 and E11.5 (Robert- Moreno et al. 2008; Robert- Moreno 
et al. 2005; Kumano et al. 2003). In situ hybridization shows a patched pattern of 
Notchl expression in the ventral domain of the E9.5 and E10.5 dorsal aorta in the 
AGM region (Robert- Moreno et al. 2005; Robert- Moreno et al. 2008). Further in situ 
hybridization of E10.5 AGM region shows that some GATA2 positive cells of the 
dorsal aorta are also Notchl +Jagged1+ indicating a role for Notchl and Jagged1 in 
haematopoietic development (Robert- Moreno et al. 2005). It has been established 
that Notchl -/- ES cells do not contribute to the haematopoietic system and that 
Notchl mutants have impaired intra- embryonic haematopoiesis (Kumano et al. 2003; 
Hadland et al. 2004). However, at E9.5 Notchl mutants have retarded development 
and severe vascular defects meaning there is limit to their use as a tool in 
investigating the role of Notchl in dHSC development (Krebs et al. 2000). 
Work being carried out in our lab involves the use of conditional lines and blocking 
antibodies to try to address the role of Notchl in haematopoietic development in a 
targeted way. To supplement this work I carried out detailed phenotypical and 
functional analysis of Notchl positive cells in the populations of interest of the 
developing haematopoietic system. This was carried out using a monoclonal rat anti - 
Notchl antibody received from the H. Robson MacDonald's lab at the Ludwig 
Institute for Cancer Research Ltd., Lausanne (Fiorini et al. 2009). These results give 
us a more detailed insight into Notchl expression and the stages of dHSC 
development in which Notchl may be important. 
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3.1 Phenotypic Analysis of Notchl Expression 
3.1.1 Notchl expression in endothelial and haematopoietic 
populations during haematopoietic development 
Notchl expression was analysed in populations of interest in the developing 
haematopoietic system at different embryo stages. HSCs arise through the stepwise 
maturation of pre -HSC Type I to pre -HSC Type I to HSCs (fig3.1 a) (Rybtsov et al. 
2011; Taoudi et al. 2008). Unless otherwise stated the populations analysed are 
defined as: CD45 +VE -Cadherin which is enriched for haematopoietic cells; CD41" 
CD45-VE- Cadherin+ which is enriched for endothelial cells; CD41 +CD45-VE- 
Cadherin+ which is enriched for pre -HSC Type I at E10.5 and E11.5 in the AGM 
region; CD45 +VE -Cadherin+ which is enriched for pre -HSC Type II and contains 
dHSCs at E11.5 in the AGM region. Figure 3.1b shows the gating strategy used to 
analyse these populations by first gating on live cells using 7AAD exclusion and 
further gating into the populations described above based on CD45, VE- Cadherin 
and CD41 expression. The different stages at which the analysis was carried out 
include: E8.5 in the whole embryo; E9 embryo in the caudal part; E10.5 in the AGM 
region; and E11.5 in the AGM region and the YS. 
Figure 3.2a and table 3.1 show the percentage of cells, of each population, which 
were Notchl positive over the course of the different embryo stages. The cell 
populations analysed all contained Notchl+ cells at all stages. The endothelial 
population contains the highest proportion of Notchl+ cells at all stages compared to 
the other populations analysed. The proportion of Notchl+ cells in each population 
does not significantly change over the course of the different stages aside from a 
significant drop in the percentage of Notchl+ haematopoietic cells between E8.5 and 
E9 (p= 0.0346). There is also a trend which shows an increase in the percentage of 
Notchl+ cells in the CD45 +VE -Cadherin+ population between E10.5 and E11.5, the 
time at which some of the cells of the CD45 +VE -Cadherin+ population become 
functional pre -HSC Type II and HSCs. 
The flow cytometry data was further analysed to try and discern if there was a 
difference between each population in the level of Notch 1 expression found on the 
positive cells. The median value of PE fluorescence in the Notchl+ population was 
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taken as an indicator of the level of Notchl expression. In figure 3.2b median PE 
fluorescence for the different Notchl populations is shown. In the endothelial 
(CD41 "CD45VE- Cadherin +) and CD41 +CD45VE- Cadherin+ populations (CD45- 
VE-Cadherin+ populations) the level of Notchl expression in E9, E10.5, and E11.5 is 
higher than the level of expression in the haematopoietic (CD45+VE- Cadheriri) and 
the CD45+VE- Cadherin +populations. Thus, although the percentage of Notchl+ cells 
may be similar (e.g. E11.5 CD41 +CD45VE- Cadherin+ 70.4% ±19.6 and CD45 +VE- 
Cadherin+ 73.2% ±10.8), the level of Notchl expression may be different (e.g. E11.5 
CD41 +CD45VE- Cadheriri 10656 ±2271 and CD45+VE- Cadherin+ 1990 ±366). 
Over different embryo stages the level of Notchl expression within a Notchl 
population also changes. There is a significant increase in the level of Notchl 
expression during development between E8.5 and E11.5 in the endothelial (CD41" 
CD45VE- Cadherin+) population (p= 0.0103), and the CD41 +CD45VE- Cadherin+ 


































Notchl Strep PE 
Figure 3.1: HSC development and Gating strategy Notchl analysis. 
A: HSC arise through the step wise maturation of preHSC I through preHSC II to 
HSCs (Rybtsov et al. 2011; Taoudi et al. 2008). B: Live cells were gated based on 
7AAD exclusion and then further gated into populations of interest. G1: 
Haematopoietic cells (CD45 +VECad -); G2: preHSC II enriched (CD45 +VECad +); 
G3: preHSC I enriched (CD41 +CD45- VECad +); G4: Endothelial cells (CD41- 
CD45- VECad +). All gating was based on FMOs (top row) Notchl expression in 
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Figure 3.2: Percentage of Notchl+ cells and level of Notchl expression in 
populations of interest in embryos of different stages. 
A: Percentage of Notchl+ cells in populations of interest at different stages of 
embryo development. B: Median level of PE fluorescence in Notchl+ populations at 
different stages of embryo development. There is a significant difference between the 
mean of PE fluorescence between E8.5 and E11.5 of the CD41 -CD45 "VECad+ 
population (p= 0.0103), and the CD41 +CD45 "VECad+ population (p= 0.0143). 
Haematopoietic cells (CD45 +VECad "); Endothelial cells (CD41 "CD45 "VECad +); 
preHSC I enriched (CD41 +CD45 "VECad +); preHSC II and dHSC enriched 
(CD45 +VECad +). E8.5 whole embryo; E9 embryo caudal part; E10.5 AGM region; 
E11.5 AGM region. Mean ±SD. Results obtained from 3/4 independent experiments 
per stage. 
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At E11.5 the yolk sac is not able to autonomously generate HSCs, but they can be 
generated autonomously in the AGM region. The populations of interest between the 
E11.5 yolk sac and AGM region were compared to see if a difference in Notchl 
expression might correlate with the functional difference between the 2 organs (fig 
3.3). The percentage of Notchl cells in each population (fig 3.3a) was not 
significantly different though there was a trend that the mature haematopoietic and 
endothelial populations had a higher percentage of Notchl+ cells. The levels of 
Notchl expression (fig 3.3b) in these populations are not significantly different 
between the yolk sac and AGM region. This suggests that for pre -HSC populations 
Notchl is not a marker of the difference in functionally between the AGM region 
and YS, but it may be involved in a functional difference between AGM region and 
YS endothelial and haematopoietic populations. 
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Figure 3.3: Notchl expression in E11.5 AGM region and Yolk Sac. 
A: Percentage of Notchl+ cells in populations of the AGM region and Yolk Sac. B: 
Median level of PE fluorescence in the Notchl+ populations of the AGM region and 
Yolk Sac. Haematopoietic cells (CD45+VECad-); Endothelial cells (CD41"CD45- 
VECad+); preHSC I enriched (CD41 +CD45-VECad +); preHSC II and dHSC enriched 

















































































































































































































































































































































































































































































































































































































































































































































































































































































3.1.2 Expression of Notchl protein in the dorsal aorta 
The dorsal- ventral polarity of HSC development correlates with the expression of 
certain genes. Ventral expression of proteins known to be involved in HSC 
development, for example Runxl, has previously been observed ((Robert- Moreno et 
al. 2008) and own observations). To determine if Notchl protein is expressed 
differentially around the E11.5 dorsal aorta immunohistochemistry was performed. 
Transverse sections of the E11.5 AGM region stained for Notchl, VE- Cadherin, 
CD45 and DNA show that Notchl is expressed by the endothelial cells of the dorsal 
aorta (fig 3.4). A dorsal ventral polarity of Notchl protein was not observed at this 
stage. Magnification of a haematopoietic intra -aortic cluster (HIAC) in endothelium 
of the ventral domain of the dorsal aorta shows that the cells of the endothelium layer 
of the dorsal aorta at the bottom of the cell cluster express Notchl, CD45 and VE- 
Cadherin and the cells of the cluster express CD45 and VE- Cadherin (fig 3.4). This 
correlates with Notchl and NIICD protein staining previously observed at E11.5 
(Kumano et al. 2003; Del Monte et al. 2007). In correlation with previous 
observations smooth muscle cells surrounding the E11.5 dorsal aorta also express 
low levels of Notchl (Del Monte et al. 2007). 
As slight differences in protein expression might not have been detectable by 
confocal analysis, the dorsal aorta of the AGM region was sub -dissected into ventral 
(AoV) and dorsal (AoD) parts (retaining the dorsal tissue) and analysed by flow 
cytometry. Sub -sections from several E11.5 AGM regions were pooled, dissociated, 
and stained using standard protocols. Figure 3.5 shows the expression of Notchl 
compared between AoV, and AoD in the total live cells population and the 
endothelial population (CD41- CD45VE- Cadherin +), nearly all cells are Notchl+ in 
these subdisected tissues. In the total live cell compartment, the level of Notch 1 
expression in the AoV (median PE fluorescence 864) and AoD (median PE 
fluorescence 796) is similar with some cells in the AoV that are brighter for PE. 
Endothelial cells of these tissues have the highest expression of Notchl and Notchl 
expression reaches a similar maximum for AoV and AoD. The Notchl polarisation 
seen at E10.5 by in situ hybridization is not detectable at E11.5 by protein staining. 
However, AoV endothelial cells contain 2 distinct populations Notchl low and 
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3.2 Functional analysis of Notchl+ cells 
It is not possible to know solely by flow cytometry analysis whether Notchl is 
expressed by functional pre -HSCs, HSCs, or haematopoietic and endothelial 
progenitors. To answer the question whether Notchl is expressed by these cell types, 
functional analysis must be carried out. 
3.2.1 HSC precursors 
HSCs can only be identified by their ability to repopulate irradiated adult recipients; 
pre -HSCs must be matured in culture to HSCs for retrospective identification. It has 
previously been reported by our lab how to isolate and mature pre -HSCs from the 
AGM region (Rybtsov et al. 2011; Taoudi et al. 2008). This process was carried out 
as described in figure 3.6. The AGM region of E10.5 or E11.5 embryos was 
dissected and the cells dissociated into a single cell suspension. Cells with a pre -HSC 
phenotype were then sorted based on their expression of Notchl. After sorting, cells 
were made into Notchl-, Notchl+ and control co- aggregates with supportive stromal 
cells (0P9 cells). Control co- aggregates contain sorted Notchl- and Notchl+ cells 
recombined after sorting in the appropriate ratios (the ratio they were in before 
sorting). Co- aggregates were cultured on the gas liquid interface for five days (E11.5 
pre -HSCs) or seven days (E10.5 pre -HSCs) in the presence of IMDM, serum and 
cytokines: Interleukin 3 (IL3); FMS Like Tyrosine Kinase 3 Ligand (F1t3L); and 
Stem Cell Factor (SCF). After culture the cells were: 1) transplanted to assess the 
presence of HSCs; 2) added to a haematopoietic progenitor assay to assess the 




region Dissociate, stain 
and sort cell 
populations of 
interest 
Co- aggregate with 
stromal cells and culture 









Figure 3.6: Schematic representation of the experimental design to assess pre - 
HSC Notchl phenotype. 
IL3: Interleukin 3; F1t3L: FMS Like Tyrosine Kinase 3 Ligand; SCF: Stem Cell 
Factor. 
3.2.1.1 E10.5 pre -HSC Type I 
According to the flow cytometry data in section 3.2.1 at E10.5 the pre -HSC Type I 
enriched population contains 62.4% ±17.3 Notchl+ cells which express Notchl at a 
higher level than other haematopoietic populations. To assess whether functional 
preHSC I are Notchl +CD45 "VE -Cadherin+ cells from the E10.5 AGM region were 
sorted based on their Notchl expression (fig 3.7a). Approximately lee of sorted cells 
were then co- aggregated with OP9s. After seven days of culture co- aggregates were 
dissociated and assays carried out on the resultant cells. Figure 3.7b shows the level 
of repopulation of donor cells after transplantation of three co- aggregates per mouse. 
The results show that all functional preHSC I are contained in the Notchl+ 
compartment. After culture co- aggregates from the Notchl- compartment contained 
significantly fewer lives cells than the control (p= 0.0087 N1- Vs CI) (fig 3.7c) 
correlating with the fact that the number of input cells of Notchl- co- aggregates was 
less. Flow cytometry analysis of the resultant cells (fig 3.7d) shows that all co- 
aggregate types produce haematopoietic cells (CD45 +VE -Cadherin ), cells with a 
preHSC II and dHSC phenotype (CD45 +VE -Cadherin +) and endothelial cells (CD41" 
CD45 "VE -Cadherin +). Although statistical analysis of this number of samples shows 
no significant difference, there is a trend that control co- aggregates perform the best 
and produce higher proportions of all cell types analysed. Co- aggregates made from 
Notchl+ cell produce a higher proportion of haematopoietic cells (CD45 +VE - 
Cadherin) than Notchl- co- aggregates (p= 0.0087) but there is no significant 
difference in the proportion of preHSC II and dHSC enriched cells (CD45 +VE - 
Cadherin+) produced. After culture all populations produced CFU -Cs in the 
haematopoietic progenitor assay (fig 3.7 e and f) and again no significant difference 
between the co- aggregate types was found. Most CFU -C colonies identified were 
macrophage colonies but all three co- aggregate types produced CFU -GEMM 
colonies as well, indicators of the presence of a multilineage haematopoietic 
progenitor. Again there is a trend that control co- aggregates have a better output 
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Figure 3.7: Notchl expression on E10.5 pre -HSC Type I. 
A: Example of sort. Live cells (7AAD -) were gated to CD45VECad+ cells. This 
preHSC I enriched population was then sorted into Notchl- and Notchl+ populations. 
B: Long -term repopulation (4 months). 3 co- aggregates (lee each) transplanted per 
irradiated recipient. Each square represents 1 recipient. Results obtained from 3 
independent experiments. The control preHSC CI control co- aggregates contain 
sorted Notchl- and Notchl+ cells recombined after sorting in the appropriate ratios. 
C: Number of live cells per co- aggregate after culture. (* * * : p= 0.0087). D: Flow 
cytometry analysis of cells populations from co- aggregates after culture. 
Haematopoietic cells (CD45 +VECad"); Endothelial cells (CD41"CD45VECad+); 
preHSC II and dHSC enriched (CD45+VECad +). E: Number of CFU -C per 0.1 co- 
aggregate after culture. F: Number of CFU -C per 10,000 live cells after culture. No 
significant difference p= 0.8908. 
C, D, E and F results obtained from 2 independent experiments. Each circle and bar 
represents a result from 1 co- aggregate. Lines represent median point. 
CFU -C: colony forming unit - culture; BFU -E: burst forming unit erythroid; Mac: 
macrophage; GM: granulocyte, macrophage; GEMM: granulocyte, erythroid, 
macrophage, megakaryocyte. 
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3.2.1.2 E11.5 pre -HSC Type 
The same strategy that was described in the previous section was used to determine if 
pre -HSC Type I and the more mature pre -HSC Type II population express Notchl at 
E11.5. Flow cytometry data in section 3.2.2 shows that at E11.5 the preHSC CI 
enriched population contains 70.4% +19.6 Notchl+ cells which express Notchl at a 
higher level than other haematopoietic populations, similar to the % of Notchl+ 
preHSC I seen at E10.5. To assess whether functional preHSC CI are Notchl +, 
CD41 +CD45 "VE -Cadherin+ cells from the E11.5 AGM region were sorted based on 
Notchl expression (fig 3.8a). Co- aggregates were made from sorted cells with lee 
per co- aggregate. After five days of culture co- aggregates were dissociated and 
assays carried out on the resultant cells. Figure 3.8b shows the level of repopulation 
of donor cells after transplantation with 1 co- aggregate. The repopulation data shows 
that in contrast to our results at E10.5 there is no significant difference between the 
Notchl- and Notchl+ preHSC I populations in their ability to produce HSCs 
(p= 0.0841). After culture, variable numbers of cells are produced (p= 0.827) (fig 
3.8c) though Notchl+ co- aggregates produce a significantly higher proportion of 
haematopoietic cells (CD45 +VE -Cadherin) and preHSC II and dHSC enriched 
(CD45 +VE -Cadherin +) cells than the Notchl- co- aggregates (N1- Vs N1+ p= 0.0039 
and p= 0.0084 respectively) (fig 3.7d). There was no significant difference in the 
proportion of endothelial cells produced (fig 3.7d). Cells from Notchl preHSC I co- 
aggregates also produce more CFU -Cs than Notchl- co- aggregates (fig 3.7 e and f) 
but all co- aggregate types produce a variety of CFU -C colony types. At this stage 
(E11.5) the control pre -HSC Type I co- aggregates do not seem to have a better 
output than the Notchl+ co- aggregates as was observed at E10.5. In addition Notchl+ 
pre -HSC Type I retain their ability to produce a better haematopoietic output than 
Notchl- preHSCs but contrary to E10.5 the Notchl- population also contains pre- 
HSC Type I. 
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Figure 3.8: Notchl expression on E11.5 pre -HSC Type I. 
A: Example of sort. Live cells (7AAD") were gated to CD41 +CD45- VECad+ cells. 
This preHSCI enriched population was then sorted into Notchl- and Notchl+ 
populations. B: Long -term repopulation (4 months). 1 co- aggregate (lee) 
transplanted per irradiated recipient. No significant difference in HSC production 
between populations (p= 0.0841). The control preHSC CI control co- aggregates 
contain sorted Notchl" and Notchl+ cells recombined after sorting in the appropriate 
ratios. C: Number of live cells per co- aggregate after culture. No significant 
difference (p= 0.8268). D: Flow cytometry analysis of cells populations from co- 
aggregates after culture. The Notchl+ population produces a significantly higher 
proportion of CD45+VECad" and CD45+VECad+ cells than the Notchl- population 
( * *: p= 0.0039 and p= 0.0084 respectively). Haematopoietic cells (CD45+VECad"); 
Endothelial cells (CD41 "CD45VVECad+); preHSC II and dHSC enriched 
(CD45+VECad +).E: Number of CFU -C per 0.1 co- aggregate after culture. ( * *: 
p= 0.0099). F: Number of CFU -C per 1,000 live cells after culture. Notchl+ 
population produces significantly more CFU -Cs per 1000 cells ( * *: p= 0.0022). 
Results obtained from 3 independent experiments. Each circle and bar represents a 
result from 1 independent co- aggregate. Lines represent median point. 
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3.2.1.3 E11.5 pre -HSC Type II 
In our preliminary experiments we used streptavidin -APC as a secondary to 
recognise Notchl- biotinylated antibody. Staining's using this strategy showed show 
that phenotypical preHSC II reside in both Notchl- and Notchl+ compartments (fig 
3.9a). In this setting we noticed that the shift obtained for Notchl+ cells is not as 
important (only 35% of preHSC II cells are Notchl+) as the one observed when we 
used the streptavidin PE (more than 70% of the cells are Notchl +) (fig 3.2). To assess 
whether functional preHSC II are Notchl +, CD45 +VE- Cadherin+ cells from the 
E11.5 AGM region were sorted based on Notchl expression. Co- aggregates were 
made from sorted cells with approximately lee per co- aggregate. The results of 
transplantations showed that pre -HSC type II are contained in both Notchl- and 
Notchl+ populations (fig 3.9b). 
To confirm this result we performed the same experiment but using the Streptavidin 
PE to reveal Notchl expression (fig 3.9c). Notchl high expressing cells were 
separated from the Notchl low /- cells. Figure 3.9d shows the level of repopulation of 
donor cells after transplantation with one co- aggregate. Results show that functional 
E11.5 preHSC II are contained in both the Notchl-n0 and Notchlh' populations. 
Notchlh' population produces a more varied range of HSCs and as it is the smaller 
population seems to be more enriched fort preHSC II than the Notchl 41° population. 
After culture, control co- aggregates produce significantly more cells that the Notchl- 
h° or Notchl'" co- aggregates (p =0.022 preHSC II Vs N141°), although there is no 
significant difference in the number of cells produced between Notch141° and 
Notchl+ co- aggregates (p= 0.8983) (fig 3.9e). Notchl hi preHSC II co- aggregates 
produce a significantly higher proportion of haematopoietic cells and preHSC II and 
dHSC enriched (CD45 +VE- Cadherin +) cells than Notchl -n0 co- aggregates (N1" Vs 
N1+ p= 0.0012 and p= 0.0312 respectively) but there was no significant difference in 
the proportion of endothelial cells produce (fig 3.9f). Control co- aggregates produced 
the highest number of CFU -Cs (fig 3.9g); however, the proportion of cells which 
produce CFU -Cs from each population is not significantly different (fig 3.9h). In 
conclusion, the Notchlh' population has the best haematopoietic output after culture 
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Figure 3.9: Notchl expression on E11.5 pre -HSC Type II. 
A: Example of sort. Live cells (7AAD-) were gated to CD45+VECad +. This preHSC 
II enriched population was then sorted into Notchl- and Notchl+ populations using 
Notchl- biotin/Streptavidin APC staining. B: Long -term repopulation (4 months). 1 
co- aggregate (lee) transplanted per irradiated recipient. No significant difference in 
HSC production between populations (p= 0.5969). The control preHSC CII control 
co- aggregates contain sorted Notchl- and Notchl+ cells recombined after sorting in 
the appropriate ratios. 
C: Example of sort. Live cells (7AAD-) were gated to CD45+VECad +. This preHSC 
II enriched population was then sorted into NotchP"O and Notchl+ populations using 
Notchl -biotin/Streptavidin PE staining. D: Long -term repopulation (4 months). 1 co- 
aggregate (lee) transplanted per irradiated recipient. No significant difference in 
HSC production between populations (p= 0.2430). The control preHSC CII control 
co- aggregates contain sorted Notchl- and Notchl+ cells recombined after sorting in 
the appropriate ratios. E: Number of live cells per co- aggregate after culture. 
PreHSC II control co- aggregates produce significantly more cells that the Notchl 41° 
or Notchl hi co- aggregates ( * *: both p= 0.022), although there is no significant 
difference in the number of cells produced between Notch1410 and Notchl+ co- 
aggregates (p= 0.8983). F: Flow cytometry analysis of cells populations from co- 
aggregates after culture. Notchl+ population produces a significantly higher 
proportion of CD45+VECad- and CD45+VECad+ cells than the Notchl - population 
(N * *: p= 0.0012 and p= 0.0312 respectively). Haematopoietic cells (CD45+VECad-); 
Endothelial cells (CD41"CD45-VECad +); preHSC II and dHSC enriched 
(CD45+VECad+). G: Number of CFU -C per 0.03 co- aggregate after culture. ( * *: 
p= 0.0043). H: Number of CFU -C per 10,000 live cells after culture. No significant 
difference (p= 0.7573). 
Results obtained from 2/3 independent experiments. Each square /circle and bar 
represents a result from 1 independent co- aggregate. Lines represent median point. 
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3.2.2 E11.5 dHSCs, haematopoietic and endothelial progenitors 
I next turned to the question of whether mature HSCs, haematopoietic and 
endothelial progenitors are Notchl+ in the E11.5 AGM region. To determine this, 
live cells from E11.5 AGM region were sorted based on Notchl expression and 
directly assayed by transplantation into irradiated adult recipients, addition to the 
CFU -C assay or by addition to the endothelial progenitor assay (fig 3.10 a and b). 
We first confirmed that Notchl antibody staining did not block the ability of HSCs to 
repopulate bone marrow by staining E11.5 AGM region cells with Notchl and 
directly transplanting them. There was no difference between the Notchl stained and 
unstained cells in their ability to repopulate irradiated adult recipients (p= 0.2500) 
(data not shown). 
After sorting based on Notchl expression and transplantation, results show that all 
HSCs at E11.5 express Notchl and that there is no significant difference in terms of 
HSC numbers between the Notchl 10 and Notchl h' populations (p= 0.6294) (fig 3.10c). 
As Notchl hi cells represent only 4.6% of the total live cell number and Notch110 cells 
52 %, our results suggest that HSCs are enriched in the Notchhi population. 
Further investigation of the functional properties of Notchl+ cells in E11.5 AGM 
region sorted cells were directly assayed for the presence of haematopoietic and 
endothelial progenitors. The Notchl I° population contained the highest number of 
CFU -Cs (fig 3.10d) but the proportion of CFU -Cs from Notchl" cells was highest 
(fig 3.10e). The highest number and highest proportion of endothelial progenitors 
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Figure 3.10: Notchl expression on E11.5 dHSCs, haematopoietic progenitors 
and endothelial progenitors. 
A: Schematic representation of the experimental design to assess Notchl phenotype. 
B: Example of sort. Live cells (7AAD") from E11.5 AGM region were sorted into 
Notchl", Notchl I° and Notchlh' populations. C: Long -term repopulation (4 months) 
of transplantation of sorted cells. 5ee transplanted per irradiated recipient. All dHSCs 
are Notchl +, no significant difference between N1 I° and N1+ populations (p= 0.6294). 
Each square represents 1 recipient. Results obtained from 3 independent 
experiments. D: Number of CFU -C per 3ee E: Number of CFU -C per 10,000 live 
cells. Results obtained from 3 independent experiments. Mean±SD. F: Number of 
endothelial colonies per 0.7ee G: Number of endothelial colonies per 10,000 cells. 
Representative example from 2 independent experiments. Mean±SD 
Net: network ( >6 main tubules) of endothelial tubules; 4 -6: network of 4 -6 main 
endothelial tubules; 1-3: single or network of 2/3 main endothelial tubules. 
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3.2.3 Multilineage analysis of repopulated mice 
Multilineage analysis of repopulated mice was carried out to determine if the HSCs 
produced by the different cell types analysed were able to contribute to the myeloid 
and lymphoid populations and to determine if a certain cell type produced a HSC 
with a biased output. The multilineage staining strategy is shown in figure 3.11 and a 
summary of the results obtained are shown in table 3.2. Though there is variability in 
the proportions of myeloid and lymphoid repopulation in all recipients, no obvious 
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Figure 3.11: Example of flow cytometry gating for multilineage analysis. 
4 adult tissues blood, bone marrow, spleen and thymus are assessed for the presence 
of multilineage donor derived cells. A: In each tissue donor derived (CD45.1" 
CD45.2 ) cells are gated on. B: CD3 and B220 lymphoid populations in the donor 
compartment of the blood, bone marrow and spleen are assessed. C: Mac1 and Grl 
myeloid populations in the donor derived compartment of the blood, bone marrow 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































To supplement work in our lab, that is further investigating the role of Notchl in 
haematopoietic development, a detailed assessment of Notchl expression in the 
E11.5 and El 0.5 AGM region was carried out. Flow cytometry analysis was 
performed in order to determine more precisely by which cell types, and at what 
level, Notchl protein is expressed in the developing haematopoietic system. This 
analysis showed that in all the cell populations analysed Notchl is expressed to 
varying degrees. The VE- Cadherin+ endothelial (CD41-CD45 "VECad+) and 
phenotypically defined pre -HSC Type I (CD41 +CD45 "VECad +) populations 
expressed the highest levels of Notchl which increased between E8.5 and E11.5. 
This is unsurprising as Notch signalling is known to be involved in angiogenesis, 
vascular development and arterial specification (reviewed:(Roca & Adams 2007; 
Gridley 2007)) and HSCs arise in close association with the endothelium of the 
dorsal aorta (reviewed: (Medvinsky et al. 2011; Koch et al. 2013)). The more mature 
cells of the dHSC, pre -HSC CII and CD45+VE -Cad- cells, hierarchy expressed 
Notchl at lower levels. 
Next functional analysis of Notchl positive and negative cells from the E10.5 and 
E11.5 AGM regions was carried out. This showed that at E10.5 all pre -HSC Type I 
are Notchl+ and at E11.5 some become Notchl'. Pre -HSC Type II are Notchlb0ft, as 
are HSCs, though Notchl hi cells are enriched for HSCs. CFU -Cs are NotchU"O and 
the majority of endothelial progenitors are Notchl hi. These results all suggest that 
Notchl expression is highest on early haematopoietic progenitors newly derived 
from haematogenic endothelium and Notchl expression is maintained throughout 
HSC development. At E11.5, after culture co- aggregates from preHSC I Notchl+ and 
Notchlh' had a significantly better output of haematopoietic cells than their Notchl " "0 
counterparts, indicating Notchl +n cells are better primed towards a haematopoietic 
output. 
HSC production from Notchl- pre -HSCs suggests that cells may up regulate Notchl 
during culture or that there is a Notchl independent pathway during certain stages of 
HSC development, i.e. after pre -HSC specification, which can be supported in 
culture. Whether this Notchl independent HSC development exists and occurs in 
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vivo is an open question. In some experiments it was observed that control co- 
aggregates outperformed their Notchl- and Notchl+ counterparts. This suggests that 
interactions between Notchl+ and Notchl" cells may be important in HSC 
development. As endothelial cells are almost exclusively Notchl+ this could indicate 
an important role for other Notchl- supportive cell types such as stromal cells and 
mesenchymal cells in HSC development. 
However, a serious limitation to these experiments was observed. At E11.5 
CD45 +VE- Cadherin cells after culture should give rise to large numbers of HSCs 
(approximately 150) (Taoudi et al. 2008) but it has been observed by others in our 
lab that cell sorting leads to an extenuation of this maturation by a factor of up to 10. 
Taken together this suggests that 1 co- aggregate with lee pre -HSC type II should 
produce approximately 15 HSCs. The suboptimal results obtained in these 
experiments, HSCs were not produced in all co- aggregates, suggests that Notchl 
staining may be partially blocking pre -HSC maturation and/or proliferation. The 
Notchl antibody used was shown not to block D114 binding but further investigation 
into the possible blocking of other ligand binding or an ability to inhibit Notchl 
activation was not carried out (Fiorini et al. 2009). Experiments to determine if 
partial blocking of Notchl activation by this antibody is indeed taking place are 
required. Incubation of cells with and without Notchl before co- aggregate culture or 
addition of the antibody to CFU -C and endothelial assays must be carried out. This 
strategy was used to determine if anti -Notchl antibody directly blocked HSC homing 
and engraftment by staining cells with Notchl before transplantation (data no 
shown). No obvious impairment was observed, correlating with reports that Notchl 
is not required by adult HSCs in the bone marrow (Radtke et al. 1999). 
The possibility that anti - Notchl antibody is interfering with the HSC lineage 
suggests that if Notchl+ cells were not impaired after sorting, vastly higher levels of 
repopulation would be seen by Notchl+ pre -HSCs and control co- aggregates. In this 
case Notchl+ E11.5 pre -HSC Type I would be significantly more potent than the 
same negative population suggesting that even at E11.5 pre -HSC Type I are Notchl +. 
In addition if the effects of anti - Notchl antibody were removed, a significant 
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difference between the Notchl 41° and Notch pre -HSC Type II populations may be 
observed, allowing a more defined phenotype to be discerned. 
Although interpretation of the functional analysis carried out may be obscured by the 
possible blocking actions of the antibody used, it is still clear from phenotypical 
analysis that Notchl is expressed at high levels on endothelial cells and by early pre - 
HSC Type I HSC precursors followed by lower levels of Notchl on more mature 
pre -HSC Type II and HSC. Functional HSCs are shown to be Notchl suggesting 
Notchl expression is maintained throughout HSC development. 
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4 Jaggedl Expression during Haematopoietic 
Development 
In order to investigate Jaggedl expression during haematopoietic development a 
Jaggedl 
wt/tomato knock -in mouse line was produced in collaboration with Bill Skarne's 
lab at the Sanger Institute. Using this line we were able to analyse Jaggedl 
expression in the developing haematopoietic system and further investigate the 
Jaggedl+Notchl +cells previously described (Robert- Moreno et al. 2005). 
4.1 Jaggedl expression in E11.5 AGM region 
It has previously been shown by in situ hybridization and protein staining that 
Jaggedl is expressed in the E10.5 AGM region by (Robert- Moreno et al. 2005; 
Robert- Moreno et al. 2008). The E11.5 AGM region was examined for Jaggedl 
protein expression (fig 4.1). Like the Notchl staining in chapter 3, Jaggedl is 
expressed in the endothelial cells of the dorsal aorta. It is also expressed by the VE- 
Cadherin smooth muscle cells surrounding the dorsal aorta. No obvious dorso- 
ventral polarity of Jaggedl expression was observed. The majority the 
CD45+ cells of a cluster just under the endothelial layer of the dorsal aorta are 
Jaggedl+ (fig 4.1 upper panel). Examining the Runx1+ HIAC of cells in the lower 
panel of figure 4.1 we can see that, again like Notchl, Jaggedl is expressed mainly 
in the cells at the very bottom of the cluster and in the endothelium of the dorsal 
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Figure 4.1 Jaggedl expression in E11.5 AGM region. 
40x plus zoom. Transverse sections of AGM region of E11.5 embryos stained for 
Jaggedl, VE- Cadherin and CD45 (upper panel) or Jaggedl, VE- Cadherin and Runxl 
(lower panel). Nuclear staining with DAPI. V: ventral. D: dorsal. Arrow indicates 
dorsal ventral orientation. White box indicates magnified area. 
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4.2 Production of a Jaggedl reporter mouse line 
The Jaggedlt°'at° knock -in strategy and targeting vector was designed by Barry 
Rosen and Bill Skarnes at the Welcome Trust Sanger Institute. The protocol used 
was a modified small scale version of the high throughput targeting strategy used by 
their team (Skarnes et al. 2011). All diagrams are modified from Skarnes et. al 2011 
to represent the more simplified strategy used. 
4.2.1 Jaggedltomato locus 
The structure of the Jaggedltomato knock -in allele is shown is shown in figure 4.2. The 
modified locus produces a dtTomato fluorescent protein under control of the Jagged 1 
promoter. The selection cassette allowed for selection of targeted cells and was later 
removed. The construction of the Jaggedl targeting vector, and the subsequent 
targeting of the Jaggedl locus, was carried out using homologous recombination. 
The Jaggedl targeting vector had 5kb 5' and 3' homology arms to the region of the 
Jaggedl locus the dtTomato fluorescent protein gene was to be inserted. In this 
strategy the Jaggedl ATG start codon and dtTomato fluorescent protein ATG start 
codon were interchanged so that the gene was inserted under control of the Jaggedl 
promoter with minimal disruption to the gene. Some disruption to the 5' UTR region 
occurred as the targeting vector as a remnant of the construction process remains 
upstream of the dtTomato start site and some of JAG1 exon 1 was deleted when 




5' homology arm loxP loxP 
3' homology arm 
UTR Exon1 Exon2 
Figure 4.2: Design of Jaggedl -dtTomato targeting vector. 
Knock -in of dtTomato fluorescent protein gene and foxed selection cassette into the 
Jaggedl gene locus. 
UTR: untranslated region; hBact: human f3-actin promoter; Neo: neomycin resistance 
gene; pA: polyadenylation signal. 
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4.2.2 Producing the targeting vector 
4.2.2.1 Final assembly of the Jaggedl- dtTomato targeting vector 
The Jaggedl targeting vector (fig 4.3) contains: 5kb homology arms to the Jaggedl 
locus; the dtTomato fluorescent protein gene (with a beta -globin intron and SV40 
poly -A); a floxed neomycin resistance gene under control of the human beta -actin 
promoter to allow for selection of targeted cells; a Spectiomycin resistant gene to 
allow for vector selection in bacteria; a diphtheria toxin gene under a PGK promoter 
which will kill any cells in which the full linearized vector inserts in the genome 
instead of undergoing homologous recombination (Yagi et al. 1990); and an Asil 
restriction enzyme site for linearization. These features allowed the dtTomato 
fluorescent protein gene to be knocked into the Jaggedl locus and selection of 
correctly targeted cells to be carried out at a high efficiency. 
The construction of the final targeting vector was carried out using Gateway® 
technology (Invitrogen). Gateway technology is a modified form of homologous 
recombination which is site specific. The reaction is catalysed by LR clonase and L 1 
and R1 sites, L2 and R2 sites etc. recombine specifically with no cross -over between 
sites. The gateway reaction carried out to produce the Jagged 1 targeting vector is 
shown in figure 4.5. After the gateway reaction was carried out, the reaction was 
stopped and was transformed into chemically competent cells. The cells were plated 
on Spectinomycin containing YEG agar, which contains the amino acid 4- Chloro- 
DL-phenylalanine (chl -Phe). Transformed cells containing any of the individual 
plasmids or the results of an incomplete gateway reaction would not grow. The 
targeting element and the Jaggedl intermediate targeting vector are not 
Spectinomycin resistant and the pL3L4 backbone plasmid expresses the protein ccdb 
which is poisonous to all but specialized strains of bacteria. L1L2 but no L3L4 
recombination results in a plasmid that is not Spectinomycin resistant. L3L4 but no 
L1L2 recombination results in a plasmid that expresses PheS, a mutant version of 
phenylalanine (Phe) t -RNA synthetase which incorporates the toxic Phe analogue 
chl -Phe into protein during synthesis. Its toxic effect is dominant over WT PheS. WT 
E.Coli will grow normally on YEG -CI plates containing chl -Phe but PheS containing 
cells will not grow (Kast 1994). This sophisticated selection of a modularly 
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assembled vector allowed a high level of recovery of clones containing the Jaggedl 
targeting vector. This strategy is used in high throughput system by the team at 
Sanger and the modular approach allows the same targeting element and backbone to 
be used in the production of many different gene specific vectors (Skarnes et al. 
2011). Production of the targeting vector was confirmed by restriction digestion (fig 
4.4) and sequencing portions of the targeting vector. 
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Figure 4.3: Schematic of final targeting vector. 
5kb homology arms allow for recombination of dtTomato fluorescent protein gene 
into Jaggedl locus with neomycin resistant for positive selection. 
B1-4: Gateway sites; S40pA: polyadenylation signal; hBact: Human beta -Actin 
promoter; Neo: Neomycin resistant gene; pA: polyadenylation signal; ori: origin of 
replication; AsiSI: linearization restriction enzyme site; Spec: Spectinomycin 
resistance gene; DTA: Diphtheria toxin gene; PGK: phosphoglycerate kinase 
:ah.ss.dc owooRrct bonding 
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Figure 4.4: Restriction digest confirmation. 
Digest of 2 clones from Jaggedl targeting vector production. Restriction digest with 
Stul was unsuccessful as the enzyme failed to work. 
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Figure 4.5: 3 -way gateway reaction to produce Jaggedl targeting vector. 
The 3 plasmids are combined and incubated with LR donase to produce that Jaggedl 
targeting vector after selection with Spectinomycin containing YEG agar plates. 
UTR: Untranslated region; L1 -4 and R1 -4: Gateway sites; S40pA: polyadenylation 
signal; hBact: Human beta -Actin promoter; Neo: Neomycin resistant gene; pA: 
polyadenylation signal; C1onNAT: C1onNAT Resistance gene; EM7: Bacterial 
promoter; ZeoR: Zeocin Resistance gene; PheS: gene for mutant phenylalanine t- 
RNA synthetase; AmpR: Ampicillin resistance gene; CcdB: cell division B; Cat: 
chloramphenicol resistance gene; AsiSI: linearization restriction enzyme site; Spec: 
Spectinomycin resistance gene; DTA: Diphtheria toxin gene; PGK: 
phosphoglycerate kinase 
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4.2.2.2 Producing the Jagged1 intermediate targeting vector and 
dtTomato targeting element 
The Jaggedl intermediate targeting vector is a modified BAC containing the Jaggedl 
gene with 5' and 3' 5kb homology regions to Jaggedl and gateway sites to allow 
insertion of the targeting element and vector backbone. The Jaggedl intermediate 
targeting vector was produced by inserting the gateway cassettes into the Jaggedl 
BAC using the Rec /ET recombination system. The pSC 101- BAD -ya 3A -tet plasmid 
contains genes that encode the X -phage proteins Red y, a, and 13 and the recA gene 
under the control of an arabinose inducible promoter as well as a gene encoding a 
RepA protein (Wang et al. 2006). The arabinose inducible promoter is activated 
when the AraC protein forms a complex with arabinose; the conformational change 
allows activation of the pBAD promoter. Red a and ß proteins catalyse homologous 
recombination. Red y inhibits RecBCD exonuclease activity of E.Coli so that linear 
DNA molecules are stable in the cell. RecA enhances homologous recombination. 
The RepA protein is temperature sensitive and is required for plasmid replication; 
therefore the plasmid would disappear from the cells unless they are grown at 30 °C, 
this allows for the removal of the pSC101 plasmid from the host E.Coli cells after 
recombineering of the BAC is complete. 
The Gateway cassettes were first amplified by high fidelity PCR with the 
introduction of 50bp homology arms, through primer design, for specific sites in the 
JAG1 BAC. The PCR reactions were treated with DpnI after amplification which 
destroys methylated DNA thereby removing the plasmid template DNA. The PCR 
product was purified and was ready for transformation. The U- fragment contains the 
L 1 and L2 gateway sites and the G- fragment contains the L3 and L4 gateway sites. 
The BAC host E.Coli were made electrocompetent and the recombineering plasmid, 
pSC 101- BAD- yaßA -tet, was electroporated into the cells and selected with 
chloramphenicol and tetracycline. The cells were then grown at 30 °C while the 
recombineering plasmid was required. Production of the recombineering proteins 
was induced by addition of arabinose. The host cells were made electrocompetent 
and the first gateway cassette, the U- fragment, was electroporated into the cells. 
Recombineering took place at 37 °C and after the cells were again grown at 30 °C and 
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selection with Zeocin and Tetracycline carried out. The host cells were again made 
electrocompetent and the second gateway cassette, the G- fragment was 
electroporated into the cells. Recombineering took place at 37 °C and after the cells 
were then grown at 37 °C, to remove the recombineering plasmid from the culture, 
and selected with Zeocin and Carbenicilin. This process is summarized in figure 4.6. 
The cell culture was then plated on agar containing Carbenicillin and Zeocin and 
colonies are examined for the presence of the Jaggedl intermediate targeting vector. 
The vector was isolated, analysed and prepared for the gateway reaction. 
The targeting element was generated using conventional restriction -ligation cloning 
techniques but, once generated, can be used with the intermediate targeting vector of 
different genes without modification. The pENTR2b- C1onNAT plasmid was first 
modified by the addition of a polylinker into the NotI and BspEI restriction enzyme 
sites, to add the other restriction sites necessary for ligation. The dtTomato 
fluorescent protein gene was then inserted into sites Sall and SspI, and the floxed 
selection cassette into sites EcoRV and BspEI. This is shown in figure 4.7. 
Restriction digests confirming successful production of the Jaggedl intermediate 
targeting vector and the dtTomato targeting element are shown in figure 4.8. 
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Figure 4.6: Creation of the Jaggedl intermediate targeting vector. 
The recombineering plasmid is transformed into the BAC host on day O. Cells are 
then maintained at 30 °C. After selection and 48hrs growth the transcription of the 
recombineering protein genes is induced by addition of arabinose and the U fragment 
is transformed into the cells. After selection and 48hrs growth again the transcription 
of the recombineering protein genes is induced by addition of arabinose and the 
GapRep fragment is transformed into the cells. After selection and 24hrs growth the 
Jaggedl intermediate targeting vector is purified from the host cells. 
UTR: Untranslated region; Cat: chloramphenicol resistance gene; R1 -R4: Gateway 
sites; ZeoR: Zeocin Resistance gene; PheS: gene for mutant phenylalanine t -RNA 
synthetase; AmpR: Ampicillin resistance gene; Chl: Chloramphenicol; Zeo: Zeocin; 
Carb: Carbenicilin; pBAD: Arabinose inducible promoter; pSC101 ori: temperature 
sensitive origin of replication; Tet: Tetracycline resistance gene. 
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Insert polylinker into 
Notl and EcoRV sites 
Insert Tomato fluorescent 
protein gene into Sall and 
Sspl sites 
Insert selection cassette 
into Sall and Sspl sites 
pL1 L2 ClonNat 
I 
CIonNAT 
Kozak- ATG- dtTomato 
Figure 4.7: Creating plasmid with targeting element. 
A polylinker containing various restriction sites was cloned into the pL1L2 
C1onNAT plasmid. Then the dtTomato fluorescent protein gene with f3-globin intron 
and SV40 polyadenylation signal was cloned into the Sall and SspI sites followed by 
a loxP flanked Neomycin resistant gene with a human [3-actin promoter cloned into 
the BspEI and EcoRV restriction sites. 
L1 -2: Gateway sites; ori: origin of replication; S40pA: polyadenylation signal; 
hBact: Human beta -Actin promoter; Neo: Neomycin resistant gene; pA: 
polyadenylation signal; C1onNAT: C1onNAT Resistance gene. 
A 
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Figure 4.8: Restriction digest confirmation. 
Restriction digest of clones from A: intermediate targeting vector production and B: 
targeting element production. 
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4.2.3 Jagged 1wt/tomato ES Cells 
Mouse ES cells have efficient rates of homologous recombination with isogenic 
DNA (te Riele et al. 1992). The pure, linearized final targeting vector was 
electroporated into C57BL /6 ES cells (JM8.A3.N1) that contain a functioning agouti 
locus (Pettitt et al. 2009). ES cell clones with successful insertions are resistant to 
Geneticin due to the presence of the Neomycin resistance gene and were selected for 
by culturing for 10 days in the presence of Geneticin. Insertion of the linearized 
vector into double stranded breaks of the ES cell genome resulted in cell death due to 
the presence of the diphtheria toxin gene in the backbone of the targeting vector. 
After ten day's selection colonies were picked, expanded and then genotyped by 
PCR. The correct insertion was verified by southern blot of the 5' end and 3' end of 
the insertion (fig 4.9) and successful clones expand and stored. Clones with bands of 
the expected size were called knock -in clones (for example clone 6), clones with 
bands which were not the size of wild -type bands but not the expected size of a 
knock -in band were called random insertions. This could happen if the linearized 
vector was broken and the diphtheria toxin gene removed or damaged. Insertion of 
the remaining targeting vector into double stranded DNA breaks would then be 
possible. 
It has previously been shown that Jaggedl is expressed in ES cells (Lowell et al. 
2006). Flow cytometry and fluorescent microscopy of FMD11 (Jaggedl 
Wv"nat° 
knock -in ES cell line) cells showed dtTomato expression (fig 4.10). Another 
wt/tomato knock -in line examined showed similar results and the FMD11 line 
was taken forward for production of chimeras. 
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Figure 4.9: Southern Blot to confirm insertion of dtTomato fluorescent protein 
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Figure 4.10: dtTomato expression in Jagged1"tomato Knock -In ES Cells. 
A: Flow cytometry of 7AAD- cells for dtTomato fluorescence. B: Fluorescent 
microscopy for dtTomato fluorescence. JM8.A3.N1: C57BL6 ES cell line. FMD11: 
Jaggedl`t0mato Knock -in ES cell line. FMD11 representative example of Jagl"``Jt°m 2 
knock -in lines examined. 
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4.2.4 Jaggedl"t°mat° mouse line 
4.2.4.1 Generation and transmission 
Targeted ES cells contain a dominant functioning agouti locus (Pettitt et al. 2009). 
When injected into the blastocysts of C57BL /6 mice germ -line transmission of the 
ES cell's genetic material could be tracked by the presence of agouti pups in 
chimera's litters (fig 4.11a). The chimeras were a chocolate brown colour (fig 4.11b). 
Since only 1 allele of agouti in the JM8.A3.N1 ES cells was restored the modified 
Jaggedlt °mat° locus could be present in any of the chimera offspring (agouti or black). 
Jaggedl t0mat° positive pups were genotyped by PCR (fig 4.11c). The successfully 
produced Jagged1% t °mat° mice still contained the floxed beta -actin neomycin 
selection cassette. Jaggedl"t0mat0 mice were crossed with germ -line expressing cre 
mice and removal of the selection cassette confirmed by PCR (fig 4.11d). Excision of 
the selection cassette did not significantly affect tomato expression (data not shown). 
All analysis of Jaggedl "t °mat° mouse tissue shown in the remainder of this chapter 
was carried out using the Jagged l tomato line after selection cassette removal. 
The expected Mendelian inheritance for the Jagged]. tomato allele in Jaggedl"t°mat0 to 
Jaggedl`"e't crossings is 50 %. Analysis of four litters (38 pups) showed 
approximately 39% Jaggedlt °mat° offspring, slightly lower than expected but not 
outside the normal range for a sample of this size. 
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Figure 4.11: Production of Chimeras from Jagged1`O1`O Knock -In ES Cells. 
A: Schematic of targeted ES cell tracking. B16 ES cells with one agouti allele 
restored are correctly targeted. These cells are then used to produce chimeras with 
B16 blastocysts. The chimeras are then crossed with B16 mice. Agouti pups in the 
resultant litters indicates germ line transmission of the genetic material from the 
targeted ES cells and the Jaggedlk"tO knock -in locus will be in either black or agouti 
pups of a pure B16 background. A: agouti locus. a: non -functional agouti locus 
(adapted from (Pettitt et al. 2009) B: Picture of JNMS.A3.N 1 targeted ES celVVBl6 
chimeras. C: "* " is positive control. "-" is H2O control. PCR genotypíng of chimera 
offspring shows germ -line transmission of Jaggedll'`° knock -in allele. Jaggedl 
tomato band is 994óp. Ladder used 1 Kbp plus (Invitrogen). D: "+" is positive 
control. S1 -" is H2O control. Genotypíng of Cre crossed pups. Sample 5 shows 
Jagged' tomato positive PCR but not neomycin indicating excision of the selection 
cassette. Jagged 1 tomato band is 994óp. Neomycin band is 460 bp. Ladder IKbp 
plus (Invítrogen). 
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4.2.4.2 Validation of Jaggedl`Omat° transgenic mice 
Experiments to confirm that dtTomato expression in the Jagged rtiumnaw line 
correlates with Jaggedl expression were carried out. Firstly tissue from the head of 
an E12.5 embryo was sorted based on dtTomato expression and RNA extracted from 
the resultant cells (fig 4.12). The mRNA expression was investigated by qRT -PCR. 
dtTomato and JAG1 expression in dtTomato negative cells was taken as 1 and 
dtTomato and JAG1 expression relative to these cells was assessed. As shown in 
figure 4.13 relative to negative cells dtTomato low cells had higher dtTomato and. 
JAG! expression and dtTomato high cells had higher again dtTomato and JAG1 
expression levels. This result indicates that dtTomato and JAG1 gene expression 
correlate. 
Fluorescent microscopy of E11.5 Jagged l "`u`°mat° embryos are shown in figure 4.13a. 
dtTomato expression correlates with known Jagged! expression patterns at this time 
point (Le et al. 2009; Ramos et al. 2010; Sheth et al. 2007; Watanabe et al. 2006). A 
Jaggedl"°°'`°maCO E11.5 embryo was dissected and examining under a fluorescent 
microscope (fig 4.13b). dtTomato expression can be seen in a distinctive stripe 
pattern across the neural tube, the endothelium of the dorsal aorta, the developing 
e e, the head and the limbs. Flow cytometry analysis of adult thymic tissue shows 
that, as expected, dtTomato is expressed in thymic epithelial cells but not in other 
Lin-cell types (fig 4.14) (Lehar et al. 2005; Felli et al. 1999). 
To better understand how Jaggedl protein expression and dtTomato protein levels 
correlate co- staining for Jagged! and dtTomato was carried out. Transverse sections 
of E11.5 Jaggedl embryos were stained for dtTomato and Jagged! (fig 4.15). 
40x magnifications show that E11.5 neural tube cells which are Jagged! positive are 
not always dtTomato positive and vice versa. The dtTomato protein is an indicator of 
JAG! transcription and therefore cells which are not actively transcribing JAG! may 
still contain Jagged! protein but have lost dtTomato. Conversely cells which are 
actively transcribing JAG1 (and hence dtTomato) may not yet contain mature 
Jaggedl protein. 
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Figure 4.12: Sort and qRT -PCR for JAG1 and dtTOMATO. 
7AAD- live cells from the head of a E12.5 Jaggedl- dtTomato embryo were sorted 
based on dtTomato expression. RNA was extracted from resultant cells convert to 
cDNA by RT -PCR and quantified by qPCR. OP9 stromal cells were used as a qRT- 
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Figure 4.13: Jaggedrt /tomato E11.5 embryo. 
A: Florescent microscopy of El 1.5 wild -type and Jagged l "t°mat° embryos. 
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Figure 4.14: Jaggedl"/tomato Adult Thymus epithelial cells. 
Flow cytometry of Lin- adult thymic cells shows that as expected Jaggedl is 
expressed in the EPCAM+ epithelial cells but not in EPCAM- stromal cells. Carried 










Figure 4.15: Transverse sections from E11.5 Jaggedl Wt /tomato Embryos stained 
with anti -Jaggedl and anti -Tomato antibodies. 
White box indicates magnified region. Arrows indicate some double positive cells. 
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4.2.4.3 Multilineage analysis 
As this line is a knock -in and heterozygous for Jaggedl multilineage analysis of 
Jagged] "tomato adult mice was carried out. This analysis showed myeloid and 
lymphoid contribution in the bone marrow, spleen and thymus comparable to wild - 
type littermate control (fig 4.16). 
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Figure 4.16: Multilineage analysis of Jaggedrtit0mat° adult mouse. 
Flow cytometry analysis of 7AAD "CD45+ cells in Jagl"w` and Jag1\ 
t°mat° adult 
littermates A: CD3 and B220 lymphoid populations of the bone marrow and spleen. 
B: Macl and Grl myeloid populations of the bone marrow and spleen. C: CD4 and 
CD8 lymphoid populations of the thymus. 
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4.3 Analysis of Jaggedl Expression in E11.5 Embryo Using 
the Jagged1wtIt°mat° Reporter Line 
4.3.1 Fluorescent Microscopy of E11.5 Jagged1`"tt °mat °AGM 
region 
A dissected AGM region from an E11.5 Jaggedl "'t /t °mat° embryo was examined under 
a fluorescent microscope (fig 4.17a). In the AGM region the whole length of the 
dorsal aorta is positive and the developing mesonephric tubules contain bright 
dtTomato cells. Confocal analysis of transverse sections of El 1.5 Jagged 1wut°mato 
AGM region stained with anti -tomato and anti -Jaggedl shows a good co- localisation 
of Jaggedl and dtTomato (fig 4.17b). The cells of the endothelial layer of the dorsal 
aorta express Jaggedl and dtTomato and no obvious dorso- ventral polarity of either 
protein is observed. Closer examination of an HIAC shows that the cells of the 
endothelium of the dorsal aorta and the cells of the cluster express both Jaggedl and 
dtTomato (fig 4.17b lower panel) as in Jaggedl stained wild -type embryos. 
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Figure 4.17: dtTomato -Brightfield merge of E11.5 Jaggedlwt /t°mat° segments. 
A: dtTomato -Brightfield merge of E11.5 Jagged 1 wutomato AGM region. B: Transverse 
sections from E11.5 Jagged 1 wt/tomato embryos stained with anti-Jaggedl and anti - 
Tomato antibodies. White box indicates magnified region. D: dorsal; V: Ventral 
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4.3.2 Flow Cytometry of E11.5 Jagged1`"tit°mat° 
In order to study Jaggedl expression at E11.5 in the different cell types of the 
developing haematopoietic system, Jaggedl tomato E11.5 AGM region and yolk sac 
were dissected and dissociated. Cells were stained for Ter119 (for RBC exclusion), 
Notchl, CD45, CD41 and VE- Cadherin. Due to the presence of Notchl +, Jaggedl+ 
double positive cells previously reported co- expression of these markers was 
analysed (Robert- Moreno et al. 2008). Notchl and Jaggedl (dtTomato) expression 
were analysed in the populations of interest. Figures 4.16 and 4.17 show Notchl and 
Jaggedl gating of these populations in the E11.5 AGM region and yolk sac 
respectively. 
In the AGM region, the mature haematopoietic (CD45+VE- Cadherin) and 
CD45+VE- Cadherin+ populations have the lowest proportion of Jaggedl positive 
cells and the endothelial (CD41"CD45VE- Cadherin+) and CD41 +CD45 "VE - 
Cadherin+ populations have the highest (fig 4.18). The proportions of 
Jaggedl+Notchl+ cells are also lowest in the CD45+ populations and highest in the 
pre -HSC Type I containing population (CD41 +CD45VE- Cadherin+). Though 
sections of the AGM region show the endothelial cells of the dorsal aorta are 
Jaggedl and dtTomato positive, flow cytometry analysis shows the AGM region 
contains 2 different endothelial populations Jaggedl+ and Jaggedl". The endothelial 
dtTomato" population can contain Jaggedl" venous endothelial cells (Villa et al. 
2001) and/or cells which may express Jaggedl protein but are not dtTomato positive. 
In figure 4.19 analysis of the yolk sac shows that, as in the AGM region, the CD45" 
populations express higher proportions of both Notchl and Jaggedl with little or no 
Jaggedl expressed in the CD45+ populations. There are no Jaggedl+Notchl+ cells in 
the CD45+VE- Cadherin+ population of the yolk sac and in addition there is a lower 
proportion of Jaggedl hi cells in the CD41 +CD45VE- Cadherin+ population of the 
yolk sac (figures 4.18 and 4.19 red box). This absence /reduction of Jaggedl+Notchl+ 
cells in the yolk sac populations phenotypically equivalent to phenotypically defined 
pre -HSC populations in the AGM region might be a marker of the functional 
difference between these cells in the AGM region versus the yolk sac related to HSC 
production. 
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Figure 4.18: Flow cytometry E11.5 Jagged1"'°m'`"AGM region. 
Notch! and Jagged 1 expression in populations of interest in Jagged 1 E 11,5 
AGM region. Cells were first gated as 7AAD- Ter119 ". Lower panel shows FMO 
Notch 1 control on wild -type AGM region. Representative example of 3 repeat 
experiments. 
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4.3.3 Functional Analysis of Jaggedl +Notchl+ Cells 
It has previously been shown that Jaggedl+Notchl+ cells in the AGM region are also 
GATA2 positive which suggests that they are cells involved in haematopoietic 
development (Robert- Moreno et al. 2005). To determine if this double positive 
population contained pre -HSCs, the E11.5 AGM region from Jaggedl% tomato mice 
was sorted into 4 populations based on Jaggedl and Notchl expression (fig 4.20a). 
After sorting cells were co- aggregated with OP9 stromal cells and cultured for five 
days and the resultant cells were analysed. This culture technique allows for the 
maturation and expansion of pre -HSCs to dHSCs (Taoudi et al. 2008; Rybtsov et al. 
2011). After culture only co- aggregates from Jaggedl+Notchl+ cells produced HSCs 
(fig 4.20b) and these HSC were capable of producing multilineage engraftment (fig 
4.20c). The co- aggregates of double positive cells also contained the highest number 
of live cells and largest fold increase in cell number (fig 4.20d and e). Flow 
cytometry analysis (fig 4.21a) showed that double positive cells produced the highest 
proportion of haematopoietic CD45+VE- Cadherin and CD45+VE- Cadherin+ cells. In 
contrast the JaggedlNotchl+ population produced the highest proportion of 
endothelial cells (CD41-CD45- VE- Cadherin+). All populations produced some CFU - 
Cs after culture (fig 4.20b) with the Jaggedl+Notchl- and double negative 
populations producing the highest proportion of haematopoietic progenitors (fig 
4.20c). However the best mix of CFU -C types, which included the most multilineage 
CFU -GEMM, was produced almost exclusively by the JaggedliNotchl+ co- 
aggregates (fig 4.20b). All co- aggregates produced all 3 endothelial colony types (fig 
4.20d). The JaggedlNotchl+ co- aggregates produced the highest proportion of 
endothelial progenitors (fig 4.20e). In conclusion Jaggedl{Notchl+ cells give the best 
haematopoietic output after culture and pre -HSCs in the E11.5 AGM region are 
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Figure 4.20: Analysis of E11.5 Notchl +Jagged1+ AGM cells after culture (parti). 
A: Example of sort. Live (7AAD-), Ter119- cells from E11.5 Jaggedl`"`/tomato AGM 
region were sorted into 4 populations based on Jaggedl (dtTomato) and Notchl 
expression. B: Long -term repopulation (4 months) after co- aggregate culture. 1 co- 
aggregate (lee) transplanted per irradiated recipient. All HSCs are produced from 
Jaggedl+Notchl+ (J1+N1 ) cells. Each square represents 1 recipient. Results obtained 
from 3 independent experiments. C: Flow cytometry analysis of donor derived 
J1+N1+ co- aggregate repopulated mice show that HSCs derived from these cells can 
repopulate all blood lineages. Representative example of 2 analysed recipients. D: 
Number of live cells per co- aggregate after culture. E: Fold increase in cell number 
per co- aggregate during culture. J1+N1+ co- aggregates have the highest cell number 
and highest fold increase after culture. Results of D and E from 2 independent 
experiments. Bars indicate Median. 
1 experiment of transplantation and post culture analysis carried out by Heather 
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Figure 4.21: Analysis of E11.5 Notchl +Jagged1+ AGM cells after culture (part2). 
A: Flow cytometry of co- aggregate cells after culture. The trend indicates that 
J1 4N1+ co- aggregates produce a higher proportion of haematopoietic CD45+VE- 
Cadheriri (* * : p= 0.0079) and CD45+VE- Cadherin+ cells and the J 1 "N 1 + co- 
aggregates produce a higher proportion of endothelial VE- Cadherin +CD41 -CD45" 
cells ( * *: p= 0.0079). Bars indicate Median. B: Haematopoietic progenitor assay after 
culture shows that all co- aggregate types can produce CFU -Cs after culture. C: 
Number of CFU -Cs per 1,000 cells. D: Number of endothelial colonies produced 
after co- aggregate culture per 1 co- aggregate (lee). E: Number of endothelial 
colonies per 10,000 cells. Results from 2 independent experiments. Experiment 2 
performed by Heather Wilson. 
CFU -C: colony forming unit - culture; BFU -E: burst forming unit erythroid; Mac: 
macrophage; GM: granulocyte, macrophage; GEMM: granulocyte, erythroid, 
macrophage, megakaryocyte; Net: network ( >6 main tubules) of endothelial tubules; 
4 -6: network of 4 -6 main endothelial tubules; 1 -3: single or network of 2/3 main 
endothelial tubules. 
1 experiment carried out by Heather Wilson, Medvinsky lab. 
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4.4 Discussion 
Previous studies have shown that Jagged! is expressed in the AGM region in the 
dorsal aorta. In situ hybridization shows a ventral polarity of Jaggedl expressions at 
E10.5, and cells of the HIAC are positive for Jagged! (Robert- Moreno et al. 2008; 
Robert- Moreno et al. 2005). Antibody staining of the Jaggedl protein shows that the 
endothelium of the dorsal aorta is fully positive with no obvious ventral polarity 
(Robert- Moreno et al. 2008) This was confirmed by immunohistochemistry using a 
phage anti -Jaggedl antibody obtained from the McCafferty lab in Cambridge. The 
antibody had flag, human Fc and His6 regions for secondary antibody detection. The 
antibody was derived against the extra cellular portion of the Jaggedl protein and 
therefore possible to use for flow cytometry. However, co- staining with other 
antibodies in cell suspension proved problematic and a solution was not reached 
during this project (results not shown). In the meantime a method to detect Jaggedl 
expression of live cells by flow cytometry was required for this project. No previous 
Jaggedl reporter line had been reported and therefore the Jaggedl wutomatO line was 
produced. 
The fidelity of the Jagged! wt/tomato transgenic line in marking Jaggedl expression was 
assessed. At an mRNA level there was good correlation of JAG1 and TOMATO 
mRNA expression. Examining adult thymic tissue from Jaggedlwut°mat° by flow 
cytometry, thymic epithelial cells, which are known to be Jaggedl expressing, were 
dtTomato positive and non -thymic epithelial cells were dtTomato negative (Lehar et 
al. 2005; Felli et al. 1999). E11.5 Jaggedl"tomato embryos expressed dtTomato 
fluorescent protein in a pattern similar to known Jaggedl expression patterns, namely 
in the developing heart, eye, limb and head, including the distinctive stripe pattern of 
positive cells across the developing neural tube (Le et al. 2009; Manderfield et al. 
2012; Ramos et al. 2010; Watanabe et al. 2006). A closer look at Jaggedl protein and 
dtTomato protein co- localisation in the neural tube by confocal analysis of 
Jaggediwt/tomato E11.5 embryos showed that not all Jagged!+ cells are dtTomato and 
vice versa. The Jaggedltomato knock -in gene is a transcription reporter. After 
transcriptional regulation JAG1 mRNA undergoes translation to an amino acid chain 
which is then modified to and transported to produce a functional Jaggedl ligand at 
the cell surface with a certain half -life. These other processes undergo specific 
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regulation and translation, maturation and stability of the dtTomato fluorescent 
protein will not be subject to the same regulations. Cells which contain Jaggedl 
protein may no longer be undergoing active transcription of the Jaggedl gene and the 
dtTomato mRNA/protein produced during transcription may have decayed. 
Conversely dtTomato protein may be present in cells where Jaggedl transcription 
has recently been activated but from which no mature Jaggedl protein has yet been 
produced. Possible strategies to produce a reporter of Jaggedl protein expression 
may include the production of a fusion protein where the Jaggedl gene fused to a 
fluorescent protein gene; therefore fluorescence would be bound to the Jaggedl 
protein. This method is difficult as both Jaggedl and dtTomato need to be able to 
correctly fold and be functional. The addition of an amino acid sequence to Jaggedl 
may change its ability to correctly fold, function and undergo regulating 
modifications. In addition, Jaggedl and dtTomato proteins would still have different 
stabilities. Another strategy could be to produce a Jaggedl dtTomato fusion gene in 
which the stop codon from the Jaggedl gene is removed and the dtTomato gene 
sequence inserted in frame after the Jaggedl sequence separated by a T2A or IRES 
sequence. The mRNA produced would encode Jaggedl and dtTomato but after 
translation, when using a T2A linker, the link amino acid breaks giving rise to two 
separate proteins, or the IRES sequence would allow translation of Jaggedl and 
dtTomato from the same mRNA molecule. This is a translational reporter that would 
allow further tracking of Jaggedl expression than the Jaggedlt °mat° transcriptional 
reporter but again the two separate proteins would not undergo the same regulatory 
process and or have the same half -life. For the study of Jaggedl expression in the 
AGM region at E11.5 the Jaggedlt°mat° transcription reporter produced may be 
sufficient as dtTomato and Jaggedl co- localise well in the dorsal aorta. 
Another consequence of this reporter design is that the resultant mice are 
heterozygous for Jaggedl. Although Jaggedl heterozygous mice survive to adult- 
hood and are fertile they do have eye defects and some deficiency in haematopoiesis 
at E10.5 has been observed (Le et al. 2009; Xue et al. 1999; Robert- Moreno et al. 
2008). As well as this, it is not understood what effect on gene regulation this 
deficiency might have, i.e. are other Notch ligands up- regulated to compensate? A 
possible alternative could be to create a transgenic line in which a BAC containing 
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the Jaggedl gene locus is modified in a similar way to the Jaggedl locus in the 
Jaggedlt°mat° mouse line. The whole BAC can then be linearized and allowed to 
insert randomly into the genome of ES cells. The downsides to using this approach 
include: the insertion site might also disrupt another gene; the BAC may not contain 
all the regulatory elements of the Jaggedl locus; the insertion site may not be 
available for transcription simultaneously with the Jaggedl gene due to its different 
chromosomal location. It is clear that all strategies for producing a reporter line have 
their positive and negative aspects. The Jaggedlt °mat° line produced here seems to be 
a faithful reporter of Jaggedl transcription and could be useful in tracking Jaggedl 
expressing cells to better understand their role in various developmental and adult 
processes. 
Confocal analysis of the E11.5 AGM region showed that Jaggedl is expressed in the 
endothelial cells of the dorsal aorta and in the cells immediately surrounding the 
dorsal aorta. Flow cytometry showed that Jaggedl is expressed in cells of the 
developing haematopoietic system and endothelial cells. Jaggedl+ and Notchl+ 
double positive cells are also present in all the populations examined. There are little 
to no Jaggedl+Notchl+ cells in the yolk sac's CD45+VE- Cadherin+ population and 
few Jaggedlh'Notchl+ cells in the CD41 +CD45-VE- Cadherin+ population. This may 
indicate that these cells are functional pre -HSCs which are not present in the yolk sac 
at this stage. Further functional analysis of the Jaggedl+Notchl+ cells from the E11.5 
AGM region showed that after culture all HSCs were produced from the double 
positive population. This population also had the highest fold increase in cell number 
and the highest proportion of CD45 +VE- Cadherin and CD45+VE- Cadherin cells 
produced. 
In the previous chapter some pre -HSCs were shown to be Notchl- this indicates that 
if more sorted Jagged"t0mat0 E11.5 cells were cultured some pre -HSCs would be 
present in the Notchl- compartment. It is possible that in this line the heterozygous 
expression of Jaggedl may have an effect on Notchl marking of pre -HSCs, as Notch 
signalling is known to be involved in its own regulation, however, flow cytometry 
analysis did not show any obvious differences in Notchl expression between wild - 
type and Jagged`" /t°mat° in the E11.5 AGM (data not shown). Further experiments are 
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required to confirm if some pre -HSCs are Notchl negative in this mouse line. In 
addition as discussed in the previous chapter the level of HSCs produced is less than 
expected. This again indicates that the Notchl antibody may partially block pre -HSC 
maturation and proliferation, and/or HSC proliferation. However, despite the 
limitations out -lined these functional experiments indicate that Jagged1+Notchl+ 
cells from the E11.5 AGM region are the precursors of HSCs. Using these markers 
gives approximately a 1 in 8 and 1 in 3 enrichment for pre -HSC Type I and II cells 
respectively, making a significant contribution to determining the exclusive 
phenotype of pre -HSCs. This would be a very powerful tool, allowing single cell 
analysis of the developing haematopoietic system. 
Due to the small amounts of tissue available Jaggedl and Notchl sorting was carried 
out on whole E11.5 AGM region. Future work would include further sort 
experiments of Jaggedl "t °mat° embryos at E11.5 and E10.5 with the inclusion of 
Notchl and other pre -HSC markers to more precisely determine the phenotype of the 
pre -HSCs. If it was determined that pre -HSC Type I were Jaggedlh'Notchl+ this 
phenotype would give 1 in 10 enrichment for pre -HSC Type I cells in the 
CD41 +CD45-VE- Cadherin+ population. Direct transplantation of sorted 
Jaggedl "tomato E11.5 AGM region may also be carried out to determine whether 
HSCs express Jaggedl. Mapping of Jaggedl expression throughout early 
haematopoietic development is now possible using this Jaggedl "t °mat° mouse line 
bringing us closer to understanding the spatial and temporal role of Notch signalling 
in haematopoietic development. 
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5 HSC development in Jaggedl ° /° Embryos 
It has previously been shown that intra- embryonic haematopoiesis is impaired in 
Jaggedl knock -out (Jaggedl° °) embryos whereas primitive yolk sac haematopoiesis 
is unaffected. These embryos cannot efficiently generate haematopoietic progenitors 
and expression of GATA2 and Runxl, two critical transcription factors involved in 
haematopoiesis, are reduced (Robert- Moreno et al. 2008). This phenotype can 
partially be rescued by ectopic GATA2 expression during culture. Moreover 
stratification of the aortic endothelium was observed in Jaggedl °° embryos 
indicating a possible block in the endothelial -haematopoietic transition (Robert- 
Moreno et al. 2008). Taken together these results indicate that Jaggedl is involved in 
hematopoietic development. However the role of Jaggedl in dHSC development has 
never been elucidated partly due to the fact that the mutant embryos die around 
E10.5 before the emergence of the first dHSCs (El 1). 
In this chapter the role of Jaggedl in HSC development is examined in greater detail. 
Firstly its importance in HSC development is assessed by deleting Jaggedl 
specifically in the HSC lineage. Secondly, conventional Jaggedl embryos were 
investigated for the presence of functional pre -HSCs. 
5.1 Cell Autonomous Deletion of Jaggedl during HSC 
Development 
In the previous chapter it was shown that Jaggedl is expressed in endothelial cells, 
haematopoietic cells and pre -HSCs. Pre -HSCs were shown to be Notchl +Jaggedl+ 
double positive. It is therefore unclear in which cell population Jaggedl is important 
for haematopoietic development. Is Jaggedl required in a cell autonomous or cell 
non -autonomous manner? 
To determine if Jaggedl is required cell autonomously in the HSC lineage, a 
conditional Jaggedl" line was crossed with CD41 -Cre expressing line (Emambokus 
& Frampton 2003) and a sGFP reporter line (Gilchrist et al. 2003). The CD41 -Cre 
line expresses Cre recombinase under the control of the CD41 promoter and can 
activate sGFP in early E9.5 dorsal intra -aorta clusters and in approximately half the 
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pre -HSC Type I population at E10.5 (Emambokus & Frampton 2003; Rybtsov et al. 
2011). The sGFP allele contains a floxed stop cassette which is removed after cre 
mediated recombination allowing constitutive activation of GFP expression. In the 
resultant JaggedlmiCD41- Cre +sGFP+ embryos, Jaggedl should be deleted in HSC 
precursors before the emergence of the first HSC. Cells in which cre mediated 
recombination has taken place are marked by the activation of constitute GFP 
expression allowing lineage tracing. 
Compound Jagged 1 °ACD41- Cre +sGFP+ adult mouse survive and GFP+ cells were 
able to contribute to the adult haematopoietic system at a level similar to that 
observed in JaggedleflCD41- Cre +sGFP+ mice indicating Jaggedl deficiency does 
not block development of adult HSCs. They also exhibit normal contribution to both 
myeloid and lymphoid lineages (fig 5.1a). We showed by southern blot that the 
majority of GFP+ cells in the bone marrow of the Jagged1°/flCD41- Cre +sGFP +mouse 
were deleted for Jaggedl (fig 5.1b). Genotyping of individual haematopoietic 
colonies issued from the bone marrow of the Jagged1m1CD41- Cre +sGFP+ mouse 
shows that haematopoietic progenitors are derived from both Jagged1ml and 
Jaggedl HSCs (fig 5.1c). 10 GFP+ colonies were genotyped of which six were 
Jaggedl°/°. 12 GFP" colonies were genotyped of which ten were Jaggedlfl /°. 
These results indicate that Jagged1°L° cells can develop into HSC. Unpublished data 
obtained in the lab suggest that CD41 -Cre only triggers deletion of the gene of 
interest during pre -HSC development and not in adult HSCs. However this needs to 
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Figure 5.1: Cell autonomous deletion of JAG1 during HSC development 
A: Jagl "fl and Jagl °1fl mice positive for CD41 -Cre and sGFP had a similar number 
of GFP positive cells in the bone marrow with similar contribution to the myeloid 
and lymphoid lineages. B: Southern blot of bone marrow DNA of different 
genotypes shows wild -type and deleted or recombined allele. GFP positive sorted 
cells from a Jag! °/fl, CD41 -Cre +, sGFP+ mouse contained mostly Jag 1 ° or 
recombined allele and very little Jag1fl allele. C: Genotyping of CFU -Cs from 
Jagged 1 °/fl, CD41 -Cre +, sGFP+ bone marrow Jag 1 ° band 13 85óp, Jag 1 fl band 317óp. 
Positive control: tissue from Jagl' mouse. Negative control: H2O. Ladder 1 Kbp 
plus (Invitrogen). 
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5.2 Analysis of Haematopoietic Development in Jaggedl 
Knock -Out Embryos 
5.2.1 Characterisation of Jaggedl Knock -Out Line 
Jaggedl constitutive knock -out embryos were produced by crossing a conditional 
Jaggedl line (Nyfeler et al. 2005) with a line which expresses cre during 
spermatogenesis, CD41 -Cre (Emambokus & Frampton 2003). Germline deletion 
occurs in some cases and some of the offspring from JaggedlfliwtCD41 -Cre+ 
contained a fully deleted Jaggedl allele, Jaggedl °. The Jaggedl"° line was 
maintained as a heterozygous line which was viable and fertile and with no obvious 
defects. Timed matings were setup between Jaggedl `"° males and females to obtain 
Jaggedl°° embryos at E 1 0 before embryo lethality (around E10.5) (fig 5.2). 
Although these Jaggedl mutants used are not the same as previously described 
(Robert- Moreno et al. 2008), both lines have deletion of exonl of the Jaggedl locus 
and lack Jaggedl mRNA (fig 5.2b) and Jaggedl protein (Xue et al. 1999; Nyfeler et 
al. 2005); both were crossed onto C57BL /6J background. All experiments shown 
here were carried out on mice with greater than ten backcrosses to C57BL /6J. 
Jaggedl°° embryos at E10 were either indistinguishable from wild -type and 
Jaggedl" °, or had gross defects such as haemorrhaging or heart oedema (called 
Jag1 °° obv (obvious)) in approximately 50% of cases (fig 5.2c). Mendelian 
inheritance of the Jaggedl° allele, at El 0 was normal (50% het, 24.3% null) and 
Jaggedl °J° embryos were only very slightly retarded compared to wild -type and 
Jagged 1 "° littermates (Table 5.1). Jag 1 °° and Jag 1 °° obv are presented as one group 
in this chapter as no significant difference between them, in relation to the analysis 
performed, was observed. 
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Table 5.1: Inheritance Jagl° and average age of embryos 
Jagl "* Jat "tee Jag1°eJag1° °obv 
No. embryo (11 litters) 18 35 8 9 
Mendelian Ratio ( %) 25.7 50.0 11.4 12.9 
Average s.p. 33 ±2.3 33 ±1.8 31 ±1.4 31 ±1.7 
C 
t- 
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Figure 5.2: Genotyping and gross morphology of Jaggedl°I° embryos 
A: Genotyping of embryos. WT band 267óp. Jagl° band 1385bp. Ladder 1Kbp plus 
(Invitrogen). B: qPCR results showing relative expression of JAG1 in E10 AGM 
region (Wild -type set as 1). C: E l 0 Jag 1 `` w% Jag l °V" and Jag 1 °J° embryos. Obv 
indicates Jagl mutants which are distinguishable from littermates due to gross 
defects. Arrows indicate haemorrhages and heart oedema. lx obj 3z. 
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5.3.2.1 Confocal analysis of E10 Jagged1°/° Dorsal Aorta 
Previously published data shows that the dorsal aortas of Jaggedl mutants contain a 
stratified endothelial layer and Runx1+ cells are reduced or absent (Robert- Moreno et 
al. 2008). To confirm if this was true for our line, whole -mount staining and 
immunohistochemistry of fresh frozen sections of wild -type, Jaggedl \ °, and 
Jaggedl°° embryos was performed. 
Whole -mount staining against VE- Cadherin, CD45 and Runxl followed by confocal 
analysis showed that the endothelium of the dorsal aorta in Jaggedl embryos did 
not appear stratified compared to that of wild -type or Jaggedl\ °embryos (fig 5.3a). 
Jaggedl mutants still contained Runxl+ and CD45+ cells although in lower numbers. 
Transverse sections of the El0 AGM region of Jaggedl °° embryos showed a dorsal 
aorta with a smaller lumen but again no obvious thickening of the endothelial layer 
was identified. These results show that the Jaggedl mutants analysed do not have 
abnormal aortic endothelium although indications of an impaired haematopoietic 
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Figure 5.3: Confocal analysis of Jaggedi mutant embryos 
A: 20x sagittal sections of the dorsal aorta of whole -mount El() embryos stained for 
CD31, Runxl and CD45. In all examples the dorsal aorta endothelial layer closest to 
the left is the ventral side. Jagl&° embryos do not seem to have and obvious 
thickening of the endothelial layer of the dorsal aorta compared to wild -type or 
Jagl`i °. They do express CD45 and ventral Runxl but seem to have less of these 
positive cells and less clusters. B: Transverse section of El 0 embryos through the 
AGM region stained for VE- Cadherin and CD45. The dorsal aorta of the Jagl61° 
embryo has a smaller lumen but no obvious thickening of the endothelial layer of the 
dorsal aorta. Representative examples of 2 independent experiments. 
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5.3.2.2 Progenitor Assays and Flow Cytometry of E10 Jaggedl°° 
Embryos 
Previously published data showed that intra- embryonic but not yolk sac 
haematopoietic progenitors were reduced in Jagged16J° embryos (Robert- Moreno et 
al. 2008). We confirmed this for our mutant line and performed a more in -depth 
analysis of the cells types affected in the Jaggedl°m° mutants. Haematopoietic 
progenitor assay showed that less CFU -Cs are produced in the Eli) Jaggedl°/° AGM 
region than in the wild -type (p= 0.0095) (fig 5.4a) although similar numbers of CFU - 
Cs were produced by Jaggedl°!° and wild -type yolk sacs (fig 5.4b). Although CFU -C 
numbers are impaired in Jaggedl°/° AGM regions, there is no selective reduction in 
one type of progenitor over another, indicating a general impairment of progenitor 
production or proliferation. 
The number of live cells in the Jaggedl°l° AGM region was comparable to wild -type 
(fig 5.4d). Flow cytometry analysis revealed lower proportions of haematopoietic, 
CD45+VE- Cadherin and CD45+VE- Cadherin+ (pre -HSC Type II like cells), 
populations in Jaggedl°J° embryos than control embryos (fig 5.4e). The pre -HSC 
Type I enriched haematopoietic population (VE- Cadherin +CD41 +CD45 ) was also 
slightly decreased in Jaggedl°l° embryos compared to controls (fig 5.4e). These 
observations córrelate with the reduction of CFU -Cs. 
As previously discussed, the dorsal aorta of Jaggedl°/° embryos were reported to 
have a stratified endothelial layer although we have not seen this in our mutants by 
microscopy analysis. To further investigate this point, cells from El 0 AGM region 
were added to an endothelial progenitor assay. Jagged161° AGM regions did not have 
a greater number of endothelial progenitors (fig 5.4c) and flow cytometry analysis 
revealed the proportion of endothelial cells (CD41"CD45-VE- Cadherin +) similar in 
Jaggedl°/°, Jaggedl`'`° and wild -type embryos (fig 5.4e). This confirms our 
observation that Jaggedl mutants do not contain an excess of endothelial cells. 
By flow cytometry cell numbers and the proportions of haematopoietic populations 
in El0 Jaggedl°° and wild -type yolk sacs are similar (fig 5.5 a and b). This 
correlates with the observation that yolk sac CFU -Cs were unaffected in Jaggedl°° 
embryos. 
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Figure 5.4: Haematopoietic and endothelial lineages in E10 Jage° embryos 
A: Number of CFU -C per 1 embryo equivalent (ee) from Elf) Jag 1 °1° AGM region 
compared with wild -type and JaglmW` littermates ( * *: p= 0.0095). (No. of embryos 
WT:8, Het:10, KO:6) B: Number of CFU -C per lee El0 YS. (No. of embryos WT:7, 
Het:15, KO:6) C: Number of endothelial progenitors in lee of E l0 AGM region. 
(No. of embryos WT:9, Het:19, KO:8) D: Number of 7ADD- live cells in lee El0 
AGM region. E: Proportion of 7AAD- Ter119- cells: haematopoietic cells (CD45+ 
VECad-); CD45+VECad+ cells ( *: p= 0.0486; * *: p= 0.0042); CD41+CD45+ ECad+ 
cells; and endothelial cells (CD41"CD45-VECad+). Flow cytometry data is a 
cumulative of 3 independent experiments. 
Columns represent Mean±SD. Bars represent Mean. Circles represent individual 
embryos. 
CFU -C: colony forming unit - culture; BFU -E: burst forming unit erythroid; Mac: 
macrophage; GM: granulocyte, macrophage; GEMM: granulocyte, erythroid, 
macrophage, megakaryocyte; Net: network ( >6 main tubules) of endothelial tubules; 
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Figure 5.5: Flow cytometry analysis of E10 yolk sac populations 
A: Number of 7ADD- live cells in lee El0 YS. B: Elf) yolk sac. Proportion of 
7AAD -, Ter119- cells: haematopoietic cells (CD45+VECad -); CD45+VECad+ cells; 
CD41 +CD45 -VECad+ cells; and endothelial cells (CD41- CD45 -VECad +) cells. 
Data is .a cumulative of 2 independent experiments. Bars represent Mean. Circles 
represent individual embryos. 
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5.2.2 Assessment of pre -HSC in E10 Jagged1°/ °AGM region 
Previous analysis of El0 Jaggedl°° embryos showed that GATA2 and Ly -6A 
positive cells were absent from mutant embryos (Robert- Moreno et al. 2008). This 
may suggest that the HSC programme would not be executed if embryos did survive 
to E11.5, when the first HSCs emerge. However, no analysis of pre -HSCs was 
conducted in these mutants. The flow cytometry data in the previous section showed 
that cells with pre -HSC Type I and II phenotype were present in Jaggedl° °AGM 
regions (fig 5.4e). As the presence of the preHSCs in the E10.5 embryo cannot be 
assessed directly by their ability to repopulate irradiated adult mice, and the embryos 
die at this stage, explant culture of El0 AGM regions, to overcome mutant embryo 
lethality, was performed followed by transplantation of the embryonic cells to assess 
the presence of HSC. Six out of nine mice transplanted with mutant cells were 
repopulated, four of them at a high level comparable to the controls. This indicates 
that Jaggedl °° embryos contain pre -HSCs which could mature into HSCs during 
culture (fig 5.6a). Further analysis of these Jaggedl HSCs showed that they can 
contribute to secondary transplantation (fig 5.6b) and that they give rise to myeloid 
and lymphoid lineages (fig 5.6c and table 5.2). Interestingly, after culture, the 
proportion of CFU -Cs produced was quite variable in Jaggedl °° AGM regions 
compared to wild -type or Jaggedl" ° AGM region. Three out of six Jaggedl °° 
explant cultures produced a far higher proportion of CFU -Cs than wild -type or 
Jaggedl"°explants and two of these three results were from explants which did not 
produce HSCs. This implies a role for Jaggedl in CFU -C maintenance or in the 
regulation of HSC differentiation to CFU -Cs. 
Flow cytometry analysis of cells after culture show that Jaggedl AGM regions 
produce far fewer live cells compared to wild -type or Jaggedl`'`° (p= 0.039) (fig 
5.7a) but that the proportion of haematopoietic and endothelial cell types produced 
are similar between wild -type, Jaggedl° and Jaggedl °° (fig 5.7b). This suggests 
that during culture Jaggedl plays role in cell survival and proliferation, a role which 
may also be important in vivo after E10.5. The output of mature endothelial and 
haematopoietic cells remains unaffected. 
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Explant culture of Jaggedl°l° AGM regions showed that pre -HSCs do exist in 
Jaggedl°/° mutants as they can be matured in vitro to HSCs. Not all cultured 
Jaggedl°/° AGM regions produced HSCs and there was a variable CFU -C output 
correlating with a variable penetrance of the Jaggedl Ai° phenotype. A recent paper 
has suggested that in the bone marrow endothelial Jaggedl is important for HSC 
homeostasis and loss of it results in premature HSC exhaustion (Poulos et al. 2013). 
Culture of LSK cells with these Jaggedl-- endothelial cells resulted in a greater 
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Figure 5.6: Explant culture of E10 Jagged1°/ °AGM region. 
A: Wild -type, Jagl°h°` and Jag1m°E10 AGM regions were cultured for 5 or 7 days 
and transplanted into irradiated mice (0.3ee per recipient). The graph represents the 
donor contribution in the peripheral blood 4 month after transplantation. Grey dots 
represent Jag161° Obv embryos. B: Four months after the first transplantation BM 
cells from recipient mice repopulated with wild -type, Jag l mw< and Jag 1 °1 °E 10 AGM 
region cells were harvested and used in a secondary transplantation. The graph 
represents the donor chimerism in the peripheral blood 4 month after the secondary 
transplantation. C: Example of multilineage analysis performed on donor population 
in the bone marrow of mice reconstituted with Jagl" v4 or Jagl°/° cells, showing 
normal contribution to myeloid and lymphoid lineages. D: Proportion of CFU -C per 
10,000 cells after explant culture of Jagl'"v`, Jagl '" and Jagl°/° El() AGM region. 
Arrows indicate the embryos that did not generate HSCs. * indicates Jagl°I° Obv 
embryos. 
Bars represent Median. Column graph: Mean±SD. 
Table 5.2: Multilineage contribution of HSCs produced after explant culture 
Bone Marrow Spleen Thymus 
E10 AGM CD45-2 
CD3- 
8220+ 
CD3+ Gr1- Gr1+ Gr1+ 




CD3+ Gr1- Gr1+ Gr1+ 








Jag1"'^" 58.1 15.2 1.8 7.9 51.5 6.5 88.8 32.1 24.8 28.5 11.3 7.2 98.0 1.2 89.3 7 8 
Jag1"'" 90.0 20.0 4.4 1.8 51.7 12.4 81.0 25.1 50.0 7.8 2.3 5.7 98.0 9.9 80.5 5.7 
Jag1"' 52.2 26.8 3.1 4.7 39.6 9.8 84.4 32.0 11.1 25.0 9.2 5.3 89.5 0.3 96.3 2.8 
Jage' 63.0 54.4 6.7 2.7 16.4 8.6 74.0 29.2 51.9 17.3 1.5 3.3 98.0 6.3 87.1 3.7 
Jagt°'° 45.1 23.5 4.5 7.1 43.9 5.2 88.6 17.3 48.2 18.6 4.2 3.5 62.9 0.3 98.2 1.5 
Jagt°'° 86.0 30.9 3.4 2.8 42.5 7.5 77.0 26.2 49.3 21.7 2.8 2.3 98,0 9.7 80.7 6.1 
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Figure 5.7: Flow cytometry analysis of E10 AGM region after culture. 
A: Number of 7ADD- live cells in lee El0 AGM region after explant culture. ( *: 
p= 0.0339) B: El0 AGM region after explant culture. Proportion of 7AAD"Ter119- 
cells: haematopoietic cells (CD45+VECad "); CD45 +VECad+ cells; CD41 +CD45" 
VECad+ cells; and endothelial cells (CD41- CD45YECad+) cells. 
Data is a cumulative of 3 independent experiments. Bars represent Median. Each 
circle represents an individual explant. 
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In our experiments Jaggedl Ai° AGM regions were cultured in medium shared with 
wild -type or Jaggedl° AGM regions, due to the fact that Jaggedl°° embryos are 
not always distinguishable from wild -type at El O. To determine if soluble factors 
from wild -type or Jaggedl`° explants were masking an effect on Jaggedl loss on 
HSC development, experiments were carried out with only one AGM region explant 
per aliquot of medium. To test this hypothesis, AGM regions from Jaggedl 
embryos were cultured on single membranes. After culture no HSCs were generated 
by JaggedlAIA explants although some repopulation from wild -type and Jagged1"° 
controls was present (fig 5.8a). Flow cytometry analysis of these cells after culture 
show that Jaggedl°" °AGM regions produced far fewer live cells compared to wild - 
type or Jaggedl "° (p= 0.0287) (fig 5.8b). The proportion of haematopoietic cells 
produced by Jaggedl°F° AGM region was also lower, but the proportion of 
endothelial cells was similar between wild -type, Jagged 1° or Jagged l m° AGM 
region (fig 5.7c). After culture the proportion of CFU -Cs produced was quite variable 
in Jagged 1 °!° compared to wild -type or Jagged 1 wii° AGM region. In one experiment 
CFU -Cs were produced in similar proportions but in the second experiment 
Jaggedl°° °AGM regions produced lower proportions of CFU -Cs (fig 5.8d). 
These results suggest that Jaggedl°° pre -HSCs require wild -type or Jaggedl "" 
conditioned medium Jaggedl `° to mature into HSCs. However, in these experiments 
HSC activity in wild -type and Jaggedl°" controls levels of repopulation were lower 
than expected suggesting suboptimal culture which might mask pre -HSC 
development in Jaggedl mutants. Further experiments are required to determine 
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Figure 5.8: Analysis of E10 AGM region after culture without conditioned 
medium. 
A: Wild -type, Jagl6A4 and Jagl°/° E10 AGM regions were cultured for 5 days on a 
single membrane each and transplanted into irradiated mice (0.3ee per recipient). The 
graph represents the donor contribution in the peripheral blood 4 month after 
transplantation. B: Number of 7ADD" live cells in lee El0 AGM region after explant 
culture. ( *: p= 0.0287) C: El0 AGM region after explant culture. Proportion of 
7AAD"Ter119" cells: haematopoietic cells (CD45+VECad "); CD45+VECad+ cells; 
and endothelial cells (CD41 "CD45 VECad+) cells. ( *: p= 0.0298) D: Proportion of 
CFU -C per 10,000 cells after single membrane explant culture of Jagl ̀ '`e A, Jagl °h'` 
and Jagl °i° E l 0 AGM region. 
Data is a cumulative of 2 experiments. Bars represent Median. 
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5.3 Jaggedlf11fiCreERT2 +sGFP+ AGM stromal line 
To address the question of the non -cell autonomous role of Jaggedl in HSC 
development stromal lines were derived from E11.5 Jaggedl flvflCreERT2 +sGFP+ 
E11.5 AGM region. In these cell lines CreERT2 is constitutively expressed by the 
Rosa26 locus and cre recombinase activity is activated by the addition of tamoxifen. 
Once active cre can recombine the Jaggedfl allele to a JaggedlA allele and activate 
constitutive GFP expression by removal the STOP cassette from the sGFP locus. 30 
stromal lines were derived; two of these were preliminarily examined for 
recombination activity. Figure 5.9a shows line V3a. After two days of culture with 
tamoxifen at concentrations of 1µM or 31.1.M the Jaggedl fl loci are almost fully 
recombined. Figure 5.9 shows flow cytometry analysis of Jaggedl and GFP after two 
days (b) and 4 days (c) of culture with tamoxifen at 1µM and 31.1M concentrations. 
Table 5.3 summarises the percentage of GFP+ and Jaggedl- cells and the median PE 
fluorescence as an indicator of the level of Jaggedl staining. After four days' culture 
cells are nearly 100% GFP +. Jaggedl staining is decreased from 100% to 46 %, but 
Jaggedl+ cells persist after Jaggedl gene recombination. Further work is required to 
determine at what stage and in what conditions Jaggedl is fully absent from these 
stromal cell lines. 
Once it is determined by functional analysis which of the stromal cell lines can 
support pre -HSC maturation these lines can be used to assess the effect of the 
absence /down regulation of Jaggedl on pre -HSC maturation. Jaggedl can be down 
regulated or abolished before pre -HSC maturation culture and any observed 
impairment can theoretically be attributed to the absence of Jaggedl in the niche. 
The removal of Jaggedl from the cell line may change its functional abilities 
independently of Jaggedl and careful validation of results must be carried out. For 
example, rescue of pre -HSC maturation through up- regulation of Jaggedl in these 
Jagl deleted cell lines by lentivirus transfection. 
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Figure 5.9: Jagged!"1, CreERT2 +, sGFP+ stromal line after culture with 
tamoxifen. 
A: Southern blot of DNA extracted from OP9 and J1C (Jag 1 fl'fl, CreERT2 +, sGFP +) 
line after 2 days culture with/without tamoxifen. Flow cytometry analysis of GFP 
expression and Jaggedl staining of JC1 line after culture with tamoxifen for B: 2 
days and C: 4 days. Jagged 1 fl: 6.1kb. Jagged 1 A: 2.7kb. Sothern blot performed by 
Mike Stockton. 
Table 5.3: Cell types in stromal cell lines after culture. TX: tamoxifen. 
%GFP %Jagl- PE fluorescence 
Tx (µM) 0 1 3 0 1 3 0 1 3 
2 day 0.5 86.7 87.5 0.3 36.8 31.9 4407 1010 1124 
4 day 3.3 99.4 99.3 0.1 46.4 34.2 5442 235 393 
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5.4 Discussion 
It has previously been described that intra- embryonic haematopoiesis is impaired and 
that the dorsal aorta has multi -stratified endothelium in E10.5 Jaggedl knock -out 
embryos (Robert- Moreno et al. 2008). The results presented in this chapter agree that 
impaired intra- embryonic but undisrupted yolk sac (primitive) haematopoiesis occurs 
in the Jaggedl JA E10 embryos assessed. However, our assessment of the endothelial 
lineage has detected no difference between wild -type and Jaggedl °I° E l 0 embryos in 
regards to endothelial output. As the Jaggedl AI° phenotype has been observed to have 
variable penetrance (own data and Robert- Moreno et al., 2008), the number of 
embryos analysed may not have been sufficient to observe the reported endothelial 
disruption. In addition the strain of mouse used in these experiments was different 
and may not present with aortic endothelial disruption. 
This previous analysis of E10.5 Jaggedl°° embryos also showed that Runxl was 
reduced and that GATA2 and Ly -6A positive cells were absent from Jaggedl °° 
embryos (Robert- Moreno et al. 2008 and own data). These observations suggested 
that HSC development in Jaggedl A/° embryos was impaired, but no direct assessment 
of pre -HSCs or HSC development was carried out. Confirmation of this loss of 
GATA2 and reduction of Runxl in Jagged lA A E10 AGM region is required. Both are 
known to be involved in haematopoietic development (discussed in introduction 
section 1.3.4) and the presence of pre -HSCs in the absence of GATA2 and reduction 
of Runxl contribute to further understanding their involvement in HSC development. 
It has been reported that Notchl"" ES cells do not contribute to the haematopoietic 
system of chimeras indicating a requirement for Notchl in HSC development 
(Hadland et al. 2004). Jaggedl may be as a signal inducer of the Notchl+ cells that 
form definitive HSCs. Previous in situ hybridization showed Jaggedl+Notchl+ cells 
in the El 0.5 dorsal aorta which also express GATA2 (Robert- Moreno et al. 2005) I 
have functionally shown that the Jaggedl +Notch 1+ population in the E11.5 AGM 
region contains pre -HSCs and we hypothesised a cell autonomous role for Jaggedl in 
HSC development through cis -interactions with the Notchl receptor shown 
previously for Notch -Delta (Sprinzak et al. 2010). To determine if Jaggedl is 
required cell -autonomously in HSC development a Jaggedl fl'flCD41- Cre +sGFP+ 
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mouse line was assessed. If Jaggedl was required cell -autonomously in HSC 
development, you would expect that GFP+ cells could not contribute to the HSC 
lineage as GFP is a readout of cre activity. However, results indicated that Jagged1°L° 
cells can contribute normally to the haematopoietic lineage although there are 
limitations to this approach. In this line it has not yet been shown that the Jaggedl 
protein is absent from GFP+ cells before HSC development in the embryo. A study of 
Jaggedl-- ES cell contribution to haematopoietic development in chimeras, one 
similar to that carried out for Notchl, is another approach that could be used in 
determining if Jaggedl'- cells can contribute to the haematopoietic system. 
In further study Jaggedl°° embryos were shown to contain pre -HSCs which can 
mature to HSCs in vitro. However it is not clear whether this in vitro maturation is 
dependent on medium conditioned by wild -type or Jaggedl° AGM regions. If so it 
may indicate that Jaggedl and/or a downstream target of Jaggedl is required for pre - 
HSC to HSC maturation. 
In Jaggedl mutants the haematopoietic phenotype has been shown to be less severe 
than in other Notch mutants (Yoon et al. 2008; Robert- Moreno et al. 2005; Hadland 
et al. 2004; Kumano et al. 2003; Guiu et al. 2013) and pre -HSCs have been shown to 
be present in El0 Jaggedl°° embryos. This suggests that Jaggedl is dispensable in 
the HSC lineage possibly due to its redundancy with other Notch ligands. It has been 
shown that Jaggedl and Delta -like 4 are up- regulated in Jaggedl °° AGM region 
(Robert- Moreno et al. 2008). Some examples of redundancy within the Notch 
signalling system include the synergistic effects seen in: Notchl/Notch4 double 
mutants (Krebs et al. 2000); Heyl/Hey2 double mutants (Fischer et al. 2004); and 
Hesl/Hes5 double mutants (Guiu et al. 2013). There is also the possibility a 
redundancy of aortic haematopoietic development with haematopoietic development 
that takes place in the sub -aortic patches (SAPs). It has been shown that loss of 
function of all Notch ligands, through the deletion of Mind bomb -1, results in loss of 
intra- embryonic haematopoiesis (Koo et al. 2007; Yoon et al. 2008). However, 
targeted deletion of Mind bomb -1 in the aortic endothelium only results only in a 
reduction of intra- embryonic haematopoiesis (Yoon et al. 2008) suggesting a site for 
intra- embryonic haematopoiesis outside the aortic endothelium. It has also been 
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shown that pre -HSCs are localised to the aortic luminal endothelium and sub - 
endothelial layers (Rybtsov et al. 2011; de Bruijn et al. 2002; Bertrand et al. 2005). 
Taken together these reports suggest that pre -HSCs are produced in both the SAPs 
and aortic endothelium. As D111 is the Notch ligand mainly expressed in the SAPs, 
haematopoietic development at this site would be undisrupted in Jaggedl knock -outs 
(Yoon et al. 2008). As HSCs are only found in luminal endothelium of the dorsal 
aorta (Rybtsov et al. 2011) this suggest that final pre -HSC to HSC maturation occurs 
here. If this is true, it may correlate with the possibility that Jaggedl is required for 
the pre -HSC to HSC maturation. 
The Jagged1fl, CreERT2, sGFP stromal lines produced provide a valuable tool, in 
conjunction with the co- aggregate system, to assess the effect of Jaggedl 
manipulation on pre -HSCs. In conclusion it has been shown that Jaggedl is not an 
essential factor for pre -HSC production and further studies are required to better 
understand its role in HSC development. 
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6 Summary and Perspectives 
The emergence of the first definitive HSCs during development is a complicated 
process, the study of which is compounded by many factors some of which include: 
the mobile nature of haematopoietic cells; the multiple sites of haematopoietic 
development; the soluble factors involved; and the small number of pre -HSCs and 
HSCs. The Notch signalling pathway is itself quite complex. Redundancy between 
receptors and between ligands has been shown, as well as cross talk with other 
signalling pathways (e.g. Wnt signalling). Even though there has been a significant 
amount of work carried out on the role of Notch signalling in haematopoietic 
development it is still unclear at what stage and in which cell types Notch signalling 
is important. For this reason, a large part of this work was to better characterise the 
expression of Notchl and Jaggedl during haematopoietic development, two 
components of the Notch signalling pathway shown to have a role in embryonic 
haematopoiesis. To achieve this I produced a Jaggedl reporter line which allowed us 
to determine that pre -HSCs in the E11.5 AGM region are Notchl +Jaggedl +. This 
information could provide a useful enrichment strategy for pre -HSCs and, pending 
further study, be used to distinguish functional pre -HSCs in the AGM region from 
phenotypically defined pre -HSCs in other tissues. The detailed study of Notchl 
expression in the developing haematopoietic system has shown that as a marker on 
its own Notchl does not define a particular HSC developmental stage and is 
expressed throughout HSC development. It is however expressed most highly by 
endothelial and early pre -HSC Type I cells coinciding with a possible role for Notch 
signalling in endothelial to haematopoietic transition. 
The other part of this project focused on the role of Jaggedl during HSC 
development. Although it was clearly shown that Jaggedl has a role during 
haematopoietic development, as Jaggedl mutant embryos contain few infra- 
embryonic progenitors, its role during HSC development had never been elucidated. 
My results show for the first time that Jaggedl is dispensable for pre -HSC formation 
during embryonic development. 
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Future questions that need to be addressed include: 
Is Jaggedl involved in the maturation of pre -HSC into HSCs? In vitro we 
showed that pre -HSCs are present in Jaggedl embryos. However some 
redundancy with other ligands or other signalling pathways could overcome 
the absence of Jaggedl. A better characterisation of the cultured Jaggedi ' 
AGM region has to be performed to analyse the expression of other ligands 
(D114, Dlll, Jag2) and other factors which may support pre -HSC to HSC 
maturation. 
Does Jaggedl play a role cell -autonomously or non -cell autonomously in 
HSC formation? My results show that Jaggedl is expressed in pre -HSCs but 
also in endothelial cells /other stromal cells in AGM region. To determine the 
site of haematopoietic involvement of Jaggedl, we started to use a 
conditional approach where Jaggedl was deleted specifically in the HSC 
lineage using a CD41 -Cre line. The preliminary results suggest that HSC can 
develop when Jaggedl is deleted cell -autonomously in Jaggedlm1CD41 -Cre+ 
mice. I also generated stromal cell lines in which Jaggedl can be deleted in 
an inducible manner. This line will be used to assess the role of Jaggedl 
expression in the niche of the pre -HSCs. 
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Figure 7.1: Isotype Controls. 
For A1488, A1647, V450 and PE control for A: E11.5 AGM region B: E11.5 YS and 
C: Co-aggregate after culture. For A1488, A1647, V500, BV421, PerCP_Cy5.5 E: 
E11.5 AGM region F: E11.5 YS 
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7.2 Confocal Sections Controls 
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Figure 6.4: Confocal Sections Jaggedl and dtTomato staining controls. 
E11.5 Neural Tube 40x. Top row Jaggedlwt/Tom bottom row Jaggedlwt /wt 
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Figure 6.5: Confocal wholemount staining controls. E11.5 Embryo 20x. 
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7.4 Purity of Sorted Cells 
Table 6.1: Percentage of cells not in other gate. N1: Notchl; J1: Jaggedl. 











I N1- I N1+ II N1- II N1+ 
FM37 99 97.1 99 87.9 
E11.5 pre-HSC FM41 N/A 98 99 90.7 
FM43 N/A N/A N/A N/A 
NI- Nilo Ne" 
FM32 N/A N/A N/A 
FM39 99 86 90 
E11.5 Direct FM42 96 88 82.8 
Expl 98.2 93.8 94.7 
Exp2 98.7 88.6 98.1 
J1+ N1- J1- N1+ J1- N1- J1+ N1+ 
FM50 79.2 81.2 98.5 62.6 
Jaggedlwrim`" E11.5 FM52 N/A N/A N/A N/A 
FM56 81.1 80.5 97.2 69.2 
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